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   I	  
AMBRA1,	  autophagy/beclin-­‐1	  regulator	  1	  
ATG,	  autophagy	  related	  proteins	  
ATG5,	  autophagy	  related	  5	  
ATG7,	  autophagy	  related	  7	  
ATG14,	  autophagy	  related	  14	  
ATGMOs,	  translation	  blocking	  morpholinos	  
Baf	  A1,	  bafilomycin	  A1	  
BCL2,	  B-­‐cell	  CLL/lymphoma	  2	  
BECN1,	  beclin	  1,	  autophagy	  related	  
B.	  schlosseri,	  Botryllus	  schlosseri	  	  
cDNA,	  complementary	  DNA;	  	  
chd,	  chordin	  
chrm4,	  cholinergic	  receptor,	  muscarinic	  4	  
C.	  intestinalis,	  Ciona	  intestinalis	  	  
CNS,	  central	  nervous	  system	  
D.	  rerio,	  Danio	  rerio	  
dpf,	  days	  post	  fertilisation	  
DIG,	  digoxigenin	  
dgkz,	  diacylglycerol	  kinase,	  zeta	  
DLCs,	  dynein	  light	  chains	  	  
DYNLL1,	  dynein,	  light	  chain,	  LC8-­‐type	  1	  
EGFP,	  Enhanced	  Green	  Fluorescent	  Protein	  
ER,	  endoplasmic	  reticulum	  
EST,	  Expressed	  Sequence	  Tags	  
gsc,	  goosecoid	  homeobox	  	  
hpf,	  hours	  post	  fertilisation	  
IDPs,	  Intrinsically	  Disordered	  Proteins	  
KIAA0226,	  RUBICON/RUN	  domain	  and	  cysteine-­‐rich	  domain	  containing,	  Beclin	  1-­‐interacting	  
protein	  
MAP1LC3/LC3,	  microtubule-­‐associated	  protein	  1A/1B-­‐light	  chain	  3	  
mdk,	  midkine	  (neurite	  growth-­‐promoting	  factor	  2)	  
MISMMO,	  five-­‐nucleotide-­‐mismatched	  MOs	  
MOs,	  morpholinos;	  	  
mRNA,	  messenger	  RNA	  
NBT/BCIP,	  5-­‐nitro-­‐blue	  tetrazolium	  chloride/bromo-­‐4-­‐chloro-­‐3'-­‐indolyphosphate	  p-­‐toluidine	  
salt	  
ORF,	  open	  reading	  frame	  
PBS,	  phosphate-­‐buffered	  saline	  
PCR,	  polymerase	  chain	  reaction	  
PFA,	  paraformaldehyde	  
	  





PIK3C3,	  phosphatidylinositol	  3-­‐kinase,	  catalytic	  subunit	  type	  3	  
PIK3R4/Vps15/p150,	  phosphoinositide-­‐3-­‐kinase,	  regulatory	  subunit	  4	  
qPCR,	  real	  time-­‐polymerase	  chain	  reaction	  
RACE,	  rapid	  amplification	  of	  cDNA	  ends	  
RT-­‐PCR,	  reverse	  transcriptase-­‐polymerase	  chain	  reaction	  
SEM,	  scanning	  electron	  microscopy	  
S.E.M.,	  standard	  error	  of	  the	  mean	  	  
SL,	  splice	  leader	  sequence.	  
shha,	  sonic	  hedgehog	  a	  
SH3GLB1,	  SH3-­‐domain	  GRB2-­‐like	  endophilin	  B1	  
SPLICMOs,	  splicing	  blocking	  morpholinos	  
TP53,	  tumor	  protein	  p53	  
TUNEL,	   terminal	  deoxynucleotidyl	   transferase-­‐mediated	   fluorescein-­‐dUTP	  nick	  end	   labeling	  
assay	  
UVRAG,	  UV	  radiation	  resistance	  associated	  
WMISH,	  Whole	  Mount	  In	  Situ	  Hybridization	  




















	   III	  
The	   study	   of	   autophagy	   is	   a	   new	   research	   field	   that	   has	   recently	   obtained	   great	  
attention	   due	   to	   the	   involvement	   of	   autophagy	   in	   several	   developmental	   and	  
pathophysiological	   processes.	   In	   the	   last	   years,	   zebrafish	   has	   become	   a	   powerful	   model	  
organism	  to	  study	  the	  genes	  that	  play	  important	  roles	  during	  development,	  and	  thus,	  in	  this	  
project,	  I	  used	  a	  reverse	  genetics	  approach	  and	  the	  zebrafish	  as	  a	  model	  organism	  to	  study	  
the	   role	   and	   the	   functions	   of	   Ambra1,	   a	   key	   protein	   involved	   in	   the	   early	   steps	   of	  
autophagosome	  formation.	  Ambra1-­‐deficient	  mice	  are	  embryonic	   lethal,	  and	  show	  defects	  
in	  the	  central	  nervous	  system,	  with	  hyperproliferation	  of	  the	  neuroepithelium,	  exencephaly	  
and	  imperfect	  closure	  of	  the	  neural	  tube,	  thus	  suggesting	  that,	  in	  mouse,	  Ambra1	  is	  crucial	  
for	  the	  proper	  nervous	  system	  development.	  	  
In	  Chapter	  I,	  it	  is	  described	  the	  identification	  and	  characterization	  of	  the	  two	  paralogous	  
genes,	  ambra1a	  and	  ambra1b,	  which	  encode	  the	  two	  isoforms	  of	  this	  protein	   in	  zebrafish.	  
Transcripts	  of	  both	  genes	  are	  present	  as	  maternal	  RNAs	  in	  the	  early	  stages	  of	  development,	  
while	  afterwards	  they	  are	  mainly	  localized	  in	  the	  head,	  suggesting	  a	  potential	  role	  for	  these	  
proteins	  in	  the	  development	  of	  the	  central	  nervous	  system	  also	  in	  zebrafish.	  The	  knockdown	  
of	   both	   proteins	   is	   associated	   with	   severe	   developmental	   abnormalities,	   early	   embryonic	  
lethality	  and	  impairment	  of	  the	  autophagic	  process.	  Moreover,	  the	  results	  obtained	  suggest	  
the	   possible	   acquisition	   of	   specific	   functions	   by	   the	   two	   paralogous	   genes	   that	   are	   both	  
required	  during	  development	  and	  do	  not	  compensate	  each	  other	  following	  knockdown.	  
In	   Chapter	   II	   the	   possibility	   that,	   also	   in	   zebrafish,	   the	   functional	   silencing	   of	   Ambra1	  
could	   lead	   to	   uncontrolled	   cell	   proliferation	   was	   confirmed	   by	   Phospho-­‐Histone-­‐H3	  
immunohistochemistry	   in	   both	   ambra1	   zebrafish	   morphants.	   Moreover,	   the	   cell-­‐
autonomous	   capability	   of	   Ambra1-­‐depleted	   cells	   to	   hyperproliferate	   was	   analysed	   by	  
transplantation	   experiments	   that	   showed	   a	   higher	   proliferation	   rate	   in	   ambra1a	   and	  
ambra1b	  chimeras	  with	  respect	  to	  controls.	  	  
Chapter	  III	  describes	  involvement	  of	  Ambra1a	  and	  Ambra1b	  on	  zebrafish	  skeletal	  muscle	  
development	  and	  compares	  the	  phenotype	  of	  zebrafish	  ambra1-­‐depleted	  embryos	  with	  that	  
of	   Ambra1gt/gt	  mouse	   embryos.	  Morphological	   analysis	   of	   morphant	   embryos	   reveals	   that	  
the	   silencing	  of	  ambra1	   impairs	   locomotor	  activity	  and	  muscle	  development.	  More	   severe	  
phenotypes	  are	  obtained	  by	  knockdown	  of	  maternal	  transcripts,	  therefore,	  underlining	  the	  
role	  of	  these	  proteins	  during	  development.	  
Finally,	   Chapter	   IV	   reports	   the	   cloning	   and	   characterization	  of	  ambra1	   in	   the	   tunicate	  
Botryllus	  schlosseri,	  a	  model	  species	  of	  a	  colonial	  ascidian.	  This	  is	  the	  first	  characterization	  of	  
ambra1	   transcripts	   in	   a	   non-­‐vertebrate	   organism.	   The	   deduced	   amino	   acid	   sequence	   is	  
shorter	   then	   vertebrate	   Ambra1	   proteins	   but	   still	   contains	   the	   WD40	   domain	   as	   well	   as	  
other	  amino	  acid	  residues	  that	  are	   important	  for	  polyubiquitination	  or	  caspase	  cleavage	  of	  
the	   protein.	   However,	   the	  B.	   schlosseri	  protein	   lacks	   other	   important	   domain	   such	   as	   the	  
DLC1-­‐binding	   consensus	  motifs	   (TQT)	   that,	   in	   vertebrates,	   docks	   the	  protein	   at	   its	   specific	  






Lo	  studio	  dell’autofagia	  costituisce	  un	  campo	  di	  ricerca	  che	  ha	  recentemente	  ottenuto	  
una	   notevole	   attenzione	   grazie	   al	   coinvolgimento	   che	   questo	   processo	   sembra	   avere	   sia	  
durante	  lo	  sviluppo	  sia	  nella	  vita	  adulta,	  in	  numerose	  condizioni	  fisiologiche	  e	  patologiche.	  	  
In	   questo	   progetto	   di	   ricerca	   ho	   utilizzato	   lo	   zebrafish	   come	   organismo	   modello	   e	  
applicato	  un	  approccio	  di	  genetica	  inversa	  per	  la	  caratterizzazione	  e	  lo	  studio	  delle	  funzioni	  
di	   Ambra	   1,	   una	   proteina	   chiave	   coinvolta	   nelle	   fasi	   iniziali	   di	   formazione	   della	   vescicola	  
autofagosomica.	   Nel	   topo,	   il	   silenziamento	   di	   Ambra1	   porta	   non	   solo	   ad	   una	   riduzione	  
dell’attività	   autofagica	  ma	   anche	   a	   letalità	   embrionale	   e	   al	   mancato	   sviluppo	   del	   sistema	  
nervoso	  centrale.	  Gli	  embrioni	  presentano	  iperproliferazione	  del	  neuroepitelio,	  esencefalia	  e	  
chiusura	  imperfetta	  del	  tubo	  neurale,	  risultati	  che	  suggeriscono	  un	  ruolo	  cruciale	  di	  Ambra1	  
per	  un	  corretto	  sviluppo	  del	  sistema	  nervoso.	  	  
La	  tesi	  è	  stata	  divisa	   in	  quattro	  capitoli,	   il	  primo	  dei	  quali	  descrive	  l’identificazione	  e	  la	  
caratterizzazione	   dei	   due	   geni	   paraloghi	   ambra1a	   e	   ambra1b,	   che	   codificano	   per	   le	   due	  
isoforme	   di	   questa	   proteina	   presenti	   nello	   zebrafish.	   I	   trascritti	   di	   entrambi	   i	   geni	   sono	  
presenti,	  nell’ovocita	  e	  durante	  le	  prime	  ore	  dello	  sviluppo,	  come	  mRNA	  materno	  mentre	  a	  
stadi	  successivi	  i	  trascritti	  materni	  vengono	  degradati	  e	  sostituiti	  da	  quelli	  embrionali.	  Questi	  
si	   localizzano	  prevalentemente	   a	   livello	   cefalico	   suggerendo	  un	  potenziale	   ruolo	   di	   queste	  
proteine	   anche	   nello	   sviluppo	   del	   sistema	   nervoso	   centrale	   dello	   zebrafish.	   Gli	   embrioni	  
ottenuti	   dopo	   silenziamento	   delle	   due	   proteine	   presentano	   letalità	   a	   stadi	   di	   sviluppo	  
precoci,	  numerose	  alterazioni	  morfologiche	  e	  una	  rilevante	  riduzione	  dell’attività	  autofagica.	  
Inoltre,	   i	   risultati	   ottenuti	   suggeriscono	   la	   possibile	   acquisizione	   di	   funzioni	   specifiche	   da	  
parte	  dei	  due	  geni	  paraloghi,	  geni	  che	  sono	  entrambi	  necessari	  per	  uno	  sviluppo	  corretto	  e	  
che	  non	  si	  compensano	  uno	  con	  l’altro	  in	  seguito	  al	  silenziamento.	  
Nel	   Capitolo	   II	   è	   stato	   confermato,	   mediante	   colorazione	   immunoistochimica	   per	  
l’istone	   H3	   fosforilato,	   che	   il	   silenziamento	   di	   entrambi	   i	   geni	   porta	   ad	   un	   aumento	   della	  
proliferazione	   cellulare.	   Inoltre,	   è	   stato	   dimostrato,	   mediante	   esperimenti	   di	   trapianto	  
cellulare,	   che	   cellule	   prive	   di	   Ambra1	   sono	   in	   grado	   di	   iperproliferare	   in	  maniera	   cellulo-­‐
autonoma.	   E’	   stata,	   infatti,	   osservata	   una	  maggiore	   proliferazione	   cellulare	   nelle	   chimere	  
ambra1a	  e	  ambra1b	  rispetto	  ai	  controlli.	  	  
Il	   Capitolo	   III	   descrive	   il	   coinvolgimento	   di	   Ambra1a	   e	   Ambra1b	   nello	   sviluppo	   del	  
muscolo	  scheletrico	  di	  zebrafish	  e	  compara	  la	  morfologia	  di	  questo	  tessuto	  nei	  morfanti	  per	  
Ambra1a	  e	  Ambra1b	  e	  negli	  embrioni	  di	  topo	  Ambra1gt/gt,	  nei	  quali	  è	  stato	  inattivato	  il	  gene	  
per	   Ambra1.	   In	   entrambi	   i	   casi	   lo	   sviluppo	   del	   tessuto	   muscolare	   è	   chiaramente	  
compromesso.	   Fenotipi	   più	   gravi	   sono	   ottenuti	   dal	   silenziamento	   dei	   trascritti	   materni,	  
sottolineando	   così	   il	   ruolo	   fondamentale	   di	   queste	   proteine	   durante	   le	   prime	   fasi	   dello	  
sviluppo	  embrionale.	  
Infine,	   il	  Capitolo	   IV	  descrive	   il	   clonaggio	  e	   la	  caratterizzazione	  di	   ambra1	  nel	   tunicato	  
Botryllus	   schlosseri,	   una	   specie	   modello	   di	   ascidia	   coloniale.	   Si	   tratta	   della	   prima	  
caratterizzazione	   di	   trascritti	   ambra1	   in	   un	   organismo	   non-­‐vertebrato.	   La	   sequenza	  
amminoacidica	  dedotta	  è	  più	  corta	  rispetto	  alle	  proteine	  Ambra1	  dei	  vertebrati,	  ma	  contiene	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   V	  
sia	  il	  dominio	  WD40,	  tipico	  di	  questa	  proteina,	  che	  altri	  residui	  amminoacidici	  importanti	  per	  
la	   poliubiquitinazione	  e	  per	   il	   taglio	  proteolitico	   catalizzato	  dalle	   caspasi.	   La	  proteina	  di	  B.	  
schlosseri	  è	  però	  priva	  di	  altri	  domini	  importanti	  quali	  il	  motivo	  di	  consenso	  per	  il	  legame	  alla	  
dineina	  che,	  nei	  vertebrati,	  lega	  la	  proteina	  al	  suo	  specifico	  sito	  citoscheletrico	  in	  assenza	  di	  
induzione	  del	  processo	  autofagico.	  L’espressione	  di	  questo	  gene	  è	  stata	  verificata	  nei	  diversi	  





	   1	  
AUTOPHAGY	  
Autophagy	  is	  an	  evolutionary	  conserved	  self-­‐degradative	  process	  by	  which	  cells	  degrade	  
and	   recycle,	   using	   the	   lysosomal	   machinery,	   various	   cellular	   constituents,	   including	  
misfolded	   proteins	   and	   protein	   aggregates,	   lipids,	   intracellular	   pathogens	   and	   damaged	  
organelles.	  
This	   process	   is	   crucial	   to	   maintain	   cellular	   homeostasis	   and	   represents	   an	   adaptive	  
response	  to	  different	  stress	  stimuli,	  such	  as	  nutrient	  deprivation	  or	  cell	  damage.	  It	  has	  been	  
demonstrated	   that	   autophagy	   plays	   important	   roles	   during	   embryo	   development	   and	  
cellular	   differentiation	   [1,	   2],	   normal	   physiology	   and	   survival	   during	   starvation	   and	   ageing	  
[3].	  Failure	  to	  remove	  aggregates	  of	  damaged	  toxic	  proteins	  could	  explain	  why	  autophagy	  is	  
involved	   in	   several	   human	   disorders	   such	   as	   inflammatory	   diseases	   [4],	   and	  
neurodegenerative	   conditions	   including	   Huntington’s	   disease,	   Parkinson’s	   disease,	  
amyotrophic	  lateral	  sclerosis	  and	  Alzheimer’s	  disease	  [5].	  Autophagy	  has	  also	  been	  identified	  
as	   a	   critical	   process	   in	   oncogenesis	   and	   cancer	   progression	   [6,	   7].	   The	   early	   stages	   of	  
oncogenesis	  are	  associated	  with	  down-­‐regulation	  of	  autophagy-­‐related	  genes	  and	  several	  of	  
these,	   such	   as	   Beclin	   1,	   Bif-­‐1,	   Atg4C,	   and	   UVRAG,	   have	   been	   found	   to	   possess	   tumor	  
suppressor	  activity.	  By	   contrast,	   in	   later	   stages	  of	   tumorigenesis,	   autophagy	   could	  provide	  
cancer	   cells	   with	   a	   survival	   strategy	   under	   unsuitable	   conditions,	   like	   nutrient	   shortage,	  
chemotherapy	  or	   irradiation,	   therefore,	  acting	   in	  a	   tumor	  promoting	  way.	   Finally,	   in	   some	  
congenital	   muscular	   dystrophies	   the	   increase	   of	   dysfunctional	   mitochondria	   and	   the	  
subsequent	   loss	  or	  damage	  of	  muscle	  fibers	  were	  found	  to	  be	   linked	  to	  a	  misregulation	  of	  
the	  autophagic	  process	  [8].	  	  
There	   are	   three	   major	   forms	   of	   autophagy:	   macroautophagy,	   usually	   referred	   as	  
“autophagy”,	   chaperone-­‐mediated	   autophagy	   (CMA)	   and	   microautophagy,	   working	   with	  
different	  cellular	  mechanisms	  and	  playing	  distinctive	  functions	  [9].	  	  
CMA	   is	   a	   selective	   form	   of	   autophagy	   that,	   to	   date,	   has	   been	   reported	   only	   in	  
mammalian	  cells	  [10].	  In	  this	  process	  the	  soluble	  cytosolic	  proteins	  containing	  a	  KFERQ-­‐like	  
sequence	  motif	  are	  recognized	  by	  a	  cytosolic	  chaperone	  complex,	  containing	  the	  heat	  shock	  
cognate	   protein	   of	   70	   kDa	   (Figure	   1).	   The	   complex	   then	   associates	   directly	   with	   the	  
lysosomal	  membrane	  receptor	  Lamp2	  that	  mediates,	  with	  the	  help	  of	  a	  second	  chaperone,	  
translocation	   of	   the	   substrate	   proteins	   into	   the	   lysosomal	   lumen	   with	   subsequent	  
degradation	  by	  lysosomal	  hydrolases	  [10].	  	  




Figure	  1. Schematic	  diagram	  illustrating	  three	  main	  types	  of	  autophagy	  in	  mammalian	  cells:	  macroautophagy,	  
microautophagy	  and	  chaperone-­‐mediated	  autophagy	  (CMA).	  Figure	  modified	  from	  [11].	  
In	   microautophagy,	   cytosolic	   contents	   are	   directly	   engulfed	   by	   invagination	   at	   the	  
lysosomal	  membrane	  itself,	  without	  the	  formation	  of	  autophagosomes	  [12].	  	  
Macroautophagy	   is	   the	   process	   where	   portions	   of	   cytoplasm	   containing	   long-­‐lived	  
proteins	   and	   damaged	   organelles	   are	   isolated	   in	   a	   double	   membrane	   vesicle	   called	  
autophagosome	   [13].	   The	   autophagosomes	   fuse	   with	   the	   lysosomes,	   thereby	   forming	  
autolysosomes,	  where	   lysosomal	   enzymes	  work	   on	   the	   degradation	   of	   cytosolic	   contents.	  
The	  process	  consists	  of	  a	  cascade	  of	  steps	  that	  are	  finely	  regulated	  and	  relies	  upon	  a	  specific	  
subset	  of	  AuTophaGy-­‐related	  (Atg)	  genes	  first	  identified	  in	  yeast	  [14].	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Autophagy	  induction	  
The	   target	   of	   rapamycin,	  mTOR,	   is	   a	   serine/threonine	   protein	   kinase	   that	   plays	   a	   key	  
role	  in	  the	  induction	  of	  autophagy	  and	  regulation	  of	  cell	  growth	  [15].	  This	  protein	  is	  able	  to	  
respond	   and	   integrate	   different	   signals	   including	   nutrient	   availability,	   presence	   of	   growth	  
factors,	  hypoxia	  and	  stress	  stimuli.	  In	  mammalian	  cells	  mTOR	  forms	  two	  functionally	  distinct	  
protein	   complexes:	   the	   complex	   mTORC1	   who	   plays	   a	   major	   role	   in	   the	   regulation	   of	  
autophagy	   and	   the	   complex	   mTORC2.	   In	   the	   presence	   of	   nutrients	   or	   growth	   factors,	  
mTORC1	   blocks	   the	   autophagic	   process,	   by	   means	   of	   its	   association	   with	   the	   ULK1/2	  
complex	   (see	   later)	   and	  phosphorylation	  of	   the	  Atg13	  protein	   [15].	  mTORC2	   is	   involved	   in	  
skeletal	  muscle	  autophagy	  regulation	  in	  fasting	  condition	  via	  the	  Akt-­‐FoxO3	  pathway	  [16].	  
Initiation	  and	  nucleation	  of	  autophagosome	  	  
Autophagosome	   formation	   starts	   at	   the	   phagophore	   (autophagosome	   precursor,	   also	  
defined	   as	   pre-­‐autophagosomal	   structures)	   assembly	   sites	   (PAS)	   (Figure	   2).	   As	   regards	   to	  
membrane	   source,	   it	   has	   been	   hypothesized	   that	   autophagosomes	   could	   originate	   from	  
intracellular	  membrane	  structures	  like	  the	  endoplasmic	  reticulum	  [17].	  	  
The	   autophagosome	   initiation	   requires	   the	   ULK1	   complex	   (Atg1	   in	   yeast)	   that	   is	  
negatively	   regulated	   by	  mTORC1.	   In	   the	   absence	   of	   nutrient	   or	   growth	   factor	  mTORC1	   is	  
inactivated	  and	  dissociates	  from	  the	  ULK1/2	  complex	  that	  is	  composed	  also	  by	  FIP200,	  Atg13	  
and	  Atg101.	  ULK1/2	  complex	  is	  then	  activated	  and	  can	  move	  to	  the	  endoplasmic	  reticulum.	  
Here	  the	  complex	  regulates	  the	  activity	  of	  Beclin1	  (homologue	  of	  Atg6)	  complex	  that	  recruits	  
the	   class	   III	   phosphoinositol-­‐3-­‐kinase	   Vps34	   (Vacuolar	   protein	   sorting	   34)	   to	   produce	  
phosphatidylinositol-­‐3-­‐phosphate	  (PtdIns(3)P),	  a	  component	  that	  is	  crucial	  to	  the	  elongating	  
phagophore.	   This	   activity	   is	   coordinated	   by	   the	   interaction	   of	   Beclin	   1	  with	   several	   other	  
proteins	  such	  as	  p150,	  a	  homologue	  of	  Vps15,	  Atg14L	  or	  Barkor,	  a	  homologue	  of	  Atg14	  and	  
AMBRA1	  [18].	  The	  PtdIns(3)Ps	  recruit	  at	  the	  membrane	  the	  double	  FYVE-­‐containing	  protein	  
1	  (DFCP1)	  and	  other	  proteins	  [18],	  and	  the	  complex	  accumulate	  in	  specific	  structures	  of	  the	  
ER	  named	  omegasome	  for	  their	  Ω-like	  form.	  	  
Autophagosome	  elongation	  	  
The	   elongation	   of	   the	   phagophore	   to	   form	   the	   omegasome	   is	   mediated	   by	   two	  
ubiquitin-­‐like	   conjugation	   systems	   that	   together	   promote	   the	   assembly	   of	   the	   ATG16L	  
complex	   and	   the	   processing	   of	   LC3.	   The	   first	   ubiquitylation-­‐like	   reaction	   in	   autophagy	  
process	  involves	  ATG5	  and	  ATG12	  [19].	  ATG12	  is	  covalently	  tagged	  to	  ATG5	  in	  a	  conjugation	  
reaction	  catalyzed	  by	   two	  additional	  proteins,	  ATG7	   [ubiquitin	  activating-­‐enzyme	   (E1)	   like]	  
and	  ATG10	  [ubiquitin-­‐conjugating-­‐enzyme	  (E2)	  like]	  [20].	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The	   second	   ubiquitylation-­‐like	   reaction	   requires	   the	   conjugation	   of	   the	   soluble	  
cytoplasmic	  protein,	  Atg8	  (LC3	  in	  mammals)	  with	  a	  lipid	  phosphatidylethanolamine	  (PE).	  LC3	  
is	   cleaved	   by	   the	   protease	   Atg4	   [21],	   resulting	   in	   the	   cytosolic	   isoform	   LC3-­‐I.	   LC3-­‐I	   is	  
conjugated	   to	   phosphatidiletanolamine	   (PE)	   in	   a	   reaction	   that	   requires	   Atg7	   and	   Atg3	   to	  
form	   LC3-­‐II	   [22].	   LC3-­‐II	   levels	   correlate	  with	   autophagic	   vacuole	   number	   that	  makes	   it	   an	  
excellent	  marker	  for	  studying	  autophagy	  [23].	  
Figure	  2.	  Schematic	  representation	  of	  autophagosome	  formation.	  mTOR	  complex	  1	  (mTORC1)	  blocks	  the	  ULK1	  
(Atg1	   homolog)	   complex	   under	   nutrient-­‐rich	   conditions.	   Upon	   autophagy	   induction,	   the	   ULK1	   complex	  
(including	   ULK1,	   Atg13,	   FIP200,	   and	   Atg101)	   is	   activated	   and	   translocates	   to	   a	   certain	   domain	   of	   the	  
endoplasmic	   reticulum	   (ER).	   Once	   in	   the	   ER,	   the	   ULK1	   complex	   regulates	   the	   class	   III	   phosphatidylinositol	  
(PtdIns)	   3-­‐kinase	   complex	   (including	   Beclin	   1,	   Atg14(L)/barkor,	   Vps15,	   Vps34,	   and	   Ambra1).	   Recruitment	   of	  
Beclin	  1	  to	  the	  PtdIns3-­‐kinase	  complex	   is	  also	  sensitive	  to	  starvation.	  Formation	  of	  PtdIns(3)P	  recruits	  double	  
FYVE-­‐containing	   protein	   1	   (DFCP1)	   and	   promotes	   the	   formation	   of	   the	   omegasome,	   from	   which	  
autophagosomes	   appear	   to	   be	   generated.	   The	   Atg12–Atg5–Atg16L1	   complex	   and	   the	   LC3	   (Atg8	   homolog)–
phosphatidylethanolamine	   (PE)	   conjugate	  play	   important	   roles	   in	   the	  elongation	  and	  closure	  of	   the	   isolation	  
membrane.	  The	  Atg12–Atg5	  Atg16L1	  complex	  is	  also	  required	  for	  formation	  of	  the	  covalent	  bond	  between	  LC3	  
and	  PE.	  	  Figure	  modified	  from	  [18].	  	  
Autophagosome	  maturation	  and	  fusion	  
Mature	   autophagosomes	  move	   along	  microtubules	   in	   a	   dynein-­‐dependent	  manner	   to	  
vacuoles	   (yeasts)	  or	   to	   lysosomes	   (mammals)	   clustered	  around	   the	  microtubule-­‐organizing	  
center	  (MTOC).	  Before	  they	  merge	  with	  a	  lysosome,	  the	  autophagosome	  may	  merge	  with	  an	  
endosome,	   forming	   an	   anfisoma.	   The	   breakdown	   of	   the	   autophagic	   body	   results	   in	   the	  
release	  of	  the	  load	  within	  the	  lumen,	  where	  the	  cytoplasmic	  components	  are	  degraded.	  The	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AMBRA1	  	  
AMBRA1	   (activating	   molecule	   in	   Beclin1-­‐regulated	   autophagy)	   is	   a	   highly	   conserved	  
large	  protein	  (approximately	  1300	  amino	  acids)	  that	  presents	  a	  WD40	  domain	  at	   its	  amino	  
terminus	  [25].	  	  
This	  protein	  is	  expressed	  at	  high	  level	  in	  the	  mouse	  developing	  brain	  [25]	  and,	  in	  adult,	  
in	   brain	   compartments,	   such	   as	   the	   hippocampus,	   cerebellum	   and	   striatum,	  which	   are	   all	  
severely	   affected	   in	   neurodegenerative	   conditions	   [26].	   According	   to	   this,	   during	   mouse	  
embryogenesis,	   Ambra1	   has	   shown	   to	   be	   crucial	   for	   the	   proper	   nervous	   system	  
development	   (Figure	   3).	   This	   was	   demonstrated	   by	   mouse	   Ambra1	   knockout,	   an	  
experimental	  approach	  that	  produces	  early	  embryonic	  lethality,	  severe	  abnormalities	  in	  the	  
neural	  tube	  development,	  uncontrolled	  cell	  proliferation	  and	  excessive	  cell	  death	  [25].	  
Figure	  3.	  Neural	  tube	  defects	   in	  Ambra1	  mutant	  embryos.	  Analysis	  of	  cell	  proliferation	  in	  wild-­‐type	  (q,	  s)	  and	  
Ambra1gt/gt	   (r,	  t)	  embryos	  on	  transverse	  sections	  of	  E8.5	  cephalic	  neural	  folds	   in	  prospective	  hindbrain	  region	  
(mitoses,	  arrows	   in	  q,	   r)	  and	  on	  sagittal	   sections	  of	  E10.5	   forebrain	   (BrdU	  uptake,	   s,	   t).	  TUNEL	   (TdTmediated	  
dUTP	   nick	   end	   labelling)	   staining	   of	   E10.5	   brain	   (m,	   n)	   and	   E9.5	   spinal	   cord	   (o,	   p)	   in	   wild-­‐type	   (m,	   o)	   and	  
Ambra1gt/gt	   (n,	   p)	   embryo	   sections.	   E14.5	   wild-­‐type	   (i)	   and	   Ambra1gt/gt	   (j)	   embryos	   are	   characterized	   by	  
prominent	  exencephaly.	  Histological	  analysis	  of	  E12.5	  wild-­‐type	  (k)	  and	  Ambra1gt/gt	  (l)	  embryos	  on	  cross-­‐section	  
show	   the	   absence	   of	   a	   normal	   ventricular	   system,	   the	   extensive	   overgrowth	   of	   the	   proliferative	  
neuroepithelium	   in	   the	   diencephalon	   (Di)	   and	   spinal	   cord	   (Sc),	   and	   the	   enlarged	   fifth	   ganglia	   (VG)	   in	   the	  
Ambra1gt/gt embryo.	  Scale bars:	  c,	  g,	  h,	  k,	  500	  mm; d,	  1	  mm;	  e,	  150	  mm;	  i,	  2	  mm;	  m,	  s,	  400	  mm;	  o,	  78mm;	  and	  
q,	  50mm.	  Figures	  as	  well	  as	  figure	  legends	  were	  taken	  from	  [25].	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This	   protein,	   identified	   in	   mouse	   as	   a	   positive	   regulator	   of	   the	   Beclin	   1-­‐dependent	  
program	   of	   autophagy,	   promotes	   the	   interaction	   of	   Beclin	   1	   with	   its	   target,	   the	   kinase	  
Vps34,	  thus	  mediating	  the	  nucleation	  of	  autophagosome	  [25].	  
Ambra1	   is	   an	   intrinsically	   disordered	   protein	   (IDP)	   [27],	   that	   is	   fine	   regulated	   by	  
independent	   modifications	   and	   possesses	   the	   capability	   of	   binding	   a	   number	   of	   other	  
regulatory	  partners	  involved	  in	  many	  cell	  processes	  including	  autophagy,	  apoptosis	  and	  cell	  
proliferation	  [28].	  	  
In	  cell	  physiological	  conditions,	  Ambra1	  is	  anchored,	  together	  with	  Beclin	  1	  and	  Vps34,	  
to	  the	  dynein	  light	  chain,	  DLC1,	  by	  means	  of	  two	  DLC-­‐binding	  consensus	  motifs	  (TQT)	  located	  
at	  the	  C-­‐terminal	  of	  the	  protein.	  After	  autophagy	  induction,	  the	  activated	  ULK1	  complex	  can	  
phosphorylate	   Ambra1	   thus	   determining	   its	   release	   from	   dynein.	   The	   complex	   formed	   by	  
Ambra1,	   Beclin	   1	   and	   Vps34	   is	   now	   free	   to	   translocate	   to	   the	   ER	  where	   autophagosome	  
nucleation	  takes	  place	  [26]	  (Figure	  4).	  ULK1	  is	  thus	  a	  direct	  regulator	  of	  Ambra1	  activity.	  
Figure	  4.	  Dynamic	   interaction	  of	  AMBRA1	  with	  the	  dynein	  motor	  complex	   in	  physiological	  cell	  conditions	  and	  
after	  autophagy	  induction.	  Figure	  modified	  from	  [26].	  
Moreover,	   it	   has	   been	   demonstrated	   that	   the	   down-­‐regulation	   of	   DLC1	   expression	  
determines	   the	   dissociation	   of	   Ambra1	   from	   the	   dynein	   motor	   complex	   and	   leads	   to	   a	  
significant	   increment	   of	   autophagosomes	   both	   in	   normal	   cell	   conditions	   and	   during	  
starvation	  or	   treatment	  with	   rapamycin	   [26].	   Likewise,	  Ambra1	  mutants,	   lacking	   the	  DLC1	  
binding	   domain,	   have	   an	   increased	   ability	   to	   induce	   autophagy	   compared	   to	   the	   Ambra1	  
wild-­‐type	  cells.	  Furthermore,	  the	  autophagy	  induction	  due	  to	  the	  down-­‐regulation	  of	  DLC1	  is	  
prevented	   if	  Ambra1	   is	  concomitantly	   inactivated	  thus	  confirming	   its	  direct	   involvement	   in	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The	  autophagic	  induction	  is	  regulated	  not	  only	  by	  the	  positive	  ULK1	  phosphorylation	  of	  
Ambra1	  but	  also	  by	  means	  of	  other	   recently	  discovered	  protein	   interactions	   [27].	   In	  basal	  
condition,	   Ambra1	   is	   linked	   to	   the	   dinein	   motor	   complex	   but	   also	   inhibited	   by	  
phosphorylation,	  at	  the	  residue	  Ser52,	  catalyzed	  by	  the	  complex	  mTORC1.	  This	  prevents	  the	  
Ambra1	   specific	   activity	   in	   the	   autophagic	   process.	   As	   above	   described,	   after	   autophagy	  
induction,	   ULK1	   can	   phosphorylate	   Ambra1	   thus	   allowing	   its	   release	   from	   dinein	   motor	  
complex.	  However,	   the	   interaction	  between	   the	   two	  proteins	   is	   reciprocal,	   as	  Ambra1	  has	  
been	   shown	   to	   control	   and	   increase	   ULK1	   stability	   and	   function	   by	   stimulation	   of	   the	   E3	  
ligase	   TRAF6	   activity.	   This	   enzyme,	  which	   is	   able	   to	   interact	  with	   both	   ULK1	   and	   Ambra1	  
proteins	  catalyzed	  a	  ubiquitylation	  reaction	  on	  ULK1-­‐Lys-­‐63	  (Figure	  5).	  	  
Figure	   5.	   Proposed	   model	   of	   AMBRA1	   regulation	   in	   ULK1	   ubiquitylation.	   In	   basal	   conditions,	   AMBRA1	   is	  
maintained	  in	  an	  inactive	  state	  by	  mTOR	  phosphorylation	  and	  by	  its	  anchoring	  to	  the	  dynein	  motor	  complex.	  
After	  autophagy	  induction,	  AMBRA1	  and	  ULK1	  are	  active.	  AMBRA1	  enhances	  ULK1	  kinase	  activity	  and	  stability	  
by	   promoting	   its	   Lys-­‐63-­‐linked	   ubiquitylation	   and	   self-­‐association	   through	   TRAF6.	   ULK1	   primes	   AMBRA1	  
detachment	   from	   the	   dynein	   complex	   through	   a	   positive	   phosphorylation.	   Coupling	   these	   regulatory	   events	  
may	   represent	   a	   positive	   feedback	   to	   sustain	   autophagy	   in	   a	   continuous	   loop.	   Figure	   modified	   and	   figure	  
legend	  taken	  from	  [27].	  
Part	  of	  the	  cellular	  pool	  of	  Ambra1	  is	  instead	  normally	  localized	  to	  mitochondria,	  where	  
the	  proteins	  are	  linked	  to	  Bcl-­‐2	  by	  means	  of	  N-­‐	  and	  C-­‐terminal	  binding	  domains.	  If	  autophagy	  
is	  induced,	  the	  proteins	  are	  released	  and	  free	  to	  interact	  with	  Beclin	  1	  and	  to	  promote	  the	  
autophagic	  process	  [29].	  Release	  of	  Ambra1	  proteins	  from	  Bcl-­‐2	  occurs	  also	  after	  induction	  
of	   the	  apoptotic	  process	  thus	  underlining	  the	  proposed	  crosstalk	  between	  the	  two	  cellular	  
processes	  [28].	  Recently	  it	  has	  been	  shown	  that	  levels	  of	  this	  protein	  are	  important	  for	  the	  
cell	   in	   order	   to	   choose	   between	   an	   autophagic	   pro-­‐survival	   response	   or	   the	   apoptotic	  
process.	   Ambra1	   proteolysis	   at	   the	   amino	   acid	   residue	  D482	   is	   then	   required	   to	   interfere	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At	  the	  mitochondrial	  level	  Ambra1	  interacts	  also	  with	  the	  Parkin	  protein	  that	  is	  involved	  
in	  the	  induction	  of	  a	  selective	  form	  of	  the	  autophagic	  process,	  the	  mitophagy,	  by	  means	  of	  
which	  damaged	  mitochondria	  are	  removed	   form	  the	  cell.	  Following	  mitochondria	  damage,	  
Ambra1	   is	   recruited	  near	   these	  organelles	  where	   it	   is	   involved	   in	  Vps34	  enzyme	  activation	  
and	  the	  induction	  of	  the	  mitophagy	  process	  [31].	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Species:	  Danio	  rerio	  
Figure	   6.	   Schematic	   representation	   of	   an	   adult	   male	   and	   female	   zebrafish	   specimen	   with	   characteristic	  
horizontal	  stripes	  running	  along	  the	  body	  and	  fins.	  
The	  zebrafish	  (Danio	  rerio)	  is	  a	  small	  tropical	  freshwater	  fish,	  native	  of	  the	  river	  Ganges,	  
in	  the	  northeastern	  region	  of	   India	  and	  currently	  exported	  all	  over	  the	  world	   (Figure	  6).	   In	  
last	  years,	  it	  has	  become	  a	  favorite	  model	  organism	  to	  study	  biological	  processes.	  	  
Zebrafish	  is	  small,	  easy	  to	  breed	  and	  maintain	  in	  laboratory	  condition.	  Adult	  females	  spawn	  
hundreds	   of	   eggs	   once	   every	   5	   days.	   Fertilization	   is	   external	   and	   allows	   an	   immediate	  
analysis	  of	  the	  progeny	  at	  different	  stages	  of	  development,	  without	  the	  need	  of	  dissection	  
and	  sacrifice	  of	  pregnant	  females	  as	  required	  in	  mammalian	  models.	  	  
The	   embryos	   and	   larvae	   of	   these	   fish	   are	   transparent	   and	   present	   rapid	   external	  
development	   with	   all	   major	   organs	   developing	   within	   36	   h	   at	   28.5°C	   [32],	   thus	   allowing	  
micromanipulation	   and	   in	   vivo	   observation	   and	   analysis	   of	   embryogenesis	   and	  
organogenesis.	  The	  zebrafish	  reaches	  sexual	  maturity	  in	  approximately	  3-­‐4	  months	  [33].	  
These	   characteristics	  make	   this	  model	   particularly	   suitable	   for	   genetic	   and	   developmental	  
biology	   techniques	  such	  as	  cell	   transplantation	  or	  microinjection	  of	  DNA	  or	  RNA,	  aimed	  at	  
the	  production	  of	  transgenic	  lines,	  over-­‐expression	  of	  mRNA	  or	  gene	  silencing	  by	  means	  of	  
morpholino	  (MO)	  oligonucleotides.	  The	  microinjection	  of	  MOs	  is	  efficient	  and	  rapid,	  and	  it	  is	  
the	  most	  commonly	  used	  and	  validated	  antisense	  zebrafish	  technology	  to	   investigate	  gene	  
loss	  of	  function,	  signaling	  pathways	  and	  the	  roles	  of	  specific	  proteins	  in	  development	  or	  drug	  
response.	   Injected	   MOs	   typically	   generate	   a	   graded	   severity	   of	   phenotypes,	   but	   not	   a	  
complete	  loss-­‐of-­‐function.	  This,	  together	  with	  the	  possibility	  to	  modulate	  the	  concentration	  
of	  the	  injected	  MOs,	  may	  be	  seen	  as	  a	  distinct	  advantage	  when	  complete	  knockout	  results	  in	  
early	  lethality,	  as	  observed	  for	  most	  autophagic	  genes	  in	  mice	  [2].	  	  
As	   a	   vertebrate	   species,	   zebrafish	   is	   more	   closely	   related	   to	   humans	   than	   invertebrate	  
models.	   Indeed,	   their	   genomes	   are	   highly	   conserved	   and	   approximately	   70%	   of	   human	  
genes	   have	   orthologs	   in	   zebrafish	   [34].	   Among	   these	   genes,	  many	   are	   actually	   present	   as	  
paralogs	   because	   Teleost	   underwent	   genome	   duplication	   [35].	   This,	   due	   to	   the	   sub-­‐
functionalization	  of	  paralog	  genes,	  may	  be	  helpful	  to	  better	  understand	  their	  function.	  	  
Due	  to	  this	  high	  genomic	  conservation,	  zebrafish	  mutant	  lines	  have	  been	  prepared	  through	  
chemical	  mutagenesis	   and	   identified	   by	  means	   of	   genetic	   screens.	   These	   lines	   have	   been	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mechanisms	  of	  development,	  including	  those	  that	  determine	  the	  formation	  of	  the	  embryo,	  
define	   the	  organization	  of	  distinct	   regions	  of	   the	  brain	  and	  allow	  the	   formation	  of	   specific	  
neural	  circuits	  [36-­‐	  38].	  	  
These	  mutant	  lines	  can	  be	  found	  at	  the	  website:	  
http://www.sanger.ac.uk/resources/zebrafish/genomeproject.html.	  
Moreover,	  other	  mutant	  lines	  can	  be	  now	  obtained	  by	  using	  novel	  powerful	  gene	  targeting	  
strategies,	  named	  CRISPR-­‐Cas9	  and	  TALEN,	   that	  are	  based	  on	   induced	  mutations	  and	  have	  
already	  been	  successfully	  applied	  to	  zebrafish	  [39-­‐	  41].	  
A	   database	   that	   provides	   information	   on	   the	   genetics,	   genomics	   and	   the	   development	   of	  
zebrafish	  is	  available	  at:	  http://www.zfin.org.	  
Zebrafish	   embryo	   development	   is	   similar	   to	   those	   of	   other	   teleost	   fish	   and	   has	   been	  
described	  in	  detail	  by	  Kimmel	  and	  coo-­‐workers	  [32].	  The	  principal	  developmental	  stages	  are	  
represented	  in	  Figure	  7.	  	  
Differently	  from	  eutherian	  mammals,	  where	  maternal	  effects	  on	  embryos	  are	  exerted	  in	  real	  
time	  at	   the	  placental	  boundary,	   in	  oviparous	  species,	   like	  zebrafish,	  maternal	   factors,	  both	  
mRNA	   and	   proteins,	   are	   provided	   in	   their	   large	   oocytes	   to	   sustain	   and	   direct	   early	  
development	  [42].	  	  
Maternal	  mRNAs	  are	  the	  almost	  unique	  translational	  templates	  for	  protein	  synthesis	  in	  the	  
initial	   embryogenesis	   and	   are	   responsible	   for	   the	   maternal	   programming	   of	   subsequent	  
development.	  Moreover,	   there	   is	  a	   timely	   interplay	  between	  maternal	  mRNA	  degradation,	  
starting	  at	  the	  midblastula	  transition	  (MBT),	  at	   the	  10th	  cleavage	  cycle	   (512-­‐cell	  stage;	  3	  h	  
post-­‐fertilization)	   and	   carried	  out	   at	   different	   rates	  depending	  on	   the	  messenger,	   and	   the	  
onset	  of	  zygotic	  transcription,	  including	  that	  of	  a	  number	  of	  micro-­‐RNAs	  responsible	  for	  the	  
clearance	  of	  several	  hundred	  of	  maternal	  messages	  [43,	  44].	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Figure	   7.	   Schematic	   representation	   of	   several	   stages	   of	   zebrafish	   development.	  Hpf:	   hours	   post	   fertilization.	  
Dpf:	  days	  post	  fertilization.	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ZEBRAFISH	  SKELETAL	  MUSCLE	  
In	   vertebrates,	   skeletal	   muscle	   contains	   fibers	   of	   different	   type,	   with	   specific	  
physiological	  and	  biochemical	  properties	  that	  make	  them	  suited	  to	  different	  functions	  [45].	  
Slow-­‐twitch	  (Type	  I)	  or	  oxidative	  fibers	  contain	  a	  large	  number	  of	  mitochondria	  in	  which	  ATP	  
is	  generated	  by	  oxidative	  metabolic	  processes,	  thus	  providing	  a	  higher	  resistance	   level	  and	  
allowing	  the	  maintenance	  of	  contractile	  activity	  for	  long	  period	  [46].	  These	  fibers	  present	  a	  
typical	  red	  color	  that	  is	  given	  by	  high	  levels	  of	  myoglobin	  and	  high	  vascularization	  [47].	  	  
Fast-­‐twitch	   (Type	   I)	   or	   glycolytic	   fibers	   contain	   a	   low	  number	   of	  mitochondria.	   In	   this	  
case,	   ATP	   is	   generated	   very	   rapidly	   by	   anaerobic	   metabolic	   processes	   and	   muscle	   fibers	  
contractile	   activity	   is	   reduced	   [46],	   The	   physiological	   difference	   in	   contraction	   activity	  
between	  the	  two	  type	  of	   fibers	   is	  a	  consequence	  of	  the	  type	  of	  myosin	   isoform	  present	   in	  
the	  thick	  filament	  [47].	  
Zebrafish	   is	   a	   great	   model	   organism	   to	   study	   muscle	   development	   due	   to	   the	   rapid	  
external	   embryonic	   development,	   the	   large	   proportion	  of	   the	   body	   constituted	  by	  muscle	  
(around	  80%)	  and	  the	  spatial	  separation	  of	  fiber-­‐type	  in	  the	  embryonic	  myotome	  [46]	  that	  is	  
maintained	   throughout	   adult	   stages.	   Actually,	   fast	   muscle	   fibers	   are	   multinucleated	   and	  
located	  inside	  the	  somite,	  whereas	  slow	  muscle	  contains	  mononucleated	  fibers	  and	  forms	  a	  
subcutaneous	   layer	   [46,	   48,	   49].	   Zebrafish	   muscle	   contains	   also	   muscle	   pioneer	   cells,	  
belonging	  to	  the	  slow	  muscle	  and	  located	  in	  a	  medial	  position	  of	  the	  developing	  somite	  and	  
the	  medial	  fast	  fiber	  cells	  [49].	  
Muscle	  activity	  beginning	  is	  temporally	  separated	  in	  the	  different	  types	  of	  fiber:	  the	  first	  
spontaneous	   contraction	   in	   slow-­‐twiched	   fibers	   appears	   in	   the	  embryo	  at	   17	  hpf	   [50]	   and	  
the	  touch-­‐evoked	  coiling	  behavior	  is	  initially	  detectable	  at	  21	  hpf	  [51],	  while	  the	  fast-­‐twitch	  
fibers	  start	  contraction	  after	  hatching	  [52].	  
Zebrafish’s	  myogenesis	  is	  regulated	  by	  the	  Myogenic	  Regulatory	  Factors	  (MRFs)	  that	  are	  
members	  of	  the	  basic	  helix-­‐loop-­‐helix	  transcription	  factor	  family	  [53].	  In	  particular,	  the	  first	  
genes	   to	   be	   expressed	   are	  myogenic	   differentiation	   1	   (myod1)	   and	  myogenic	   regulatory	  
factor	  5	  (myf5).	  	  
In	   zebrafish	   myogenesis	   starts	   before	   somite	   segmentation,	   when	   midline	   hedgehog	  
signals	   induce	  cells	  of	   the	  presomitic	  mesoderm	  to	  differentiate	   into	  adaxial	   cells	   [48,	  53].	  
The	  adaxial	   cells,	  which	   represent	   the	  precursor	  of	   slow	  muscle	  as	  well	  as	  muscle	  pioneer	  
cells	   [48],	   are	   initially	   aligned	   medially	   next	   to	   the	   notochord	   where	   they	   express	   the	  
transcription	  factor	  Myod1	  (Figure	  8,	  blue	  cells).	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Figure	   8.	   Schematic	   representation	   of	   transverse	   sections	   of	   developing	   somite	   showing	   the	   lateral	  
migration	   of	   the	   adaxial	   cells	   (blue)	   followed	   by	   the	   onset	   of	   differentiation	   and	   fusion	   of	   the	   fast-­‐twitch	  
myoblasts	  (green),	  sc,	  spinal	  cord,	  nc,	  notochord.	  Figure	  modified	  from	  [46].	  
These	  cells	  migrate	  radially	  to	  reach	  the	  lateral	  surface	  of	  the	  somite	  where	  they	  form	  
the	  superficial	   slow	  twich	  mononucleated	   fibers	   [54].	  Moreover,	  a	  small	  portion	  of	  adaxial	  
cells	  maintains	  its	   location	  adjacent	  the	  nothocord	  to	  differentiate	  into	  the	  muscle	  pioneer	  
cells	   [49]	   that	   form	   the	   horizontal	   myoseptum.	   The	   slow	   fibers	   express	   the	   transcription	  
factor	  prox1	  [54]	  and	  the	  slow	  isoform	  of	  the	  Myosin	  Heavy	  Chain	  (MyHC).	  
Fast	  twitch	  multinucleated	  fibers	  develop	  from	  the	  posterior	  half	  of	  each	  newly	  formed	  
somite,	  by	  differentiation,	   independently	  of	  hedgehog	  signaling,	  of	  a	  second	  population	  of	  
cells	  expressing	  myoD	  [48,	  53]	  (Figure	  8,	  green	  cells)	  and	  the	  fast	  MyHC	  isoform.	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MORPHOLINO	  GENE	  KNOCKDOWN	  	  
The	   agents	   that	   inhibit	   or	   reduce	   the	   expression	   of	   a	   gene	   of	   interest	   are	   commonly	  
called	   knockdown	   agents.	   Since	   they	   bind	   to	   the	   sense	   sequence	   of	  mRNA,	   they	   are	   also	  
called	  antisense	  oligos	  [55].	  
There	  are	  three	  main	  types	  of	  knockdown	  agents:	  
• S-­‐DNAs	   (phosphorothioate-­‐linked	   DNAs)	   that	   use	   the	   enzyme	   RNase	   H	   to	   cut	   the	   RNA	  
target	  sequence	  [56].	  
• siRNAs	  (short	   interfering	  RNAs)	  that	  are	  the	  mediators	  of	  sequence-­‐specific	  degradation	  
of	  mRNA.	   They	   consist	   of	   fragments	   of	   21-­‐22	   nucleotides,	   generated	   by	   the	   cutting	   of	  
longer	  dsRNAs	  (double	  strand	  RNAs).	  The	  technique	  of	  siRNA	  was	  discovered	  in	  1990,	  and	  
since	  then	  was	  widely	  used	  in	  the	  field	  of	  biological	  research	  [57].	  	  
• Morpholinos	   (MOs)	   that	   create	   a	   steric	   block	   and	   inhibit	   translation	   or	   splicing	   of	   the	  
target	  gene	  [58].	  
MOs	  are	  synthetic	  molecules,	  typically	  25	  bases	  in	  length,	  designed	  and	  synthesized	  by	  
Gene	   Tools	   (http://www.gene-­‐tools.com).	   They	   bind	   to	   the	   target	   complementary	  
sequences	  of	  RNA	  by	  nucleic	  acid	  base-­‐pairing.	  Their	  name	  derives	  from	  the	  MO	  structure	  of	  
the	  constituent	  units,	  each	  containing	  one	  of	  the	  four	  nitrogenous	  bases	  (A,	  C,	  G	  or	  T)	  linked	  
to	  a	  six	  atoms	  morpholine	  ring	  instead	  of	  a	  ribose	  or	  deoxyribose	  molecule.	  The	  morpholine	  
rings	  are	   then	  connected through	  phosphorodiamidate	   instead	  of	  phosphates	  groups	   [33].	  
MOs	   are	   resistant	   to	   nucleases	   degradation	   and	   thus	  more	   stable	   than	   other	   knockdown	  
agents	  [58].	  	  
Normally	   MOs	   are	   complementary	   to	   a	   region	   between	   the	   5'-­‐CAP	   and	   the	   first	   25	  
nucleotides	  after	  the	  translation	  initiation	  codon	  (AUG),	  beyond	  which	  the	  inhibitory	  activity	  
of	   morpholino	   decade.	   MOs	   do	   not	   degrade	   the	   target	   RNA,	   but	   sterically	   invade	   the	  
secondary	  structure	  of	  the	  mRNA	  thereby	  preventing	  the	  recognition	  of	  the	  ribosome	  and,	  
as	   a	   consequence,	   blocking	   the	   protein	   translation	   (Figure	   9).	   These	   knockdown	   agents	  
reduce	  in	  a	  very	  efficient	  and	  specific	  manner	  gene	  expression,	  in	  particular,	  the	  translation	  
of	  the	  target	  mRNAs	  [55]	  When	  a	  specific	  antibody	  is	  available,	  a	  Western	  Blot	  analysis	  can	  
demonstrate	  the	  effective	  reduction	  of	  the	  protein	  translation.	  Otherwise,	  efficiency	  of	  MOs	  
must	  be	  obtained	  with	  other	  alternative	  strategies	  [59].	  	  
Besides	  inhibiting	  the	  translation,	  a	  MO	  can	  also	  act	  on	  the	  maturation	  of	  the	  pre-­‐mRNA	  
in	   the	   nucleus	   (splice-­‐blocking	   MO).	   These	   MOs	   are	   complementary	   to	   splice	   acceptor	  
(intron-­‐exon	   boundary)	   or	   donor	   (exon-­‐intron	   boundary)	   sites	   in	   the	   unspliced	   RNA	   and	  
therefore	  are	   in	   competition	   for	   these	  binding	   sites	  with	   the	   splicing	  apparatus	   (Figure	  9).	  
The	  binding	  of	  these	  MOs	  may	  result	  in	  the	  loss	  of	  an	  exon	  or	  in	  the	  intron	  retention,	  in	  the	  
resulting	  mRNAs	  [60]	  This	  knockdown	  has	  the	  advantage	  of	  allowing	  an	  easy	  quantification	  
of	   the	   efficiency	   of	   MO,	   by	   RT-­‐PCR	   analysis	   of	   the	   RNA	   extracted	   from	   microinjected	  
embryos	  [61].	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Figure	  9.	  Schematic	  representation	  of	  different	  types	  of	  MO	  oligos.	  
This	  technology	  is	  particularly	  used	  in	  zebrafish	  and	  allows	  the	  study	  of	  the	  function	  of	  
genes.	   The	  MO	   is	  microinjected	   in	   fertilized	   eggs	   at	   the	   stage	   of	   one/two	   cells	   to	   blocks	  
translation	   of	   the	   target	   genes.	   The	   embryos	   phenotypically	   modified	   by	   MO	   are	   called	  
morphants	  [62].	  	  
Sometimes	  MOs	  can	  be	  toxic	  to	  cells	  and	  produce	  off-­‐target	  effects.	  It	  can	  cause	  stress-­‐
induced	   apoptosis	   in	   central	   nervous	   system	   and	   somites.	   Although	   the	   MOs	   act	   in	   a	  
sequence-­‐specific	  way,	  there	  is	  always	  the	  possibility	  that	  it	  also	  blocks	  translation	  of	  other	  
genes	  with	  similar	  sequences	  [59].	  Therefore,	  specificity	  of	  morphants	  phenotypes	  requires	  
some	  checks	  phenotype	  [59]:	  	  
• two	  morpholinos,	  non-­‐overlapping	  and	  therefore	  complementary	   to	  different	  portions	  
of	  the	  target	  transcript,	  should	  produce	  the	  same	  phenotypic	  effects;	  
• use	  of	  a	  mismatch	  MO	  (a	  modified	  oligonucleotide	  which	  differs	  for	  4-­‐5	  bases	  from	  the	  
specific	  MO)	   that	   is	   unable	   to	   bind	   to	   the	   target	   gene	   and,	   consequently,	   should	   not	  
produce	  a	  morphant.	  
• rescue	   experiments	   in	  which	  MOs	   are	   co-­‐injected	  with	   an	  mRNA	   encoding	   the	   target	  
protein	   should	   recover,	   at	   least	   partially,	   the	  normal	   phenotype.	   To	  prevent	   the	  MOs	  
from	  blocking	  the	  injected	  messenger,	  this	  must	  derives	  from	  another	  organism,	  or	  the	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AMBRA1	   is	   a	   positive	   regulator	   of	   the	   BECN1-­‐dependent	   program	   of	   autophagy	   recently	  
identified	  in	  mouse.	  In	  this	  study,	  we	  cloned	  the	  full-­‐length	  cDNAs	  of	  ambra1a	  and	  ambra1b	  
zebrafish	  paralogous	   genes.	  As	   in	  mouse,	  both	  Ambra1	  proteins	   contain	   the	   characteristic	  
WD40	  repeat	  region.	  The	  transcripts	  of	  both	  genes	  are	  present	  as	  maternal	  RNAs	  in	  the	  eggs	  
and	   display	   a	   gradual	   decline	   until	   8	   hpf,	   being	   replaced	   by	   zygotic	   mRNAs	   from	   12	   hpf	  
onwards.	  After	  24	  hpf,	  the	  transcripts	  are	  mainly	  localized	  in	  the	  head,	  suggesting	  a	  possible	  
role	   in	   brain	   development.	   To	   check	   their	   developmental	   roles,	   we	   adopted	   morpholino	  
knockdown	   to	   block	   either	   translation	   (ATGMOs)	   or	   splicing	   (SPLICMOs).	   Treatment	   with	  
ATGMOs	  causes	  severe	  embryonic	  malformations,	  as	  prelarvae	  could	  survive	  for	  only	  3	  and	  
4	   days	   in	   ambra1a	   and	   b	   morphants,	   respectively.	   Treatment	   with	   SPLICMOs	   led	   to	  
developmental	  defects	  only	  at	  a	  late	  stage,	  indicating	  the	  importance	  of	  maternally	  supplied	  
ambra1	  transcripts.	  Analysis	  of	  the	  levels	  of	  Lc3-­‐II,	  an	  autophagosome-­‐specific	  marker,	  in	  the	  
presence	   of	   lysosome	   inhibitors	   evidenced	   a	   reduction	   in	   the	   rate	   of	   autophagosome	  
formation	   in	   both	   MOs-­‐injected	   embryos	   at	   48	   hpf,	   more	   pronounced	   in	   the	   case	   of	  
ambra1a	   gene.	   Although	   some	   defects,	   such	   as	   body	   growth	   delay,	   curved	   shape	   and	  
haemorrhagic	  pericardial	  cavity	  were	  present	  in	  both	  morphants,	  the	  occurrence	  of	  specific	  
phenotypes,	   such	   as	   major	   abnormalities	   of	   brain	   development	   in	   ambra1a	  morphants,	  
suggests	  the	  possible	  acquisition	  of	  specific	  functions	  by	  the	  two	  paralogous	  genes	  that	  are	  
both	  required	  during	  development	  and	  do	  not	  compensate	  each	  other	  following	  knockdown.	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INTRODUCTION	  
Autophagy	   is	   an	   evolutionarily	   conserved	   catabolic	   process	   used	   to	   break	   down	   and	  
recycle,	   through	   the	   lysosomal	   machinery,	   long-­‐lived	   proteins	   and	   organelles	   in	   order	   to	  
maintain	   a	   homeostatic	   environment	  within	   the	   cell.	   This	   process	   is	   tightly	   regulated	   and	  
plays	   several	   important	   roles	   in	   embryo	   development,	   differentiation,	   normal	   physiology,	  
survival	   during	   starvation	   and	   ageing	   [1,2].	   Three	   types	   of	   autophagy	   are	   known:	  
macroautophagy	   (usually	   referred	   as	   “autophagy”),	   microautophagy,	   and	   chaperone-­‐
mediated	   autophagy,	   working	   with	   different	   cellular	   mechanisms	   and	   playing	   distinctive	  
functions	   [3].	  Macroautophagy	   is	   responsible	   for	   the	   bulk	   degradation	   of	  macromolecules	  
and	   damaged	   cytoplasmic	   organelles	   in	   a	   double-­‐membrane-­‐bound	   vesicle,	   the	  
autophagosome	   [4].	   Failure	   to	   remove	  aggregates	  of	  mutated	   toxic	  proteins	   could	  explain	  
the	  key	  pathogenic	  effect	  of	   impaired	  autophagy	   in	  neurodegenerative	  diseases,	   including	  
Huntington	  disease,	  Parkinson	  disease,	  amyotrophic	  lateral	  sclerosis,	  and	  Alzheimer	  disease	  
[5,6].	   Autophagy	   has	   also	   been	   identified	   as	   a	   critical	   process	   in	   oncogenesis	   and	   cancer	  
progression	  [7,8].	  Moreover,	   in	  some	  congenital	  muscular	  dystrophies,	  defective	  activation	  
of	  the	  autophagic	  machinery	  causes	  accumulation	  of	  dysfunctional	  mitochondria,	  leading	  to	  
damage	  and	  the	  subsequent	  loss	  of	  muscle	  fibers	  [9].	  
A	  great	  number	  of	  papers,	  reviewed	  by	  Di	  Bartolomeo	  and	  coworkers	  [10],	  suggest	  that	  
autophagy,	   in	   eukaryotes,	   represents	   a	   crucial	   mechanism	   during	   the	   development	   of	  
multicellular	   organisms.	   Several	   proteins,	   called	   AuTophaGy-­‐related	   proteins	   (ATG),	   first	  
identified	  in	  yeast	  [11],	  participate	  in	  the	  different	  steps	  of	  the	  autophagic	  process:	  vacuole	  
initiation,	  elongation	  and	  fusion	  with	  the	   lysosomes.	  Autophagosome	  formation	  requires	  a	  
BECN1-­‐containing	  complex	  that	  recruits	  the	  class	  III	  phosphatidylinositol	  3-­‐kinase	  (PIK3C3)	  to	  
produce	  phosphatidylinositol-­‐3-­‐phosphate.	  This	  activity	  is	  coordinated	  by	  the	  interaction	  of	  
BECN1	   with	   several	   other	   proteins,	   including	   the	   regulatory	   protein	   kinase	  
PIK3R4/Vps15/p150,	   the	   UV	   radiation	   resistance-­‐associated	   protein	   (UVRAG),	   SH3GLB1	  
(endophilin	  B1/Bif-­‐1),	  AMBRA1	  (autophagy/beclin-­‐1	  regulator	  1),	  BCL2	  (B-­‐cell	  CLL/lymphoma	  
2),	   ATG14	   (autophagy	   related	   14),	   and	   KIAA0226	   (RUN	   domain	   and	   cysteine-­‐rich	   domain	  
containing,	  Beclin	  1-­‐interacting	  protein	  /RUBICON)	  to	  form	  different	  protein	  complexes	  that	  
mediate	  distinct	  functions	  in	  membrane	  trafficking	  [12,13].	  
A	  positive	  regulator	  of	  the	  BECN1-­‐dependent	  program	  of	  autophagy	  has	  been	  recently	  
identified	   in	  mouse	  as	  AMBRA1	   [14].	  AMBRA1	   is	  normally	  docked	   in	  mammalian	  cells	  at	  a	  
specific	   cytoskeletal	   site	   (the	  dynein	   light	   chain,	  DYNLL1),	  wherefrom	   it	   is	  unleashed	  upon	  
autophagy	   induction	   to	   translocate	   to	   the	   autophagosome	   origin	   sites	   on	   the	   ER	   [15].	  
AMBRA1	  is	  primarily	  expressed,	  during	  mouse	  embryogenesis,	  in	  the	  neural	  plate	  of	  the	  CNS	  
and	  it	   is	  crucial	   for	  the	  proper	  nervous	  system	  development.	  AMBRA1-­‐deficiency	   in	  mouse	  
embryos	  is	  lethal,	  due	  to	  neural	  tube	  developmental	  defects	  as	  well	  as	  abnormal	  neural	  cell	  
proliferation	  [14].	  
Currently,	   zebrafish	   is	   one	   of	   the	   leading	   models	   for	   studying	   not	   only	   early	  
development,	  a	  phase	  of	   the	   life	  cycle	   in	  which	  zebrafish	  has	  a	  recognized	  superiority,	  but	  





closely	   related	   to	   humans	   than	   invertebrate	   models	   and,	   at	   the	   same	   time,	   it	   offers	  
numerous	  advantages,	  such	  as	  external	   fertilization,	   the	  rapid	  development	  of	   transparent	  
embryos,	   and	   the	   large	   number	   of	   offspring,	   compared	   with	   non-­‐fish	   vertebrate	  models.	  
Within	  six	  days,	  the	  transparent	  embryos	  and	  larvae	  complete	  their	  development,	  allowing	  
in	  vivo	  visualization	  and	  analysis	  of	  all	  developmental	  stages	  and	  organogenesis.	  Moreover,	  
the	   zebrafish	   often	   contains	   duplicate	   copies	   of	   genes	   that	   are	   instead	   present	   as	   single	  
copies	  in	  mammals.	  This	  is	  helpful	  to	  obtain	  additional	  insight	  into	  the	  multiple	  functions	  of	  
the	   human	   counterpart	   [16].	   Herein,	   two	   zebrafish	   ambra1	   genes	   were	   identified	   and	  
analysed	  for	  their	  function	  in	  embryonic	  development.	  Ambra1a	  and	  ambra1b	  genes	  appear	  
to	   be	   paralogous	   and	   their	   expression	  was	   detected	   throughout	   embryonic	   development.	  
Morpholino-­‐based	  silencing	  of	  both	  genes	  resulted	  in	  developmental	  defects	  similar	  to	  those	  
observed	   in	   the	   AMBRA1-­‐deficient	   mouse	  model.	   Presence	   of	   paralog-­‐specific	   alterations	  
suggests	  the	  possibility	  of	  subfunctioning	  of	  the	  two	  genes	  and	  demonstrates	  that	  zebrafish	  
is	  a	  viable	  model	  for	  the	  study	  of	  AMBRA1	  functions.	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METHODS	  
Fish	  maintenance	  and	  embryo	  collection	  
Zebrafish	   of	   wild-­‐type	   (WT)	   strain,	   purchased	   from	   local	   pet	   shops,	   were	  maintained	  
according	  to	  Westerfield	  and	  Lawrence	  [29,30].	  Embryos	  were	  obtained	  by	  natural	  spawning	  
and	  cultured	  in	  zebrafish	  Fish	  Water	  solution	  at	  28.5°C	  with	  a	  photoperiod	  of	  14	  h	  light/10	  h	  
dark.	  The	  developmental	  stages	  were	  determined	  according	  to	  the	  hpfs	  and	  morphological	  
features	  [31].	  	  
RNA	  extraction,	  reverse	  transcription	  and	  quantitative	  polymerase	  chain	  reaction	  (qPCR)	  
Total	   RNA	   was	   extracted	   from	   pools	   of	   20	   to	   60	   embryos	   at	   the	   desired	   stages	   of	  
development	  using	  TRIzol	  reagent	  (15596-­‐018,	   Invitrogen)	  according	  to	  the	  manufacturer’s	  
instructions.	  The	  number	  of	  embryos	  was	  chosen	  according	  to	  the	  embryo	  size	  at	  each	  time	  
point.	  The	  RNA	  samples	  were	  kept	  at	  -­‐80°C	  until	  use.	  
For	   qPCR,	   1	   µg	   of	   total	   RNA	   obtained	   from	   three	   different	   pools	   of	   embryos	   at	   each	  
developmental	  stage	  was	  used	  for	  cDNA	  synthesis,	  employing	  iScript	  cDNA	  Synthesis	  Kit	  (Bio-­‐
Rad)	   and	   following	   the	   manufacturer’s	   protocol.	   PCRs	   were	   performed	   with	   SYBR	   green	  
method	   in	   a	   iQ5	   iCycler	   thermal	   cycler	   (179-­‐8891,	   Bio-­‐Rad).	   All	   samples	   were	   analysed	   in	  
triplicate	  in	  20	  μl	  volumes.	  Each	  reaction	  mixture	  consisted	  of	  2	  μl	  of	  diluted	  (1/10)	  cDNA,	  10	  
μl	   of	   2X	   concentrated	   iQ	   TM	   SYBR	   Green	   Supermix	   (170-­‐8882,	   Bio-­‐Rad),	   containing	   SYBR	  
Green	  as	  a	  fluorescent	  intercalating	  agent,	  0.3	  μM	  of	  forward	  primer	  and	  0.3	  μM	  of	  reverse	  
primer.	  Real-­‐time	  PCR	  conditions	  were	  optimized	  after	  trying	  various	  times	  and	  temperatures	  
for	  each	  cycling	  step.	  The	  reaction	  conditions	  were	  as	  follows:	  enzyme	  activation	  at	  95°C	  for	  3	  
min	  followed	  by	  45	  cycles	  of	  denaturation	  (30	  s	  at	  95°C),	  annealing	  (30	  s	  at	  60°C	  for	  arginine	  
rich	  protein,	  arp,	  30	  s	  at	  54°C	   for	  ambra1a	  and	  ambra1b,	  30	  s	  at	  55°C	   for	  18S,	  and	  30	  s	  at	  
60°C	  for	  becn1,	  and	  extension	  (20	  s	  at	  72°C).	  Fluorescence	  monitoring	  occurred	  at	  the	  end	  of	  
each	  cycle.	  The	  extension	  phase	  of	  the	  last	  cycle	  was	  prolonged	  by	  10	  min.	  Primer	  specificity	  
and	   the	   absence	   of	   primer-­‐dimer	   formation	   during	   real-­‐time	  PCR	   analysis	  was	   indicated	   in	  
each	  sample	  by	  the	  presence	  of	  a	  single	  peak	   in	  the	  dissociation	  (melt)	  curve	  at	  the	  end	  of	  
the	  amplification	  program.	  The	  specificity	  of	  each	  primer	  set	  was	  also	  analysed	  by	  sequencing	  
of	   the	  obtained	   fragment.	  18S	  and	  arp	  mRNAs	  were	  used	  as	  normalizers	   in	  each	  sample	   in	  
order	   to	   standardize	   the	   results	   by	   eliminating	   variations	   in	  mRNA	  and	   cDNA	  quantity	   and	  
quality.	  The	  data	  obtained	  were	  analysed	  using	  the	   iQ5	  optical	  system	  software	  version	  2.0	  
(Bio-­‐Rad)	  including	  GeneEx	  Macro	  iQ5	  Conversion	  and	  genex	  Macro	  iQ5	  files.	  Modification	  of	  
gene	  expression	  is	  represented	  with	  respect	  to	  the	  control	  sampled	  at	  the	  same	  time	  of	  the	  
treatment.	  The	  primer	  sequences	  are	  reported	  in	  supplementary	  Table	  4.	  
Cloning	  of	  zebrafish	  ambra1a	  and	  ambra1b	  cDNAs	  
A	   BLASTN	   search	   for	   zebrafish	   ambra1	   cDNA	   sequence	   was	   performed	   in	   the	   NCBI	  




(NP_766257)	   as	   query.	   Two	  Danio	   rerio	   cDNA	   sequences	   were	   obtained:	   XM_002667669	  
(coding	   for	  ambra1a,	   as	   named	   in	   this	   paper)	   and	  XR_084457	   (coding	   for	  ambra1b).	   ESTs	  
databases	  were	   also	   analysed	   but,	   due	   to	   the	   length	   of	   the	   ambra1	   cDNA,	   no	   full-­‐length	  
clones	  were	  found,	  but	  only	  fragments	  of	  both	  sequences.	  
Based	   on	   the	   predicted	   sequences,	   primers	   covering	   overlapping	   fragments	   were	  
designed	   for	   RT-­‐PCR	   and	   to	   obtain	   the	   5’-­‐	   and	   3’-­‐UTR	   regions	   according	   to	   the	   cloning	  
strategy	   described	   in	   Supplementary	   Figure	   1.	   RNA	   ligase-­‐mediated	   rapid	   amplification	   of	  
cDNA	  5’-­‐ends	  (RLM-­‐5’-­‐RACE)	  and	  3’-­‐RACE	  were	  performed	  using	  the	  FirstChoice	  RLM-­‐RACE	  
kit	   (AM1700M,	   Ambion),	   following	   the	   manufacturer’s	   instructions,	   with	   the	   primers	  
reported	  in	  supplementary	  Figure	  1.	  These	  analyses	  were	  accomplished	  using	  RNA	  extracted	  
from	   2-­‐	   and	   48-­‐hpf-­‐old	   embryos.	   The	   full-­‐length	   open	   reading	   frame	   (ORF)	   of	   zebrafish	  
ambra1a	  (accession	  number:	  XM_002667669)	  and	  ambra1b	  (accession	  number:	  XR_084457)	  
were	  amplified	  from	  2-­‐hpf	  zebrafish	  embryo	  total	  cDNA	  with	  pair	  of	  primers	  located	  outside	  
of	  the	  start	  and	  stop	  codon	  regions	  (see	  Supplementary	  Figure	  1)	  and	  cloned	  into	  pCR®-­‐Blunt	  
vector.	  Both	  strands	  were	  sequenced	  for	  each	  gene.	  	  
Synteny	  and	  phylogenetic	  analyses	  
Genomic	  analysis	  of	  conserved	  syntenies	  between	  human	  and	  zebrafish	  ambra1	  genes	  
were	   examined	  using	   the	   Synteny	  database	  with	   zebrafish	   as	   the	   source	   genome	   (release	  
Sanger	   Zv9)	   and	   the	   human	   genome	   (release	   GRCh37.p2)	   as	   the	   outgroup.	   The	   sliding	  
window	  size	  was	  settled	  at	  25	  genes	  [17].	  This	  program	  is	  designed	  for	  analysing	  genomes	  
that	  have	  undergone	  complete	  duplication	  during	  evolution.	  It	  identifies	  pairwise	  clusters	  of	  
orthologs	  and	  paralogs	  simultaneously.	  	  
Phylogenetic	   relationships	   of	   zebrafish	   ambra1	   genes	   were	   derived	   by	   aligning	   their	  
deduced	   amino	   acidic	   sequences	   together	   with	   AMBRA1	   sequences	   reported	   for	   other	  
vertebrate	  species	  using	  the	  Clustal	  W	  program	  [32].	  All	  alignment	  positions	  were	  included	  
in	   the	   analysis.	   The	   tree	   was	   generated	   by	   the	   Maximum	   likelihood	   method	   [33],	   as	  
implemented	  in	  the	  RaxML	  7.2.6	  program	  [34].	  Insertions	  and	  deletions	  were	  not	  taken	  into	  
account.	  Bootstrap	  resamplings	  were	  also	  performed	  to	  test	  the	  robustness	  of	  the	  trees	  and	  
1000	  replicates	  were	  done.35	  Program	  setting	  is	  detailed	  in	  the	  figure	  legend.	  
Morpholinos	  	  
All	  the	  MOs	  were	  obtained	  from	  Gene	  Tools	  (Philomath,	  OR,	  USA).	  The	  antisense	  MOs	  
used	   for	   the	   silencing	   of	   zebrafish	  ambra1a	   and	  ambra1b	  were	   designed	   against	   the	  ATG	  
translation	   initiation	   site	  according	   to	   the	   following	   sequences:	  MO1-­‐ambra1a	   (5-­‐CTC	  CAA	  
ACA	  CTC	  TTC	  CTC	  ACT	  CCC	  T	  -­‐3’)	  and	  MO1-­‐ambra1b	  (5’-­‐TTT	  TCC	  TCT	  TTA	  GTG	  CTC	  CAC	  GGC	  
C-­‐3’).	  	  
The	  antisense	  splice	  variant	  MOs	  were	  designed	  for	  both	  genes	  on	  the	  sequence	  at	  the	  
exon	  3-­‐intron	  3	   junction:	  MO2-­‐ambra1a:	   5’-­‐TGT	  AAT	  CAA	  AGT	  GGT	  CTT	  ACC	  TGT	  C-­‐3’	  and	  
MO2-­‐ambra1b:	   5’-­‐	   TGA	   AAT	   TGA	   TTG	   TTA	   CCT	   ATC	   TGG	   A-­‐3’	   (the	   exon	   complementary	  
sequence	  is	  underlined).	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As	   controls,	  we	  used	   five-­‐nucleotide-­‐mismatched	   control	  MOs:	  MO1-­‐ambra1a-­‐5m	   (5’-­‐	  
CTC	  gAA	  AgA	  CTg	  TTC	  CTg	  AgT	  CCC	  T-­‐3’)	  and	  MO1-­‐ambra1b-­‐5m	  (5’-­‐TTa	  TgC	  TgT	  TTA	  GTc	  CTC	  
CAC	  cGC	  C-­‐3’)	   (lowercase	  bold	   letters	   indicate	   the	  mismatch	  changes).	  Finally,	  we	  used	  an	  
MO	  against	  the	  ATG	  translation	  initiation	  site	  of	  tp53	  mRNA,	  tp53	  MO:	  5ʹ′-­‐GCG	  CCA	  TTG	  CTT	  
TGC	  AAG	  AAT	  TG-­‐3ʹ′	  (MO4-­‐tp53)	  [19].	  
All	   the	   MOs	   were	   reconstituted	   at	   1	   mM	   in	   nuclease-­‐free	   water.	   Different	   MOs	  
concentrations	   were	   tested	   in	   a	   range	   between	   1	   and	   2.5	   µg/µl.	   MOs	   and	   mRNAs	   (see	  
below)	  were	  injected	  into	  the	  yolk	  mass	  of	  1-­‐	  or	  2-­‐cell	  embryos.	  These	  were	  then	  incubated	  
in	  1X	  Fish	  Water	  (50X:	  25	  g	  Istant	  Ocean,	  39.25	  g	  CaSO4,	  and	  5	  g	  NaHCO3	  for	  1	  l)	  at	  28.5°C.	  
MOs-­‐	  and/or	  mRNAs-­‐injected	  embryos	  were	  raised	  to	  the	  desired	  stages	  for	  observations	  or	  
collected	  for	  further	  analysis.	  	  
In	   order	   to	   verify	   the	   knockdown	   effectiveness	   of	  MO1-­‐ambra1a	   and	  MO1-­‐ambra1b,	  
the	   5’-­‐UTR	   region	   of	   both	   paralogs,	   containing	   the	   MOs	   target	   sequence,	   was	   cloned	   in	  
pCR®-­‐BluntII-­‐TOPO	   vector	   (K280002,	   Invitrogen),	   in-­‐frame	   upstream	   of	   the	   fluorescent	  
protein	  EGFP	  coding	  region.	  The	  nucleotide	  portion	  including	  MOs	  target	  sequence	  and	  EGFP	  
was	   XbaI	   and	   EcoRI	   digested	   and	   subcloned	   into	   pCS2+	   expression	   vector.	   The	   resulting	  
expression	   vectors	   were	   verified	   by	   sequencing.	   Linearized	   plasmids	   (1	   μg)	   were	   used	   as	  
templates	   for	   the	   synthesis	  of	   capped	  synthetic	  mRNAs	  with	   the	  mMESSAGE	  mMACHINE®	  
SP6	  Kit	  (AM1340,	  Ambion).	  Synthetic	  mRNAs	  were	  precipitated	  by	  centrifugation	  in	  LiCl	  and	  
their	   integrity	   confirmed	   by	   formaldehyde-­‐agarose	   electrophoresis.	   Stock	   of	   synthetic	  
mRNAs	  solutions	  were	  quantified	  by	  absorbance	  and	  diluted	  to	  desired	  concentrations	  in	  1X	  
Danieau’s	  buffer	  for	  microinjection.	  
The	   effectiveness	   of	   SPLICMOs	   for	   exon	   skipping	   was	   confirmed	   by	   the	   presence	   of	   a	  
significant	   amount	   of	   shorter	   RNA	   products	   detected	   by	   RT-­‐PCR	   with	   two	   set	   of	   specific	  
primers	   flanking	   the	   splice	   site	   (Am1a-­‐F5	   with	   Am1a-­‐R6	   for	   ambra1a	   and	   Am1b-­‐F5	   with	  
Am1b-­‐R4	  for	  ambra1b,	  see	  supplementary	  Table	  4).	  
In	  vitro	  transcription	  
For	  rescue	  experiments,	  since	  the	  injected	  synthetic	  mRNAs	  should	  not	  contain	  the	  MOs	  
target	   sequences,	  modified	   cDNAs	  were	   amplified	   for	  ambra1a1,	  ambra1a3	   and	  ambra1b	  
with	  forward	  primers	  containing	  silent	  mutations	  and	  the	  restriction	  site	  of	  ClaI	  and	  reverse	  
primers	   containing	   the	   restriction	   site	   of	   XhoI	   (see	   supplementary	   Figure	   1	   and	  
supplementary	  Table	  4	  for	  details).	  The	  resulting	  PCR	  products	  were	  cloned	  into	  the	  pCR®-­‐
Blunt	   vector	   and,	   after	   complete	   sequencing	   to	   check	   for	   lack	   of	   nucleotide	   changes	   that	  
could	  alter	  the	  amino	  acidic	  sequence	  or	  interrupt	  the	  translation	  reading	  frame,	  subcloned	  
into	  pCS2+	  expression	  vector	  using	  ClaI	  and	  XhoI	  restriction	  enzymes.	  
Linearized	  plasmids	  (1	  µg)	  were	  used	  as	  templates	  for	  the	  synthesis	  of	  capped	  synthetic	  
mRNAs,	  which	  were	  purified	  as	  described	  above.	  
The	  pGEM	  plasmids	  containing	  the	  last	  280	  and	  267	  nucleotides	  plus	  the	  3’-­‐UTR	  regions	  
of	  ambra1a1	  and	  ambra1b,	  respectively,	  were	  used	  to	  synthesize	  digoxigenin	  (DIG)-­‐labelled	  




cloned	   into	   pGEM-­‐T	   Easy	   vector.	   DIG-­‐labeled	   riboprobes	   were	   synthesized	   by	   in	   vitro	  
transcription	  with	  SP6	  and	  T7	  RNA	  polymerases,	  respectively	  (Sp6	  RNA	  polymerase,	  10	  810	  
274	   001;	   T7	   RNA	   polymerase,	   10	   881	   767	   001,	   Roche),	   following	   the	   manufacturer’s	  
instructions.	  	  
Whole-­‐mount	  in	  situ	  hybridization	  and	  microscopy	  analyses	  
WMISH	   was	   performed,	   on	   normal	   and	   treated	   embryos,	   essentially	   as	   reported	   by	  
Thisse	  and	  Thisse	  [36].	  Embryos	  were	  fixed	  overnight	  in	  4%	  paraformaldehyde	  (PFA,	  P6148,	  
Sigma)	  in	  phosphate-­‐buffered	  saline	  (PBS)	  at	  the	  desired	  stage	  of	  development.	  For	  embryos	  
older	  than	  24	  hpf,	  pigmentation	  was	  suppressed	  by	  raising	  embryos	  in	  0.03%	  PTU	  (1-­‐phenyl-­‐
2-­‐thiourea,	  P7629,	  Sigma)	  in	  Fish	  Water.	  Afterwards,	  the	  embryos	  were	  washed	  in	  PBT	  (PBS	  
plus	  0.1%	  Tween	  20,	  P1379,	  Sigma)	  and	  dechorionated	  with	  forceps.	  They	  were	  treated	  with	  
methanol	  and	  stored	  at	  -­‐20°C.	  Methanol-­‐stored	  embryos	  were	  rehydrated	  in	  methanol/PBS	  
series,	   permeabilized	   by	   proteinase	   K	   (10	   µg/ml),	   prehybridized,	   and	   then	   hybridized	  
overnight	  at	  65°C	  with	  1	  ng/µl	  of	   the	  appropriate	  riboprobe	   in	  the	  Hybridization	  Mix	   (HM:	  
50%	   formamide,	   5×SSC,	   0.1%	   Tween	   20,	   50	   µg/ml	   heparin	   and	   500	   µg/ml	   tRNA).	   After	  
HM/SSC	  and	  SSC/PBT	  washing	  series,	  embryos	  were	  preincubated	   in	  blocking	  solution	   (2%	  
sheep	   serum,	  and	  2	  mg/ml	  BSA	   in	  PBT)	  and	   then	   incubated	  overnight	  at	  4°C	  with	  alkaline	  
phosphatase	  (AP)-­‐conjugated	  anti-­‐DIG	  antibodies	  (11	  093	  274	  910,	  Roche)	  diluted	  1:3,000	  in	  
blocking	  solution.	  After	  PBT	  washing,	  embryos	  were	  pre-­‐soaked	  in	  staining	  buffer	  and	  then	  
incubated	   in	   NBT/BCIP	   (5-­‐nitro-­‐blue	   tetrazolium	   chloride/bromo-­‐4-­‐chloro-­‐3'-­‐
indolyphosphate	   p-­‐toluidine	   salt	   Stock	   solution,	   11	   681	   451	   001,	   Roche)	   for	   blue	   staining.	  
WMISH-­‐stained	  embryos	  were	  mounted	   in	  80%	  glycerol	   in	  PBT	  or	  cleared	  and	  mounted	   in	  
2:1	   benzyl	   benzoate/benzyl	   alcohol,	   observed	   under	   a	   Leica	   DMR	   microscope	   (Leica	  
Microsystems	  Srl,	  Milano,	  Italy)	  and	  photographed	  with	  a	  Leica	  DC500	  digital	  camera	  (Leica	  
Microsystems	  Srl,	  Milano,	  Italy)	  
All	  riboprobes	  for	  WMISHs	  are	  listed	  in	  supplementary	  Table	  5.	  	  
For	   histology	   analysis,	   zebrafish	   WMISH-­‐stained	   larvae	   at	   6	   dpf	   were	   fixed	   in	   4%	  
paraformaldehyde	   at	   RT	   for	   2	   h	   and	   processed	   into	   an	   alcohol–xylene	   series	   followed	   by	  
paraffin	  embedding.	  	  
Blood	   vessels	   were	   visualized	   by	   endogenous	   alkaline	   phosphatase	   activity	   at	   3	   dpf	  
following	  the	  protocol	  of	  Serbedzija	  et	  al	  [37].	  
For	  scanning	  electron	  microscopy	  (SEM)	  material	  was	  fixed	  in	  6%	  glutaraldehyde	  in	  0.1	  
M	  cacodylate	  buffer	  (pH	  6.9)	  overnight	  at	  4°C.	  The	  post-­‐fixed	  samples	  were	  dehydrated	  in	  a	  
graded	   ethanol	   series,	   dried	   at	   the	   critical	   point	   and	   coated	  with	   gold.	   The	   samples	  were	  
observed	   with	   a	   Stereoscan	   260	   (Cambridge	   Instruments	   Ltd,	   Cambridge,	   UK)	   scanning	  
electron	   microscope,	   operating	   at	   12	   kV.	   For	   semithin	   section,	   material	   was	   fixed	   in	   6%	  
glutaraldehyde	   in	   0.1	   M	   cacodylate	   buffer	   (pH	   6.9)	   overnight	   at	   4°C.	   After	   washing	   in	  
cacodylate	  buffer,	   the	  specimens	  were	  post-­‐fixed	   in	  1%	  OsO4	   in	  the	  same	  buffer	   for	  two	  h	  
and	  dehydrated	  in	  a	  graded	  ethanol	  series	  followed	  by	  propylene	  oxide.	  The	  specimens	  were	  
stained	  with	  uranyl	  acetate	  while	  undergoing	  dehydration	  in	  75%	  ethanol.	  The	  samples	  were	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embedded	   in	   Araldite	   resin.	   Thin	   sections	   were	   cut	   with	   an	   Ultracut	   S,	   Reichert	  
ultramicrotome	   (New	   York,	   USA),	   stained	   with	   toluidine	   blue	   and	   examined	   with	   a	   light	  
microscope.	  
Immunoblotting	  analysis	  
Embryos	  were	   homogenized	   in	   CelLytic	  Mammalian	   Tissue	   extraction	   reagent	   (C3228,	  
Sigma-­‐Aldrich).	   Twenty	   micrograms	   of	   protein	   extracts	   were	   separated	   on	   a	   13.5%	   SDS-­‐
polyacrylamide	  gel	  and	  electroblotted	  onto	  PVDF	  (IPVH20200,	  Millipore)	  membranes.	  Blots	  
were	   incubated	  with	   a	   rabbit	   anti-­‐LC3	   antibody,	   (#2775,	   Cell	   Signaling)	   and	   a	   rabbit	   anti-­‐
BECN1	  antibody	  (Santa	  Cruz	  H-­‐300	  #11427)	  in	  5%	  non-­‐fat	  dry	  milk	  in	  TBS	  plus	  0,1%	  Tween20	  
overnight	   at	   4°C.	   Detection	   was	   achieved	   using	   horseradish	   peroxidase-­‐conjugate	   anti	  
mouse	  IgG	  antibody	  (711-­‐036-­‐152,	  Jackson	  Immunoresearch)	  and	  visualised	  with	  ECL	  PRIME	  
(RPN2232,	   GE	   Healthcare)	   using	   ECL-­‐Hyperfilm	   (28-­‐9068-­‐37,	   GE	   Healthcare).	   Rabbit	   anti-­‐
Actin	   antibody	   (A2066,	   Sigma	   Aldrich),	   was	   used	   to	   monitor	   equal	   protein	   loading.	   The	  
antibody	   is	   made	   against	   the	   SGPSIVHRKCF	   peptide	   that	   is	   100%	   identical	   in	   beta	   and	  
gamma	  Actin	  and	  91%	  in	  alpha	  Actin.	  	  
To	  assess	   the	   rate	  of	  autophagic	   flux	  upon	  Ambra1	  downregulation,	   Lc3-­‐II	   levels	  were	  
analysed	   in	   48	  hpf	   embryos	   incubated	  with	   the	   lysosome	   inhibitor	   bafilomycin	  A1	   (1	  mM)	  
(Sigma	  Aldrich	  #B1793)	  for	  6	  h	  and	  then	  fixed	  for	  immunoblotting	  analysis.	  
Quantification	   of	   chemiluminescent	   signals	   was	   performed	   with	   the	   Gel	   Doc	  
densitometer	  (BioRad,)	  using	  the	  Quantity	  One	  imaging	  software,	  version	  4.4.0.	  All	  samples	  
were	  run	  in	  triplicate	  and	  averaged.	  
Apoptotic	  assays	  
Apoptotic	   cells	   in	   the	   embryos	   were	   detected	   by	   the	   TdT-­‐mediated	   fluorescein-­‐dUTP	  
nick	   end	   labeling	   (TUNEL)	   assay.	   The	   TUNEL	   assay	   was	   performed	   using	   alkali	   stable	  
digoxigenin-­‐dUTP	  and	  TdT	  (terminal	  deoxynucleotidyl	  transferase)	  (03	  333	  574	  001,	  Roche).	  
Embryos	  were	  fixed	  in	  4%	  PFA	  (overnight,	  4°C),	  treated	  with	  methanol	  and	  stored	  at	  -­‐20°C.	  
Methanol-­‐stored	   embryos	   were	   rehydrated	   in	  methanol/PBS	   series	   and	   permeabilized	   by	  
proteinase	  K	  (10	  µg/ml).	  Afterwards,	  the	  embryos	  were	  washed	  in	  PBT	  (5x5	  min,	  RT)	  and	  in	  
ethanol/acetic	   acid	   (2:1)	   (20	   min	   RT).	   After	   incubation	   with	   TUNEL	   buffer	   (30	   min,	   RT),	  
embryos	  were	  incubated	  in	  100	  µl	  TUNEL	  reaction	  mixture	  (overnight,	  RT).	  The	  reaction	  was	  
stopped	  by	  washing	  samples	  with	  PBT/EDTA	  1mM	  (2x1	  h,	  RT).	  Samples	  were	  then	  processed	  
as	   for	   the	  whole-­‐mount	   in	   situ	   hybridization	   and	   stained	  with	   the	   AP	   substrate	   Fast	   Blue	  
(Fast	  Blue	  BB	  4-­‐benzoylamino-­‐2,5-­‐diethoxybenzenediazonium	  chloride	  hemi	   [zinc	   chloride]	  
salt,	   F3378,	   Sigma)	   plus	  NAMP	   (3-­‐hydroxy-­‐2-­‐naphthoic	   acid	   2,4-­‐dimethylanilide	   phosphate	  
N5000,	  Sigma).	  Stained	  embryos	  were	  mounted	   in	  80%	  glycerol	   in	  PBT	  and	  examined	  with	  
Leica	  SP5	  confocal	  microscope.	  
Apoptotic	   cells	   were	   estimated	   within	   the	   same	   area	   in	   five	   embryos	   of	   each	  
experimental	  condition.	  All	  data	  were	  represented	  as	  the	  mean	  ±	  S.D.	  Statistical	  significance	  





Sequencing	   was	   performed	   on	   double-­‐stranded	   DNA	   using	   the	   ABI	   PRISM	   Dye	  
Terminator	  Cycle	  Sequencing	  Core	  Kit	  (Applied	  Biosystems,	  Monza,	  Italy).	  Electrophoresis	  of	  
sequencing	  reactions	  was	  completed	  on	  the	  ABI	  PRISM	  model	  377,	  version	  2.1.1	  automated	  
sequencer.	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RESULTS	  
Isolation	  and	  characterization	  of	  the	  zebrafish	  ambra1	  genes	  and	  deduced	  proteins	  
Two	  predicted	  sequences,	  XM_002667669	  (coding	  for	  ambra1a,	  as	  named	  in	  this	  paper)	  
and	   XR_084457	   (coding	   for	   ambra1b),	   were	   identified	   by	   bioinformatics	   tools	   using	   the	  
mouse	  AMBRA1	  amino	  acid	  sequence	  (NP_766257) as	  query.	  The	  whole	  coding	  region	  of	  the	  
two	   transcripts,	   as	  well	   as	   the	   5’-­‐	   and	   3’-­‐untranslated	   terminal	   regions	   (UTRs),	  were	   then	  
sequenced	   using	   RNA	   extracted	   from	   2-­‐	   and	   48-­‐hpf	   (hours	   post-­‐fertilization)	   embryos,	  
according	  to	   the	  cloning	  strategy	  reported	   in	  supplementary	  Figure	  1.	  Sequences	  obtained	  
by	  RT-­‐PCR	  and	  cloning	  display	  differences	  with	  the	  above-­‐predicted	  sequences	  as	  well	  as	  the	  
presence	   or	   absence	   of	   predicted	   exons.	   Data	   on	   the	   nucleotide	   features	   of	   the	   different	  
transcript	  variants	  identified	  and	  sequenced	  in	  this	  work	  are	  described	  in	  Table	  1.	  
Figure	   1.	   Genomic	   structure	   and	   organization	   of	   zebrafish	   and	   mouse	   ambra1	   genes.	   Plain	   boxes	   indicate	  
exons.	   The	   coding	   region	   is	   in	   colour	   and	   numbered	  with	   Roman	   numerals.	   Boxes	   of	   exon	   8	   are	   dashed	   in	  
transcripts	  where	  it	  may	  be	  absent.	  The	  positions	  of	  the	  WD40	  domain,	  BECN1	  and	  DYNLL1	  binding	  regions	  are	  
indicated.	  Introns,	  represented	  as	  lines,	  are	  not	  drawn	  to	  scale,	  but	  the	  corresponding	  lengths	  can	  be	  found	  in	  
supplementary	  Table	  1	   together	  with	   the	  exon	  sizes.	  Exons	   in	   zebrafish	  ambra1a	  and	  b	   are	   similar	   in	   size	   to	  





The	  genomic	  organization	  of	  the	  two	  genes,	  obtained	  by	  sequence	  analysis	  of	  the	  new	  
cDNAs	  with	  the	  BLAT	  program,	  is	  described	  in	  Figure	  1	  and	  compared	  with	  that	  of	  the	  mouse	  
Ambra1	   gene.	   In	   supplementary	   Table	   1,	   we	   report	   the	   sizes	   of	   each	   of	   the	   exons	   and	  
introns.	   The	   canonical	   splice	   consensus	   sites	   “GT”	   and	   “AG”	   are	   present	   in	   all	   zebrafish	  
ambra1	  introns.	  	  
The	   zebrafish	   gene	   ambra1a	   is	   alternatively	   spliced,	   generating	   four	   variant	   carboxy-­‐
terminal	   sequences.	   The	   entire	   coding	   sequence	   of	   the	   four	   ambra1a	   transcripts	   was	  
obtained	   by	   overlapping	   fragments	   of	   different	   lengths.	   Given	   the	   long	   and	   alternatively	  
spliced	   transcripts,	  all	   the	   four	  variants	  were	  also	  amplified	  with	  a	  set	  of	  primers	   localized	  
before	   and	   after	   the	   start	   and	   stop	   codons	   (see	   supplementary	   Figure	   1).	   The	   fragments	  
were	  then	  cloned	  and	  sequenced	  to	  verify	  the	  accuracy	  of	  the	  overlapping	  processes.	  All	  the	  
four	  variants	  cloned	  lacked	  exon	  8,	  as	  it	  occurred	  in	  one	  of	  the	  two	  transcripts	  encoded	  by	  
mouse	  Ambra1	  gene	  (see	  Figure	  1,	  exon	  boxed	  with	  dashed	  line).	  However,	  PCR	  performed	  
with	  a	  sense	  primer	   located	  on	  exon	  7	  and	  an	  antisense	  primer	  specific	   for	  each	  ambra1a	  
form	   showed	   that	  exon	  8	   could	  be	   transcribed,	  but	   at	   very	   low	   levels	  with	   respect	   to	   the	  
forms	  lacking	  this	  exon	  (data	  not	  shown).	  The	  presence	  of	  exon	  8	  as	  well	  as	  the	  expression	  of	  
all	   the	   identified	   transcripts	   were	   checked	   at	   2-­‐	   and	   48-­‐hpf	   (see	   Table	   1).	   No	   transcript	  
containing	  exon	  8	  was	  found	  for	  the	  ambra1a4	  variant	  at	  both	  2-­‐	  and	  48-­‐hpf.	  	  
Ambra1b	   gene	   contains	   19	   exons	   as	   ambra1a,	   with	   the	   same	   genomic	   organization.	  
Though	   several	   3’-­‐RACE	   analyses	   using	   sense	   primers	   localized	   on	   different	   regions	   of	   its	  
coding	   sequence	   were	   performed,	   only	   one	   transcript	   was	   identified	   for	   this	   gene.	  
Moreover,	  no	  transcript	  variant	  lacking	  exon	  8	  was	  sequenced	  or	  identified	  by	  PCR	  analysis.	  
The	   mouse	   Ambra1	   gene	   (sequence	   used	   NP_766257),	   as	   the	   human	   one	   (not	   shown,	  
sequence	   used	  Q9C0C7),	   presents	   the	   same	   genomic	   organization	   as	   the	   zebrafish	   genes,	  
but	   it	   contains	   only	   18	   exons.	   Nevertheless,	   the	  mouse	   last	   exon	   (18th)	   contains	   a	   longer	  
coding	   region	  with	   respect	   to	   the	   corresponding	   exon	  18	  of	   zebrafish	  ambra1	   genes.	   This	  
difference	  explains	  the	  low	  identity	  in	  the	  C-­‐terminal	  regions	  of	  mammals	  and	  zebrafish	  full-­‐
size	   Ambra1	   deduced	   proteins	   (Figure	   2).	   Cloning	   results	   show	   that,	   although	   there	   is	   no	  
consistency	   with	   respect	   to	   intron	   size	   (supplementary	   Table	   1),	   the	   overall	   gene	  
architecture	  has	  been	  conserved	  across	  species.	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GenBank	  Accession	   2	  hpf	   48	  hpf	  
ambra1a1	   307	  bp	   182	  bp	  
3948	  bp	   1315	  aa	   HE602022	   x	   x	  
4035	  bp	   1344	  aa	   -­‐	   x	   x	  
ambra1a2	   307	  bp	   266	  bp	  
3297	  bp	   1098	  aa	   HE602023	   x	   x	  
3384	  bp	   1127	  aa	   -­‐	   x	   x	  
ambra1a3	   307	  bp	   540	  bp	  
2367	  bp	   788	  aa	   FR846231	   x	   x	  
2454	  bp	   817	  aa	   -­‐	   -­‐	   x	  
ambra1a4	   307	  bp	   362	  bp	  
2175	  bp	   724	  aa	   HE602022	   -­‐	   x	  
2262	  bp	   753	  aa	   -­‐	   -­‐	   -­‐	  
ambra1b	   350	  bp	   1269	  bp	   4083	  bp	   1360	  aa	   FR846230	   x	   x	  
	  	  	  	   Table	  1.	  Summary	  of	  the	  principal	  features	  of	  the	  cloned	  transcripts	  for	  zebrafish	  ambra1	  genes.	  
Alignment	  of	  the	  zebrafish	  Ambra1a1	  and	  b	  amino	  acid	  sequences	  with	  those	  of	  human	  
and	   mouse	   indicates	   that	   the	   primary	   structure	   of	   Ambra1	   proteins	   is	   highly	   conserved	  
among	  vertebrates	  (Figure	  2)	  and	   is	  represented	  by	  a	  WD40	  protein	  of	  about	  1,300	  amino	  
acids.	   Zebrafish	   Ambra1a1	   and	  Ambra1b	   polypeptides	   exhibit	   55%	   identity	   to	   each	   other,	  
and	  56	  and	  58%	  identity	  with	  human	  and	  mouse	  AMBRA1s,	  respectively	  (Table	  2).	  The	  WD40	  
motif	  (amino	  acids	  49–175	  of	  human	  AMBRA1)	  shows	  very	  high	  identity	  among	  the	  human,	  
mouse	   and	   zebrafish	   AMBRA1	   polypeptides	   (Table	   2).	   The	   region	   involved	   in	   the	   binding	  
with	  the	  BECN1	  protein	  presents	  a	  lower	  identity	  ranging	  from	  45	  to	  52%,	  according	  to	  the	  
presence	  or	  absence	  of	  exon	  8.	  Binding	  sites	  to	  the	  dynein	  light	  chain	  (DYNLL1)	  are	  present	  
only	   in	   Ambra1a1,	   Ambra1a2	   and	   Ambra1b	   proteins,	   all	   three	   containing	   the	   double	   TQT	  
domain	  (Table	  2).	  	  




Figure	   2.	  Multiple	   sequence	   alignment	   of	   human	   (Hs,	  Homo	   sapiens,	  Q9C0C7),	  mouse	   (Mm,	  Mus	  musculus,	  
NP_766257)	   and	   zebrafish	   (Dr,	   Danio	   rerio)	   Ambra1	   proteins	   was	   originated	   with	   the	   program	   ClustalW.	  
Zebrafish	  Ambra1	  amino	  acid	  sequence	  is	  inferred	  from	  the	  coding	  sequences	  cloned	  in	  this	  study	  (Ambra1a1,	  
HE602022;	   Ambra1a2,	   HE602023;	   Ambra1a3,	   FR846231;	   Ambra1a4,	   HE602024;	   Ambra1b,	   FR846230).	   In	   the	  
alignment,	   identical	   residues	   in	   all	   sequences	   are	   indicated	   by	   ‘*’.	   Conservative	   and	   semi-­‐conservative	  
substitutions	  are	  indicated	  by	  ‘:’	  and	  ‘.’,	  respectively.	  The	  WD40	  repeats-­‐region	  at	  the	  N-­‐terminus	  is	  shadowed	  
in	  yellow,	  the	  region	  involved	  in	  the	  BECN1	  interaction	  in	  green	  and	  the	  binding	  site	  to	  the	  dynein	  light	  chain	  
(DYNLL1)	   in	   light	   blue,	   with	   the	   TQT-­‐domain	   in	   red.	   Position	   of	   exon	   8,	   inside	   BECN1	   binding	   region,	   is	  
underlined.	  	  




WD40	   Becn1	  b	   DYNLL1	  b	  
Tot.	  
identity	  
WD40	   BECN1	  b	   DYNLL1	  b	  
Tot.	  
identity	  
WD40	   BECN1	  b	   DYNLL1	  b	  
Dr-­‐
ambra1a	  
55	   88	   45/50	   69	   56	   90	   46/51	   61	   56	   90	   47/52	   66	  
Dr-­‐
ambra1b	  
-­‐	   -­‐	   -­‐	   -­‐	   58	   90	   49	   74	   58	   90	   50	   79	  
Mm-­‐
ambra1	  
	   	   	   	   -­‐	   -­‐	   -­‐	   -­‐	   95	   100	   94	   92	  
Table	  2.	  Percentage	  of	  identity	  between	  Zebrafish	  Ambra1a1	  and	  Ambra1b	  polypeptides	  and	  with	  human	  and	  
mouse	  AMBRA1s.	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Conserved	  syntenies	  for	  ambra1	  genes	  and	  phylogenetic	  analysis	  
Analysis	  of	  conserved	  synteny	  between	  zebrafish	  and	  human	  genomes	  was	  performed	  
using	  the	  Syntheny	  Database	  set	  up	  on	  the	  zebrafish	  genome	  assembly	  Zv9	  and	  the	  Ensembl	  
version	   61	   [17].	   The	   duplicated	   ambra1	   genes	   share	   strong	   synteny	   with	   the	   human	  
AMBRA1.	   As	   shown	   in	   Figure	   3,	   panel	   A,	   zebrafish	  ambra1a	   and	  b	   lie	   on	   chromosomes	   7	  
(Dre7)	  and	  25	  (Dre25),	  respectively.	  Their	  genomic	  neighbourhoods	  contain	  20	  and	  12	  genes,	  
respectively,	  with	  conserved	   synteny	   to	   the	  orthologous	   region	   in	  human	  chromosome	  11	  
(Hsa11)	  in	  which	  the	  single	  AMBRA1	  gene	  is	  located	  as	  expected	  if	  zebrafish	  ambra1	  genes	  
are	  co-­‐orthologous	  to	  the	  human	  gene	  AMBRA1.	  Moreover,	  the	  Synteny	  Database	  analysis	  
(sliding	  window	  size	  25	  genes)	  shows	  that	  the	  linkage	  fragments	  of	  chromosomes	  7	  and	  25	  
containing	  ambra1a	  and	  b	  enclose	  other	  genes	  that	  are	  duplicated	  in	  zebrafish	  and	  present	  
as	   single	   gene	   in	  mammals,	   such	   as:	  midkine	   (mdk),	  diacylglycerol	   kinase-­‐zeta	   (dgkz),	  M4	  
muscarinic	  cholinergic	  receptor	  (chrm4)	  and	  PDH	  finger	  protein	  21A	  (phf21a).	  These	  findings	  
suggest	   that	   the	   zebrafish	   ambra1a	   and	   ambra1b	   genes	   are	   paralogs,	   which	   most	   likely	  
arose	  as	  a	   result	  of	   the	  genome-­‐wide	  duplication	   that	  occurred	  at	   the	  base	  of	   the	   teleost	  
radiation	  [18].	  
To	  determine	  whether	  the	  presence	  of	  two	  ambra1	  genes	  is	  a	  general	  feature	  of	  teleost	  
genomes,	   genomic	   database	   from	   Tetraodon	   nigroviridis,	   Takifugu	   rubripes,	   Gasterosteus	  
aculeatus	   and	   Oryzias	   latipes	   were	   screened	   on	   the	   BLAT	   program	  
(http://genome.ucsc.edu/cgi-­‐bin/hgBlat?command=start)	   using	   Ambra1a	   and	   b	   sequences	  
as	   queries.	   However,	   no	   duplicated	   ambra1	   genes	   could	   be	   detected	   in	   these	   genomes,	  
suggesting	  that,	  in	  these	  species,	  one	  of	  the	  duplicated	  genes	  was	  silenced	  and	  subsequently	  
lost.	   Moreover,	   analysis	   of	   teleost	   fishes	   EST	   libraries	   did	   not	   suggest	   the	   presence	   of	  
transcripts	  deriving	  from	  duplicated	  genes.	  
A	  phylogenetic	  analysis	  was	  performed	   to	   study	   the	  evolutionary	   relationships	  among	  
the	  AMBRA1	   genes	  using	   the	  amino	  acid	   sequence	  of	   zebrafish	  Ambra1a	  and	  b	  and	  other	  
published	   Ambra1	   sequences.	   The	   resulting	   tree	   (Figure	   3,	   panel	   B)	   shows	   that	   tetrapods	  
and	  teleostean	  fishes	  share	  a	  common	  ancestor	  for	  the	  AMBRA1	  gene	  family.	  Moreover,	  the	  
tree	   suggests	   that	   a	   duplication	   arose	   within	   the	   teleostean	   clade	   giving	   birth	   to	   the	  
paralogous	   forms	   of	   ambra1	   found	   in	   zebrafish.	   The	   separation	   of	   the	   two	   paralogous	  
zebrafish	  genes	  is	  very	  well	  supported	  (bootstrap	  value:	  1000/1000).	  Moreover,	  Danio	  rerio	  






Figure	   3.	   Conserved	   synteny	   neighbouring	   the	   AMBRA1	   locus	   and	   evolutionary	   relationship	   of	   the	   known	  
ambra1	  genes.	  (A)	  Graphical	  representation	  of	  conserved	  synteny	  neighbouring	  the	  AMBRA1	  locus	  between	  D.	  
rerio	   chromosomes	   7	   (Dre7)	   and	   25	   (Dre25)	   and	   H.	   sapiens	   chromosome	   11	   (Hsa11).	   The	   analysis	   was	  
performed	   with	   the	   Synteny	   Database	   program	   (http://teleost.cs.uoregon.edu/acos/synteny_db/)	   with	   a	  
sliding	  window	   size	  of	   25	   genes.	   Synteny	  analysis	   shows	   that	   the	  portion	  of	   zebrafish	   chromosome	  7	   (Dre7)	  
that	   contains	  ambra1a	  and	   the	  portion	  of	   zebrafish	   chromosome	  25	   (Dre25)	   that	   contains	  ambra1b	   possess	  
other	  four	  genes	  that	  are	  orthologous	  to	  genes	  in	  the	  portion	  of	  human	  chromosome	  11	  (Hsa11)	  that	  contains	  
AMBRA1.	   Gene	   names	   are	   from	   Ensembl	   (http://www.ensemblgenomes.org/)	   or	   NCBI	  
(http://www.ncbi.nlm.nih.gov/gene/).	  Genes	  are	  drawn	  as	  squares.	  The	  figure	  depicts	  the	  relative	  locations	  of	  
genes,	   but	   is	   not	   drawn	   to	   physical	   scale.	   The	   positions	   of	   ambra1a,	  ambra1b	   and	  AMBRA1	   are	  marked	   in	  
green.	  Oblique	   lines	  connect	  presumed	  paralogs	  within	  chromosome	  groups.	   (B)	  Evolutionary	   relationship	  of	  
the	  known	  ambra1	   genes.	  The	  phylogenetic	   tree	  was	  calculated	  using	   the	  Maximum	   likelihood	  method	  with	  
the	  RaxML	  7.2.6	  program	  and	  by	  applying	  the	  evolutionary	  model	  JTT+G	  [41].	  Bar	  represents	  0.1	  substitutions	  
per	   site.	   Comparisons	   were	   made	   to	   the	   amino	   acid	   sequences	   of	   D.	   rerio	   Ambra1a	   (CCE04070),	   D.	   rerio	  
Ambra1b	   (CCA61107),	   Takifugu	   rubripes	   (ENSTRUG00000013113),	   Gasterosteus	   aculeatus	  
(ENSGACG00000007844),	  Orizyas	   latipes	   (ENSORLP00000017709),	   Silurana	   tropicalis	   (XP_002934144),	  Anolis	  
carolinensis	   (XP_003214662),	   Gallus	   gallus	   (ENSGALP00000013594),	   Oreochromis	   niloticus	   (XP_003458340),	  
Mus	  musculus	   (NP_766257),	  Homo	  sapiens	   (Q9C0C7).	  Numbers	   indicate	   the	  values	   supporting	   the	  branching	  
pattern	  from	  1000	  bootstraps.	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Expression	  patterns	  of	  ambra1a	  and	  b	  mRNAs	  during	  zebrafish	  development	  	  
To	   investigate	   the	   temporal	   expression	   pattern	   of	   zebrafish	   ambra1	   genes,	   together	  
with	  becn1,	  we	  performed	  qPCR	  analysis	  on	   cDNA	  obtained	   from	  different	  developmental	  
stages	   (Figure	   4).	   Gene-­‐specific	   primer	   sets	   were	   designed	   to	   span	   known	   introns,	   thus	  
revealing	  any	  contaminating	  genomic	  DNA	  as	  larger	  sized	  PCR	  fragments.	  For	  ambra1a,	  a	  set	  
of	  primers	  was	  designed	   to	   simultaneously	  amplify	   the	   four	   transcript	   variants,	  whereas	  a	  
second	   set	   could	   amplify	   only	   the	   two	   longer	   forms,	   ambra1a1	   and	   ambra1a2	   (see	  
supplementary	   Figure	   1).	   Due	   to	   constraints	   in	   fragment	   length	   for	   qPCR	   amplification,	   it	  
was	  not	  possible	   to	   select	  more	   specific	  primer	   sets	   for	   the	   shorter	   forms,	  ambra1a3	  and	  
ambra1a4.	  	  
Simultaneous	  detection	  of	  arp	  and	  18S	  rRNA	  gene	  expression	  was	  used	  to	  normalize	  the	  
expression	   level	  of	  ambra1	  variants.	   For	   the	  comparison	  of	  differences	   in	  gene	  expression	  
over	   time,	   all	   values	   were	   adjusted	   to	   the	   stage	   with	   the	   lowest	   expression	   level,	  
corresponding	  to	  becn1	  expression	  at	  8	  hpf	  which	  was	  set	  at	  an	  arbitrary	  unit	  of	  1.	  Similarly,	  
all	  ambra1	  variants	  present	  the	  lowest	  expression	  at	  this	  stage.	  	  
Figure	  4.	  Temporal	  expression	  patterns	  of	  the	  duplicated	  zebrafish	  ambra1	  genes.	  The	  graph	  shows	  the	  relative	  
mRNA	   transcript	   abundance	   of	   ambra1a	   (all	   transcript	   variants),	   ambra1a1	   and	   2	   and	   ambra1b,	   as	   well	   as	  




qPCR	   analysis	   revealed	   that	   ambra1a	   and	   b	   transcripts,	   as	   well	   as	   becn1,	   were	  
maternally	  deposited	   into	   the	  embryo.	   These	   transcripts	  dramatically	  declined	   throughout	  
the	  first	  8	  hpf,	  being	  replaced,	  thereafter,	  by	  the	  corresponding	  embryonic	  mRNAs	  up	  to	  a	  
maximum	  at	  6	  dpf	  (days	  post-­‐fertilization),	  the	  last	  stage	  examined.	  Transcripts	  of	  ambra1a	  
present	  a	  higher	  expression	  level	  at	  4	  and	  6	  dpf	  with	  respect	  to	  initially	  deposited	  maternal	  
mRNAs,	  whereas	  ambra1b	  expression	  was	  somewhat	  reduced.	  The	  contribution	  of	  the	  short	  
forms	  (ambra1a3	  and	  4),	  deduced	  from	  the	  difference	  between	  all	  ambra1a	  transcripts	  and	  
the	   two	   long	   forms,	   seems	   to	   increase	   during	   embryo	   and	   larval	   development.	   Similarly,	  
embryonic	  and	  larval	  becn1	  mRNA	  is	  much	  higher	  than	  the	  maternal	  messenger.	  
To	  further	  investigate	  the	  spatio-­‐temporal	  expression	  of	  maternal	  and	  zygotic	  ambra1a	  
and	  b	  mRNAs	  during	  zebrafish	  development,	  WMISH	  assays	  were	  performed	  on	  WT	  embryos	  
and	  larvae	  from	  0.2	  hpf	  to	  6	  dpf	  using	  digoxigenin-­‐labeled	  antisense	  ambra1a	  and	  ambra1b	  
mRNA	  probes.	   In	  order	   to	  ensure	   specificity	  and	   to	  avoid	   cross-­‐hybridizations,	  each	  probe	  
covered	  fragments	  of	  the	  C-­‐terminus	  and	  the	  3’-­‐UTR	  region.	  	  
Consistently	  with	  the	  qPCR	  results,	  ambra1a1	  and	  b	  mRNAs	  could	  be	  detected	  in	  one-­‐
cell	  stage	  embryos	  and	  distributed	  evenly	  in	  the	  blastodisc	  (Figure	  5).	  No	  or	  a	  very	  low	  signal	  
was	   found	   at	   10	   hpf	   (tail	   bud),	   in	   agreement	   with	   qPCR	   results	   showing	   a	   minimum	  
concentration	   of	   both	   transcripts	   at	   8	   hpf	   during	   gastrulation.	   At	   1	   dpf,	   the	   maternal	  
ambra1a	  mRNA	  was	  replaced	  by	  zygotic	  expression	  observed	  in	  the	  brain	  and	  otic	  vesicles.	  
At	  1	  dpf,	  ambra1b	  mRNA	  was	  concentrated	  in	  the	  head	  and	  in	  the	  trunk,	  but	  its	  expression	  
was	  less	  well	  defined	  with	  respect	  to	  ambra1a.	  At	  4	  and	  6	  dpf,	  both	  transcripts	  are	  localized	  
in	  the	  otic	  vesicles,	  oral	  cavity,	   intestine,	  swim	  bladder	  and	  trunk.	  As	  shown	  by	  histological	  
analysis,	   the	   signal	   for	   ambra1b	   is	   more	   evident	   in	   the	   apical	   border	   of	   the	   intestinal	  
epithelium	  with	  respect	  to	  ambra1a.	  	  
Chapter	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Figure	   5.	   Spatio-­‐temporal	   expression	   of	   ambra1a1	   and	   ambra1b	   mRNA	   during	   zebrafish	   development	   as	  
evidenced	   by	   whole-­‐mount	   in	   situ	   hybridization	   performed	   at	   the	   indicated	   stages.	   All	   embryos	   are	   lateral	  
views	   with	   the	   animal	   pole	   up	   (1	   cell	   and	   10	   hpf)	   and	   head	   pointing	   to	   the	   left	   (1,	   4	   and	   6	   dpf).	   10X	   =	  
magnification	  of	  the	  embryo	  (dorsal	  view)	  on	  the	  left.	  Bar	  =	  200	  μm.	  A	  and	  B:	  transverse	  histological	  sections	  6	  
μm	  thick	  of	  the	  6	  dpf	  ambra1a1	  (A)	  and	  ambra1b	  (B)	  labelled	  embryos	  (the	  dashed	  lines	  in	  6	  dpf	  whole-­‐mount	  
embryos	  indicate	  the	  position	  of	  the	  section).	  Ov	  =	  otic	  vesicle,	  Sb	  =	  swim	  bladder,	  In	  =	  intestinal	  cavity.	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Developmental	   consequences	   of	   Ambra1a	   and	   Ambra1b	  proteins	  depletion	   in	   zebrafish	  
embryos	  and	  larvae	  
MOs	  effectiveness	  	  
To	   determine	   the	   functions	   of	   ambra1a	   and	   b	   during	   zebrafish	   development,	   gene-­‐
specific	  antisense	  MOs	  targeted	  to	  the	  ATG	  region	  (MO1-­‐ambra1a	  and	  MO1-­‐ambra1b)	  were	  
injected	   into	   1-­‐cell	   embryos	   for	   translation	   knockdown.	   Five-­‐nucleotide-­‐mismatched	  MOs	  
(MISMMO)	  (MO1-­‐ambra1a-­‐5m	  and	  MO1-­‐ambra1b-­‐5m)	  were	  used	  as	  negative	  controls.	  
Due	  to	  the	  lack	  of	  specific	  antibodies	  validated	  to	  detect	  zebrafish	  Ambra1a	  or	  Ambra1b	  
proteins,	  the	  efficacy	  of	  MO1-­‐ambra1a	  and	  MO1-­‐ambra1b	  in	  targeting	  and	  blocking	  protein	  
translation	   for	   each	   paralogous	   gene	   was	   analysed	   by	   an	   alternative	   approach.	   This	   was	  
based	  on	   in	   vitro	   transcribed	  mRNAs	  encoding	   in-­‐frame	  EGFP	   fusion	   constructs	   containing	  
the	  MO-­‐targeted	  sequence	  of	  each	  ambra1	  paralog.	  Coinjection	  of	  ambra1a-­‐	  or	  ambra1b-­‐
EGFP	   fusion	   construct	   mRNAs	   with	   the	   corresponding	   5-­‐bp	   MISMMO,	   resulted	   in	   bright	  
ubiquitous	   EGFP	   protein	   expression,	   thus	   demonstrating	   that	   the	   relative	   knockdown	  
depends	  precisely	  on	  the	  complementary	  MO	  sequence	  (supplementary	  Figure	  2,	  panel	  A).	  
Coinjection	  of	  the	  EGFP	  fusion	  mRNAs	  for	  each	  paralog	  with	  the	  corresponding	  morpholino	  
resulted	  in	  a	  drastic	  reduction	  in	  the	  EGFP	  expression,	  thus	  indicating	  that	  both	  MOs	  are	  able	  
to	   efficiently	   inhibit	   protein	   translation	   (supplementary	   Figure	   2,	   panel	  A).	   To	   confirm	   the	  
absence	  of	  cross-­‐target	  effects,	  each	  MO	  was	  coinjected	  with	  the	  EGFP	  fusion	  mRNA	  for	  the	  
other	   paralog	   gene.	   In	   this	   case,	   no	   interference	   with	   EGFP	   expression	   was	   detected,	  
indicating	  that	  it	  is	  unlikely	  that	  cross-­‐targeting	  of	  MOs	  is	  occurring	  (supplementary	  Figure	  2,	  
panel	  A).	  
To	  discriminate	  between	  the	  contribution	  of	  maternal	  and	  zygotic	  ambra1	   transcripts,	  
gene-­‐specific	  antisense	  MOs	  targeted	  to	  the	  exon	  3	  -­‐	  intron	  3	  junction	  of	  the	  predicted	  pre-­‐
mRNA	   of	   each	   gene	   were	   injected	   (MO2-­‐ambra1a	   and	   MO2-­‐ambra1b).	   These	   SPLICMOs	  
caused	  the	  skipping	  of	  the	  exon	  3	  thus	  altering	  the	  translation	  reading	  frame	  of	  exon	  4	  with	  
introduction	   of	   a	   premature	   stop	   codon	   and	   production	   of	   a	   truncated	   Ambra1a	   and	  
Ambra1b	   proteins	   lacking	   all	   previously	   identified	   binding	   domains.	   The	   size	   of	   the	   mis-­‐
spliced	   product	   was	   consistent	   with	   the	   loss	   of	   the	   targeted	   exon	   3,	   as	   confirmed	   by	  
sequencing	  of	  both	  the	  mis-­‐spliced	  RT-­‐PCR	  products	  (supplementary	  Figure	  2,	  panel	  B).	  Total	  
RNAs	   extracted	   from	   4,	   6,	   8,	   12	   and	   24-­‐hpf	  WT	   and	  MO2-­‐ambra1a-­‐	   and	  MO2-­‐ambra1b-­‐
injected	   embryos	  were	   analysed	   by	   RT-­‐PCR	  with	   two	   sets	   of	   specific	   primers	   flanking	   the	  
splice	  site	  of	  each	  paralogous	  gene.	  Zygotic	  ambra1b	  expression	  takes	  place	  already	  at	  6	  hpf,	  
although	  at	  very	  low	  level,	  as	  indicated	  by	  the	  predicted	  mis-­‐spliced	  transcript	  detected	  as	  a	  
lower	  band	  when	  embryos	  are	  injected	  with	  MO2-­‐ambra1b.	  At	  8	  and	  12	  hpf,	  both	  ambra1	  
zygotic	   RNAs	   become	   predominant	   and	   almost	   completely	   abolished	   by	   SPLICMOs.	   At	   24	  
hpf,	   MO2-­‐ambra1a	   still	   efficiently	   abrogates	   ambra1a	   splicing,	   while	   the	   effect	   of	   MO2-­‐
ambra1b	  started	  to	  decrease	  as	  shown	  by	  the	  reappearance	  of	  normally	  spliced	  band.	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Optimization	  of	  MO	  injections	  
In	  order	  to	  optimize	  MO	  injections,	  8.2,	  10.3,	  15.5,	  20.6	  and	  25.8	  ng	  of	  MO1-­‐ambra1a	  or	  
MO1-­‐ambra1b,	   as	  well	   as	   of	   SPLICMOs	   (MO2-­‐ambra1a	   or	  MO2-­‐ambra1b)	   and	  MISMMOs	  
(MO1-­‐ambra1a-­‐5m	   or	   MO1-­‐ambra1b-­‐5m)	   per	   embryo	   were	   injected	   in	   triplicates.	  
Depending	   on	   the	   severity	   of	   defects	   compared	   to	   controls,	   morphant	   embryos	   from	  
ATGMOs	   were	   classified	   into	   two	   graded	   phenotypes,	   less	   affected	   as	   Class	   I	   and	   more	  
affected	   as	   Class	   II	   (Figure	   6).	   As	   expected,	   the	   highest	   numbers	   of	   dead	   embryos	   was	  
associated	  with	  the	  highest	  dose	  of	  both	  ATGMOs	  (25.8	  ng).	  On	  the	  other	  hand,	  the	  lowest	  
dose	   of	   both	   ATGMOs	   (8.2	   ng)	   showed	   the	   least	   number	   of	   abnormal	   phenotypes	  
(supplementary	   Table	   2).	   Accordingly,	   15.5	   ng	   of	   MO1-­‐ambra1a	   and	   20.6	   ng	   of	   MO1-­‐
ambra1b	  were	  chosen	  as	  optimal	  dosages	  to	  knockdown	  translation.	  At	  the	  same	  dosages,	  
MO1-­‐ambra1a-­‐5m	   and	   MO1-­‐ambra1b-­‐5m	   had	   no	   or	   very	   low	   effects	   on	   zebrafish	  
embryogenesis.	  
In	   the	   MO-­‐coinjection	   experiment,	   just	   5	   ng	   of	   MO1-­‐ambra1a	   plus	   4	   ng	   of	   MO1-­‐
ambra1b	   were	   selected	   as	   the	   best	   dosages	   for	   the	   simultaneous	   knockdown	   of	   the	   two	  
paralogous	   genes.	   In	   this	   case,	   morphant	   embryos	   were	   classified	   into	   three	   graded	  
phenotypes,	  with	  Class	  III	  corresponding	  to	  highly	  deformed	  morphants	  (Figure	  6).	  	  
Moreover,	  accordingly	  to	  the	  optimization	  analysis,	  18.5	  ng	  of	  MO2-­‐ambra1a	  and	  15.5	  
ng	   of	   MO2-­‐ambra1b	   were	   chosen	   as	   optimal	   dosages	   to	   knock	   down	   ambra1	   splicing	  
(supplementary	   Table	   2).	   Injected	   embryos	   were	   analyzed	   by	   light	   microscopy	   and	   their	  
morphology	  was	  recorded.	  	  
To	  further	  prove	  the	  specificity	  of	  the	  observed	  Ambra1	  knockdown	  phenotypes,	  each	  
ambra1	  ATGMO	  was	  coinjected	  with	  tp53/p53	  MO.	  The	  rationale	  is	  based	  on	  a	  report	  that	  
MOs	  can	  nonspecifically	  activate	  the	  tumor	  suppressor	  TP53-­‐induced	  apoptosis,	  causing	  off-­‐
target	  phenotypic	  effects	   that	  are	  not	   caused	  by	   the	   specific	  MO	  used	   [19].	  However,	   the	  
tp53	   MO	   failed	   to	   eliminate	   the	   morphant	   phenotypes	   and	   showed	   that	   these	   were	  




Figure	  6.	  Phenotypes	  of	  embryos	  or	  larvae	  at	  1	  and	  3	  dpf	  after	  treatment	  with	  the	  different	  ambra1	  ATGMOs	  
alone	  or	   together	  with	   tp53	  MO	  or	  with	   SPLICMOs.	  Morphants	  phenotypes	  are	   compared	   to	   control	   groups	  
(WT	   or	  MISMMOs).	   Phenotypes	   of	   tp53	  MO	  morphants	   are	   also	   reported.	   Animals	   are	   presented	   as	   lateral	  
view,	  anterior	  to	  the	  left.	  Bar	  =	  200	  μm.	  
Analysis	  of	  morphant	  phenotypes	  
This	   analysis	   showed	   that	   treatment	   with	   ambra1	   ATGMOs	   causes	   severe	   embryonic	  
malformations,	  because,	  at	  the	  selected	  MO	  dosages,	  ATGMOs	  morphants	  could	  survive	  for	  
only	  3	  and	  4	  days,	  respectively.	  
During	   early	   development	   (cleavage	   period,	   0-­‐3	   hpf),	   MO1-­‐ambra1a-­‐	   and	   MO1-­‐
ambra1b-­‐injected	   embryos	   could	   not	   be	   morphologically	   distinguished	   from	   the	   controls	  
(non-­‐injected	   and	   MISMMO-­‐embryos).	   However,	   by	   4	   hpf	   (sphere	   stage),	   both	   ATGMO-­‐
injected	   and	   coinjected	   embryos	   often	   exhibited	   a	   slight	   developmental	   delay,	  which	  was	  
more	  evident	  in	  the	  MO1-­‐ambra1a	  and	  coinjected	  morphants.	  	  
At	  1	  dpf,	  growth	  impairment	  was	  manifest,	  since	  both	  morphant	  embryos	  of	  Class	  II	  had	  
smaller	   head,	   reduced	   eyes	   and	   trunk,	   curved	   or	   twisted	   tail	   and	   delayed	   pigmentation	  
compared	   to	   controls.	   Otoliths	   were	   also	   smaller	   in	   size.	   Coinjection	   of	   both	   ATGMOs	  
produced	  more	   extensive	  morphological	   alterations	  with	   a	   complete	   derangement	   of	   the	  
body	  plan	  in	  Class	  III	  morphants	  (Figure	  6).	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At	  2	  dpf	  morphants	  were	  analysed	  by	  light	  microscopy	  analysis	  of	  morphology	  as	  well	  as	  
by	   scanning	   electron	   microscopy	   (SEM)	   and	   toluidine	   blue	   stained	   semithin	   sections.	   As	  
shown	   in	  Figure	  7,	  morphants	  showed	  abnormal	  head	  development	   involving	  smaller	  eyes	  
and	  pronounced	  hydrocephalus,	  that	  is	  present	  in	  both	  midbrain	  and	  hindbrain	  ventricles	  in	  
MO1-­‐ambra1a	  morphants	  compared	  with	  wild-­‐type	  and	  control	  morphants	  (Figure	  7,	  Panel	  
B).	  This	  problem	  is	  instead	  present	  only	  in	  hindbrain	  ventricles	  in	  MO1-­‐ambra1b	  morphants.	  
In	  coinjected	  morphants	  hydrocephalus	  was	  present	  in	  both	  midbrain	  and	  hindbrain	  and	  was	  
more	  severe,	  as	   shown	  by	   the	  corresponding	  semithin	  sections,	  where	  also	   the	  notochord	  
appeared	  disorganized	  (Figure	  7,	  Panel	  E).	  	  
At	   3	   dpf,	   these	   defects	   were	   further	   aggravated,	   as	   hatched	   MO1-­‐ambra1b	   and	   in	  
particular	  MO1-­‐ambra1a	   larvae	  were	  very	  poorly	  developed	  (Figure	  6).	  Abnormalities	  were	  
more	  severe	   in	  MO1-­‐ambra1a	   larvae	   (Figure	  6),	  which	  displayed	  higher	  degrees	  of	  ventral	  
curvature	  of	  the	  spine	  with	  misshapen	  tail	  (Figure	  6).	  MO1-­‐ambra1a	  larvae	  of	  class	  I	  show	  a	  
slight	  ventralizated	  phenotype	  that	  is	  more	  evident	  in	  ambra1a	  and	  ambra1b	  morphants	  of	  
class	  II	  as	  reported	  in	  supplementary	  Table	  6.	  
Figure	   7.	   Two-­‐dpf	   embryos	   treated	   with	   different	   ambra1	   ATGMOs	   and	   compared	   to	   controls.	   (A)	   SEM	  
(scanning	   electron	  microscope)	   images	   of	   dorsal	   view,	   anterior	   to	   the	   left.	   The	   white	   dashed	   lines	   indicate	  
position	   of	   the	   section	   reported	   in	   (C).	   (B)	   Light	   microscope	   image	   showing	   hydrocephalus	   (dashed	   lines).	  
Asterisks	   indicate	  midbrain-­‐hindbrain	   boundary.	   Lateral	   view	   head	   to	   the	   left.	   (C)	   Toluidine	   blue	   staining	   of	  
semithin	   transverse	   sections.	   (D)	   SEM	   images	   of	   lateral	   view	   tails	   showing	   the	   morphants	   deformities	  
compared	   to	   controls.	   (E)	   Transversal	   semithin	   sections	   stained	   with	   toluidine	   blue	   displaying	   notochord	  






At	  3	  dpf,	  light	  microscopy	  analysis	  of	  morphology	  of	  less	  deformed	  morphants	  showed	  
that	   otic	   vesicles	  were	  much	   smaller	   in	  MO1-­‐ambra1a	   and	   coinjected	  morphants	   (dashed	  
lines	   in	   Figure	   8).	   Eyes	  were	   smaller	  with	   both	  MOs,	  while	  MO1-­‐ambra1b	   and	   coinjected	  
morphants	   showed	  also	  mild	  cyclopia	   (close-­‐set	  eyes,	  white	  arrowheads	   in	  Figure	  8).	  Both	  
morphants	   presented	   pericardial	   oedema	   (arrows	   in	   Figure	   8)	   and	   persistent	   voluminous	  
and	  oedematous	  yolk	  sac.	  	  
Figure	  8.	  Close-­‐up	  lateral	  and	  ventral	  light	  microscopy	  views	  of	  3	  dpf	  wild-­‐type	  and	  ATGMOs-­‐injected	  embryos.	  
The	   genes	   targeted	   by	   ATGMOs	   are	   indicated	   for	   each	   image.	  Otic	   vesicles	   are	   smaller	   in	  MO1-­‐ambra1a	   and	  
ATGMO-­‐coinjected	  morphants	   (dashed	   lines).	  White	   arrowheads	   indicate	   cyclopia	   in	   ambra1b	   and	   coinjected	  
morphants.	  All	  morphants	  presented	  pericardial	  oedema	  (arrow).	  Bar	  =	  200	  μm	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The	  network	  of	  sub-­‐intestinal	  vessels	  at	  the	  yolk	  stalk,	  examined	  at	  3	  dpf,	  was	  devoid,	  in	  
both	   morphants,	   of	   the	   2	   to	   3	   loop	   series	   observed	   in	   WT,	   following	   blood	   vessel	  
visualization	   by	   endogenous	   alkaline	   phosphatase	   activity.	   The	   pattern	   of	   intersegmental	  
vessels	   in	   the	   trunk	  and	   tail	  was	  also	   less	  defined	   (supplementary	   Figure	  3).	   The	   lack	  of	   a	  
properly	  established	  circulation	  could	  explain	  the	  large	  yolk	  sac	  still	  present	  in	  48	  and	  72	  hpf	  
morphant	  embryos.	  
Knockdown	  of	  ambra1a	  and/or	  ambra1b	   indicates	  that	  both	  genes	  act	   in	  a	  synergistic	  
fashion	   during	   development,	   as	   the	   gravity	   and	   number	   of	   abnormalities	   when	   both	  
ATGMOs	  were	   injected	  was	  greater	   than	   the	   sum	  of	   those	  obtained	   following	   injection	  of	  
each	  ATGMO	  separately	  (Figs.	  6,	  7,	  8).	  With	  both	  MISMMOs,	  no	  morphological	  abnormalities	  
were	  observed	  up	  to	  7	  dpf.	  
Moreover,	  the	  analysis	  of	  morphant	  phenotypes	  showed	  that	  MO2-­‐ambra1a-­‐	  and	  MO2-­‐
ambra1b-­‐injected	   embryos	   (SPLICMOs)	   are	   comparable	   to	   controls	   during	   the	   first	  
developmental	  period	  (0-­‐24	  hpf).	  By	  1	  to	  3	  dpf	  morphant	  obtained	  by	  SPLICMOs	  seem	  only	  
slightly	  deformed	  with	  a	   lightly	  curved	  tail	   shape	   (Figure	  6).	  SEM	  analyses,	  performed	  at	  2	  
dpf,	  highlighted	  a	  pronounced	  hydrocephalus	   in	   the	  hindbrain	  area	  of	  both	  MO2-­‐ambra1a	  
and	  MO2-­‐ambra1b	  morphants	  (Figure	  9).	  	  
	  
Figure	  9.	  Lateral	  SEM	  and	  light	  microscopy	  views	  of	  wild-­‐type	  and	  SPLICMOs-­‐injected	  embryos.	  Top	  panel:	  Two-­‐
dpf	   embryos	   treated	  with	   ambra1a	   and	   b	   SPLICMOs	   and	   compared	   to	   controls.	   SEM	   images	   of	   dorsal	   view	  
showing	   the	   morphant	   deformities	   compared	   to	   control.	   Botton	   panel:	   Close-­‐up	   lateral	   and	   ventral	   light	  
microscopy	  views	  of	  5	  and	  10	  dpf	  WT	  and	  SPLICMOs-­‐injected	  embryos.	  The	  genes	  targeted	  by	  SPLICMOs	  are	  
indicated	  for	  each	  image.	  Otic	  vesicles	  are	  smaller	  in	  MO2-­‐ambra1a	  (dashed	  lines).	  Both	  SPLICMO	  morphants	  





Further	  abnormalities	  appeared	  later	  in	  development:	  by	  5	  dpf,	  MO2-­‐ambra1a-­‐injected	  
embryos	  showed	  developmental	  defects,	  such	  as	  a	  pronounced	  pericardial	  oedema,	  highly	  
reduced	  eyes	  and	  smaller	  otic	  vesicles	  compared	  to	  controls.	  The	  same	  abnormalities	  were	  
evident	  in	  MO2-­‐ambra1b	  embryos	  by	  10	  dpf	  (Figure	  9)	  and	  were	  similar	  to	  those	  displayed	  
by	  ATGMOs-­‐injected	  embryos	  earlier	   in	  development	  (Figure	  8).	  MO2-­‐ambra1a-­‐	  and	  MO2-­‐
ambra1b-­‐injected	  embryos	  died	  within	  12	  dpf.	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Rescuing	   of	  MO1-­‐ambra1b	   or	  MO1-­‐ambra1a	   knockdown	  with	   synthetic	  ambra1a	   and	  b	  
mRNAs	  
To	   rescue	   the	  knockdown	  phenotype,	   the	  MO1-­‐ambra1a	  was	  coinjected	  with	   in	  vitro-­‐
transcribed	  mutated	  zebrafish	  ambra1a1	  and	   1a3	  mRNAs	  encoding	   the	   full	   length	  of	  each	  
transcript	   variant,	   but	   containing	  eight	   silent	  mutations	   in	   the	   region	   recognised	  by	  MO1-­‐
ambra1a.	   Similarly	   the	   MO1-­‐ambra1b	   was	   coinjected	   with	   in	   vitro-­‐transcribed	   mutated	  
zebrafish	  ambra1b	  (Figure	  10	  and	  supplementary	  Table	  3).	  	  
We	  found	  that	  coinjection,	  at	  the	  one-­‐cell	  stage,	  of	  15.5	  ng	  MO1-­‐ambra1a	  with	  either	  
200	  pg	  of	  ambra1a1	  mRNA	  or	  150	  pg	  of	  ambra1a3	  mRNA	  was	  not	  able	  to	  fully	  rescue	  the	  
ambra1a	   loss-­‐of-­‐function	  phenotype,	  proving	   that	   this	  phenotype	  derives	   from	   the	   loss	  of	  
both	  long	  and	  short	  Ambra1a	  proteins.	  This	  was	  confirmed	  by	  coinjection	  of	  15.5	  ng	  of	  MO1-­‐
ambra1a	   with	   200	   pg	   of	   ambra1a1	   and	   150	   pg	   of	   ambra1a3	  mRNAs	   that	   led	   to	   highly	  
efficient	   rescue	   of	   the	   loss-­‐of-­‐function	   phenotype.	   The	   same	   result	   was	   obtained	   with	  
coinjection	  of	  20.6	  ng	  of	  MO1-­‐ambra1b	  with	  200	  pg	  of	  ambra1b	  mRNA,	  verifying	  that	  this	  
phenotype	  is	  a	  result	  of	  loss-­‐of-­‐function	  of	  ambra1b.	  
	   To	   test	   whether	   Ambra1a	   has	   equivalent	   functional	   capacities	   to	   Ambra1b,	   we	  
attempted	  to	  rescue	  the	  ambra1a	   loss-­‐of-­‐function	  phenotype	  by	  coinjection	  with	  ambra1b	  
mRNA	  and	  vice	   versa.	   In	   both	   cross-­‐injection	   experiments	   (15.5	   ng	  of	  MO1-­‐ambra1a	  with	  
200	  pg	  of	  ambra1b	  mRNA	  or	  20.6	  ng	  of	  MO1-­‐ambra1b	  with	  200	  pg	  of	  ambra1a1	  and	  150	  pg	  
of	  ambra1a3	  mRNAs	  )	  the	  phenotypes	  were	  not	  rescued.	  Moreover,	  in	  the	  MO1-­‐ambra1a	  (4	  
ng)	  plus	  MO1-­‐ambra1b	   (5	  ng)	   loss	  of	   function,	   a	   complete	   rescue	  was	  obtained	  only	  with	  
coinjection	  of	  ambra1a1	  (200	  pg),	  ambra1a3	  (200	  pg)	  and	  ambra1b	  (150	  pg)	  mRNAs	  (Figure	  
10	  and	  supplementary	  Table	  3).	  




Figure	  10.	  Phenotypes	  comparison	  among	  ATGMOs	  treated	  embryos	  and	  uninjected	  controls	  (WT)	  after	  the	  
different	  rescue	  experiments.	  The	  genes	  targeted	  by	  ATGMOs	  and	  the	  mRNAs	  injected	  are	  indicated	  for	  each	  
image.	  All	  the	  embryos	  are	  lateral	  view,	  anterior	  to	  the	  left.	  	  Bar	  =	  200	  μm.	  
	   	  
Chapter	  I	  
	  
	   49	  
Inhibition	   of	   ambra1a	   and	   b	   expression	   results	   in	   reduced	   autophagy	   and	   increased	  
apoptosis	  during	  embryogenesis	  
In	  order	   to	   elucidate	  whether	  Ambra1	  expression	   is	   required	   for	   autophagy	   induction	  
during	   zebrafish	   development,	   LC3-­‐II	   levels	   were	   examined	   in	   ATGMOs-­‐	   and	   SPLICMOs-­‐
injected	  embryos	  by	  immunoblotting	  analysis	  at	  48	  hpf.	  The	  analysis	  was	  also	  performed	  in	  
the	  presence	  of	  the	  lysosomal	   inhibitor	  bafilomycin	  A1	  (Baf	  A1)	  to	  prevent	  autophagosome	  
degradation,	  thus	  making	  it	  possible	  to	  measure	  the	  whole	  amount	  of	  LC3-­‐II	  produced	  at	  this	  
stage.	  As	  shown	  in	  figure	  11,	  high	  rate	  of	  autophagy	  was	  detected	  in	  control	  embryos	  (WT	  
and	   MISMMOs)	   as	   revealed	   by	   the	   strong	   increase	   of	   LC3-­‐II	   signal	   observed	   following	  
bafilomycin	   A1	   treatment.	   In	   contrast,	   the	   inhibition	   of	   either	   ambra1a	   or	   ambra1b	  
expression	  led	  to	  a	  reduced	  levels	  of	  LC3-­‐II	  in	  the	  same	  experimental	  settings.	  In	  particular,	  
ambra1a	   ATGMOs-­‐injected	   embryos	   show	   the	   lowest	   amount	   of	   LC3-­‐II,	   indicating	   a	  main	  
contribution	  of	  this	  gene	  product	  at	  this	  stage,	  possibly	  because	  of	  its	  higher	  expression	  level	  
when	   compared	   to	   ambra1b	   and	   zygotic	   ambra1a	   expression	   (Figure	   4)	   or	   due	   to	  
subfunction	  partitioning	  of	  the	  two	  ambra1	  paralogous	  genes.	  	  
Moreover,	   we	   analyzed	   whether	   the	   injection	   of	   MOs	   targeting	   the	   ambra1a	   or	   the	  
ambra1b	  genes	  affects	   the	  expression	  of	   the	  proautophagic	   factor	  Becn1,	  a	  component	  of	  
the	   class	   III	   phosphatidylinositol	   3-­‐kinase	   complex	   whose	   activity	   is	   regulated	   by	   its	  
interaction	  with	  Ambra1[14].	   Interestingly,	  Ambra1	  downregulation	   led	   to	   increased	   levels	  
of	  Becn1	  protein,	  particularly	  evident	  with	  morpholinos	  targeting	  both	  zygotic	  and	  maternal	  
transcripts	  (MO1-­‐ambra1a	  and	  ambra1b)	  (Figure	  11,	  panel	  C),	  which	  may	  be	  interpreted	  as	  
an	   attempt	   of	   the	   system	   to	   counterbalance	   the	   absence	   of	   a	   positive	   regulator	   of	   the	  
autophagic	  process.	  
To	  examine	  whether	  Ambra1a	  and	  b	  protein	  deficiency	  causes	  apoptosis,	  whole-­‐mount	  
TUNEL-­‐staining	  was	  used	  to	  detect	  apoptotic	  cells	  in	  WT	  and	  morphant	  embryos	  analyzed	  at	  
24	   hpf.	   Minimal	   evidence	   of	   apoptosis	   was	   found	   in	   WT	   (Figure	   12),	   whereas	   a	   highly	  
increased	   number	   of	   TUNEL-­‐positive	   cells	   was	   detectable	   in	   the	   head	   region	   of	   both	  
ATGMOs-­‐	   and	   SPLICMOs-­‐injected	   embryos	   (Figure	   12),	   suggesting	   that	   the	   developmental	  
defects	  may	  be	  partially	  caused	  by	  an	  increase	  of	  apoptosis.	  	  
The	   t-­‐test	   showed	   significant	   differences	   in	   the	   apoptotic	   cell	   number	   between	   both	  
ATGMOs-­‐	   and	   SPLICMOs-­‐injected	   embryos	   compared	   to	   the	   control	   embryos	   (WT	   and	  





Figure	  11.	  Analysis	  of	  autophagy	  and	  of	  BECN1	  levels	   in	  ambra1-­‐MOs	  injected	  embryos.	  (A	  and	  B)	  Analysis	  of	  
autophagy	   in	  ambra1-­‐MOs	   injected	   embryos.	   Protein	   extracts	  were	   prepared	   from	  WT	   and	   ambra1a	   (A)	   or	  
ambra1b	   (B)	   MOs-­‐injected	   embryos	   at	   48	   hpf	   and	   subjected	   to	   immunoblotting	   analysis	   using	   an	   anti-­‐LC3	  
antibody.	  A	  parallel	  set	  of	  embryos	  were	  incubated	  with	  the	  lysosome	  inhibitor	  bafilomycin	  A1	  for	  6	  h	  before	  
lysis,	  in	  order	  to	  assess	  the	  rate	  of	  autophagic	  flux	  upon	  Ambra1	  downregulation.	  A	  graph	  reporting	  data	  from	  
three	   independent	  experiments	   is	  shown	  together	  a	  representative	   immunoblot	   image.	  Values	  represent	  the	  
densitometric	  measurement	  of	   LC3-­‐II	   band	   intensities	  normalized	   to	   the	   signals	  of	   the	   loading	   control	   actin.	  
A.U.:	   arbitrary	   units.	   Please	   note	   that	   this	   LC3	   antibody	   shows	   a	   stronger	   reactivity	   for	   the	   zebrafish	   type	   II	  
form	   of	   LC3	   than	   the	   type	   I,	  which	   is	   detected	   only	   at	   longer	   exposure	   times.	   However,	   to	   ensure	   that	   the	  
detected	  LC3	  isoform	  was	  LC3-­‐II,	  protein	  extracts	  from	  HeLa	  cells	  was	  run	  as	  reference	  marker.	  (C)	  Analysis	  of	  
Becn1levels	   in	   ambra1-­‐MOs	   injected	   embryos.	   Protein	   extracts	   were	   prepared	   from	  WT	   and	   ambra1-­‐MOs-­‐
injected	   embryos	   at	   48	   hpf	   and	   subjected	   to	   immunoblotting	   analysis	   using	   an	   anti-­‐BECN1	   antibody.	   Actin	  
expression	  was	  monitored	  as	  loading	  control.	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Figure	  12.	  TUNEL	  analysis	  to	  detect	  apoptotic	  nuclei	  in	  WT	  embryos	  and	  ambra1	  ATGMOs	  (MO1-­‐ambra1a	  and	  
MO1-­‐ambra1b),	  SPLICMOs	  (MO2-­‐ambra1a	  and	  MO2-­‐ambra1b)	  and	  MISMMOs	  (MO1-­‐ambra1a-­‐5m	  and	  MO1-­‐
ambra1b-­‐5m)	   embryos	   at	   24	   hpf.	  Minimal	   evidence	   of	   apoptosis	  was	   found	   in	  WT	  while	   a	   highly	   increased	  
number	   of	   TUNEL-­‐positive	   cells	   was	   detectable	   in	   the	   head	   region	   of	   ATGMOs-­‐	   and	   SPLICMOs-­‐injected	  
embryos.	   Bar	   =	   200	   μm.	   Insert:	   differences	   in	   the	   TUNEL-­‐positive	   cell	   number	   between	   both	   ATGMOs-­‐	   and	  
SPLICMOs-­‐injected	   embryos	   compared	   to	   the	   control	   embryos	   (WT	   and	   MISMMOs).	   Values	   represent	   the	  
mean	  ±	  S.D.	  (n	  =	  5).	  *	  indicates	  that	  the	  difference	  in	  the	  expression	  levels	  are	  significantly	  different	  (P	  <	  0.05);	  
**	  (P	  <	  0.01);	  ***	  (P	  <	  0.001).	  	  




Alteration	  of	  dorso-­‐ventral	  patterning	  in	  Ambra1-­‐deficient	  embryos	  	  
To	  further	  characterize	  the	  ATGMOs	  phenotypes,	   the	  expression	  of	  marker	  genes	  that	  
are	  critical	  for	  dorso-­‐ventral	  patterning	  and	  notochord	  formation	  was	  analysed	  by	  WMISH	  in	  
morphants	   and	   compared	   to	   WT	   or	   MISMMOs	   embryos	   during	   different	   developmental	  
stages.	   For	   each	  marker	   and	   each	   developmental	   stage,	   15	   embryos	   from	   three	   different	  
microinjection	  experiments	  were	  used	  (Figure	  13).	  
The	   in	   situ	   hybridization	   assay	   showed	   that	  MO1-­‐ambra1b	   and	   coinjected	  morphants	  
displayed	  a	  decrease	   in	  the	  expression	  of	  gsc	  and	  a	  reduction	  of	  chd	   staining	   in	  the	  dorsal	  
axis.	   The	   modifications	   are	   less	   evident	   in	   MO1-­‐ambra1a	   morphants	   and	   absent	   with	  
SPLICMOs.	  	  
WMISH	   analysis	   of	   sonic	   hedgehog	   (shha),	   a	   marker	   for	   notochordal	   and	   floor	   plate	  
cells,	  showed	  undulating	  notochord	  in	  both	  ATGMOs-­‐injected	  embryos	  compared	  to	  control	  
ones.	   This	   was	   not	   evident	   with	   SPLICMOs-­‐injected	   embryos.	   SPLICMOs	   do	   not	   seem	   to	  
interfere	   with	   the	   early	   developmental	   stages	   likely	   due	   to	   the	   presence	   of	   the	   ambra1	  
maternal	  transcripts	  during	  the	  first	  developmental	  stages.	  	  
	  
Figure	   13.	   WMISH	   showing	   expression	   of	   the	   developmental	   markers,	   gsc,	   chd	   and	   shha,	   in	   ambra1-­‐MOs-­‐
injected	  and	  control	  embryos.	  Dorsal	  views	  with	  the	  head	  pointing	  to	  the	  top	  in	  1	  dpf	  embryos.	  Bar=	  200	  μm.	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DISCUSSION	  
In	   this	   study,	  we	   report	   the	   identification,	   through	   genome	   searches	   and	   targeted	  
cloning,	  of	   two	  paralogous	  ambra1	  genes	   in	  the	  zebrafish	  genome.	  The	  conserved	  synteny	  
with	  human	  AMBRA1	  gene	  located	  in	  chromosome	  11,	  suggests	  that	  ambra1a	  and	  ambra1b	  
genes,	  like	  other	  genes	  in	  chromosomes	  7	  and	  25	  they	  are	  linked	  to,	  arose	  as	  part	  of	  the	  fish-­‐
specific	  whole-­‐genome	  duplication	  that	  occurred	  after	  divergence	  of	   the	   fish	  and	  tetrapod	  
lineages.20	   Analysis	   performed	   on	   other	   available	   teleostean	   genomes	   shows	   that	   only	  D.	  
rerio	   retained	  both	  ambra1	   paralogs,	  whereas	   the	   fate	  of	   the	   second	  ambra1	   gene	   in	   the	  
other	   teleosts	   examined	   so	   far	   was	   likely	   nonfunctionalization	   and	   loss.	   Phylogenetic	  
analysis	   showed	   that	   the	   D.	   rerio	   ambra1b	   gene	   is	   the	   orthologous	   form	   of	   the	   other	  
sequenced	  teleostean	  ambra1s.	  Retention	  of	  initially	  redundant	  genes	  in	  teleost	  genomes	  is	  
expected	   to	   be	   caused	   by	   either	   neofunctionalization	   or	   subfunction	   partitioning	   of	   the	  
multiple	   roles	  of	   their	  mammalian	  ortholog,	   as	   the	  maintenance	  of	   functional	   redundancy	  
over	  long	  times	  is	  unlikely.	  Thus,	  the	  study	  of	  paralogous	  gene	  function	  in	  zebrafish	  can	  help	  
understanding	  the	  roles	  of	  the	  homologous	  human	  gene	  in	  health	  and	  disease	  [16].	  	  
Zebrafish	   ambra1a	   and	   ambra1b	   genes	   share	   the	   same	   genomic	   organization	   of	  
mammalian	  Ambra1	  genes,	  but	  present	  some	  mutual	  differences:	  ambra1a	  is	  spliced	  as	  four	  
alternative	  transcripts	  coding	  for	  proteins	  reduced	  in	  three	  ways	  in	  their	  C-­‐terminal	  region,	  
whereas	  only	  one	  transcript	  was	   identified	   for	   the	  ambra1b	  gene.	   Interestingly,	  Ambra1a3	  
and	   Ambra1a4	   proteins	   lack	   the	   DYNLL1	   binding	   domain,	   suggesting	   that	   these	   Ambra1	  
isoforms	   escape	   from	   the	   inhibitory	   interaction	   with	   the	   dynein	   complex.	   Moreover,	   the	  
majority	   of	   ambra1a	   transcript	   variants	   lacked	   exon	   8	   that	   is	   instead	   always	   present	   in	  
ambra1b	   mRNA.	   Exon	   8	   is	   located	   inside	   the	   region	   involved	   in	   the	   interaction	   with	   the	  
BECN1	   protein,	   suggesting	   a	   possible	   modulation	   of	   the	   BECN1	   binding	   properties	   of	  
AMBRA1	  and	  of	   its	   autophagic	  potential.	  Although	   the	  exon	  8	   is	   located	   inside	   the	   region	  
involved	  in	  the	  interaction	  with	  BECN1	  protein,	  human	  AMBRA1	  isoforms	  either	  containing	  
or	   not	   exon	   8	   are	   able	   to	   bind	   BECN1	   [14,21],	   suggesting	   the	   sequence	   encoding	   by	   this	  
small	  exon	  may	  regulate	  other	  functions	  of	  the	  protein.	  	  
During	   embryogenesis,	   at	   all	   time	   points	   analysed	   through	   the	   first	   6	   days	   of	  
development,	   the	   expression	   of	   ambra1a	   mRNA	   was	   greater	   than	   that	   of	   ambra1b	  
messenger,	   suggesting	   that	   ambra1a	   may	   have	   more	   important	   functions	   during	  
development.	  We	  find	  that	  the	  expression	  pattern	  of	  these	  two	  genes,	  analysed	  by	  WMISH,	  
is	   partially	   overlapping,	   but	   the	   ambra1a	   probe	   was	   more	   specifically	   localized	   in	   the	  
anterior	  brain	  and	  otic	  vesicles	  until	  4	  dpf.	  At	  6	  dpf	  the	  signal	  of	  both	  genes	  was	  weak	  and	  
hardly	  detectable	  in	  the	  brain,	  but	  evident	  in	  the	  alimentary	  canal	  and	  in	  the	  swim	  bladder.	  
Although	   this	   overlapping	   expression	   might	   suggest	   a	   potential	   for	   at	   least	   partially	  
functional	  redundancy,	  this	  was	  not	  supported	  by	  the	  rescue	  experiments.	  	  
We	   selectively	   depleted	   the	   Ambra1	   proteins	   both	   separately	   and	   together	   by	   MO-­‐
mediated	  translation	  and	  splicing	  blockages.	  The	  present	  work	  demonstrates	  that	  both	  the	  




larval	   development	   because	   the	   MO-­‐induced	   deficiency	   of	   the	   corresponding	   proteins	   is	  
associated	  with	  several	  developmental	  abnormalities	  and	  increased	  loss	  of	  viability	  at	  3	  to	  4	  
days	   after	   fertilization	   in	   ATGMOs-­‐injected	   embryos	   and	   at	   12	   days	   in	   SPLICMO-­‐injected	  
embryos.	   This	   conclusion	   is	   supported	  by	   the	   incorporation	  of	   several	  MO	   controls	   in	   the	  
experimental	  design	  (see	  Results).	  However,	  the	  neural	  abnormalities	  observed	  in	  Ambra1a	  
and	  b	   knockdowns	  are	  not	  due	   to	  activation	  of	   the	  TP53	  pathway	  because	   they	  were	   still	  
observed	   after	   coinjection	  with	   tp53	  MO.	   Embryos	   coinjected	  with	   both	   ATGMOs	   display	  
even	  more	  severe	  malformations	  with	  a	  complete	  derangement	  of	  the	  body	  plan	  in	  Class	  III	  
morphants.	   The	   increased	   mortality	   in	   zebrafish	   Ambra1s	   targeted	   loss-­‐of-­‐function	   is	  
consistent	  with	  previous	  data	  obtained	  in	  a	  mouse	  model.14	  Rescue	  experiments	  show	  that	  
the	   two	   genes	   could	   not	   compensate	   each	   other	   deficiencies,	   at	   least	   morphologically.	  
Moreover,	   in	   the	   Ambra1a	   knockdown	   experiments,	   the	   normal	   phenotype	   was	   restored	  
only	   after	   coinjection	   of	   short	   and	   long	   transcripts,	   suggesting	   specific	   functions	   also	   for	  
Ambra1a3	  and	  Ambra1a4	  proteins	  that	  lack	  the	  DYNLL1	  binding	  domain.	  
The	   phenotype	   that	   we	   observed	   with	   Ambra1a	   and	   b	   silencing	   with	   both	   ATGMOs	  
occurred	  as	  early	  as	  24	  hpf,	  suggesting	  that	  both	  paralog	  genes	  may	  play	  a	  role	  in	  the	  early	  
development	   of	   zebrafish	   and	   potentially	   during	   gastrulation.	   AMBRA1	   deficiency	   in	  mice	  
also	   results	   in	   neural	   abnormalities,	   including	   exencephaly	   due	   to	   failure	   in	   neural	   tube	  
closure.14	  
Moreover,	   the	   two	   SPLICMOs	   (MO2-­‐ambra1a	   and	   MO2-­‐ambra1b)	   that	   target	   only	  
zygotic	  ambra1	  transcripts,	  led	  to	  developmental	  defects	  only	  at	  a	  late	  stage,	  indicating	  the	  
importance	   of	   maternally	   supplied	   ambra1	   transcripts	   and	   fundamental	   functions	   of	   the	  
corresponding	  proteins	  in	  early	  embryonic	  development.	  
At	   the	  molecular	   level,	   the	   downregulation	   of	   Ambra1	   expression	   leads	   to	   autophagy	  
impairment	   associated	  with	   increased	   cell	   death,	   confirming	   the	   crucial	   role	  of	  Ambra1	   in	  
the	  crosstalk	  among	  these	  processes	  during	  embryogenesis	  and	  gametogenesis	   [22,	  23].	  In	  
accordance	  with	   what	   observed	   in	  mice	   [14],	   an	   early	   increased	   rate	   of	   cell	   proliferation	  
(manuscript	  in	  preparation)	  was	  observed	  in	  zebrafish,	  that	  is	  largely	  counterbalanced	  by	  an	  
excess	  of	  cell	  death.	  	  
The	   comparative	   analysis	   of	   zebrafish	   morphant	   phenotypes	   of	   autophagy	   genes	  
confirms	  a	  clear	  difference	  between	  the	  core	  members	  of	  the	  BECN1	  complex	  and	  the	  genes	  
involved	  at	   later	  stages	  of	  the	  autophagic	  pathway,	  such	  as	  ATG5	  and	  ATG7	  [24,25],	   in	  the	  
regulation	   of	   development,	   as	   previously	   reported	   in	   mammals.	   Indeed,	   the	   silencing	   of	  
AMBRA1	  results	   in	  early	  embryonic	   lethality	  both	  in	  fishes	  and	  mice	  with	  similar	  defects	   in	  
neural	   tube	   formation.	   Conversely,	   zebrafish	   atg5	   silencing	   causes	   a	   longer	   embryonic	  
survival	   with	   respect	   to	   ambra1	   [26],	   similarly	   to	   mice	   in	   which	   death	   occurs	   only	   after	  
birth[24].	   The	   earlier	   appearance	   of	   Ambra1a	   and	   b	   morphant	   phenotypes	   suggests	   that	  
Ambra1	  may	  play	  multiple	  roles	  in	  early	  development,	  not	  all	  directly	  related	  to	  its	  positive	  
regulation	  of	   the	  autophagic	  process.	  This	  conclusion	   is	  also	  supported	  by	   the	  observation	  
that	  conversion	  to	  the	  LC3-­‐II	  form	  is	  observed	  in	  zebrafish	  embryos	  starting	  from	  32	  hpf	  [27]	  
(and	  data	  not	  shown),	  relatively	  late	  compared	  to	  the	  onset	  of	  the	  developmental	  defects.	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Other	  interesting	  differences	  were	  also	  observed	  between	  Ambra1	  and	  ATG5	  morphant	  
embryos	  when	  the	  expression	  profiles	  of	  patterning-­‐regulating	  genes	  were	  analysed.	  Indeed,	  
Ambra1	   morphant	   embryos	   show	   a	   ventralized	   phenotype	   with	   reduced	   or	   modified	  
expression	  of	   the	  dorsal	  chd	  and	  gsc	  genes,	  while	  ATG5	  downregulation	  causes	  embryonic	  
over-­‐dorsalized	  deformities	  [25].	  The	  chd	  and	  gsc	  are	  organizer-­‐specific	  genes,	  expressed	  in	  
the	   dorsal	   mesoderm,	   which	   induce	   the	  morphogenesis	   of	   dorsal	   structures,	   such	   as	   the	  
notochord.	   Therefore,	   the	   pattern	   observed	   in	   the	   in	   situ	   hybridisation	   experiment	   with	  
ATGMOs	  may	  explain	  the	  ventralized	  phenotype	  of	  morphants.	  Also	  shha	  pattern,	  a	  marker	  
of	  the	  notochord,	  was	  differently	  shaped	  in	  morphants	  resulting	  in	  detectable	  undulations	  in	  
the	  notochord	  with	  respect	  to	  WT,	  as	  previously	  observed	  in	  mouse	  by	  Fimia	  and	  colleagues	  
[14].	  
Importantly,	   the	   inhibition	  of	  Ambra1	  expression	   interferes	  with	   the	   regulation	  of	   cell	  
proliferation	  and	  death	  during	  embryogenesis	   in	  both	  zebrafish	  and	  mice,	  while	  this	  effect	  
was	   not	   detected	   for	   atg5	   gene.	   This	   is	   probably	   due	   to	   the	   fact	   that	   the	   upstream	  
regulators	  of	  the	  autophagic	  process	  play	  a	  more	  complex	  role	  by	  interacting	  and	  regulating	  
the	   activity	   of	   members	   of	   other	   cell	   pathways	   [28].	   The	   functional	   link	   between	  
proliferation,	   apoptosis	   and	   autophagy	   suggests	   that	   these	   processes	   are	   coordinately	  
regulated	  in	  early	  development	  in	  order	  to	  limit	  uncontrolled	  cell	  demise	  and/or	  cell	  growth	  
during	  the	  profound	  remodeling	  occurring	  in	  the	  course	  of	  organogenesis.	  Collectively,	  these	  
findings	   confirm	   an	   important	   developmental	   role	   for	   Ambra1	   in	   early	   vertebrate	  
embryogenesis	   and	   provide	   compelling	   evidence	   for	   subfunctionalization	   of	   ambra1	   gene	  
paralogs	  in	  zebrafish	  after	  ancestral	  duplication.	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S-­‐Figure	  1.	  Schematic	  representation	  of	  the	  cloning	  strategy	  for	  ambra1a1,	  a2,	  a3,	  a4	  and	  ambra1b	  zebrafish	  
cDNAs.	  Primers	  used	  are	  indicated.	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S-­‐Figure	   2.	   Validation	   of	   the	   ATGMOs	   and	   SPLICMOs	   mediated	   knockdown	   of	   ambra1	   genes.	   (A)	   Control	  
experiments	  to	  verify	  the	  ATGMOs-­‐mediated	  knockdown	  of	  ambra1a	  and	  ambra1b.	  ambra1a-­‐	  and	  ambra1b-­‐
EGFP	  mRNAs	  were	  coinjected	  with	  ATGMOs	  as	   indicated	  inside	  each	  image,	  and	  embryos	  were	  examined	  for	  
the	  presence	  of	  EGFP	  fluorescence	  at	  24	  hpf.	  All	  the	  embryos	  are	  lateral	  view,	  anterior	  to	  the	  left.	  Bar=	  200	  μm.	  
(B)	  RT-­‐PCR	  analysis	  with	  cDNA	  of	  4,	  6,	  8,	  12	  and	  24	  hpf	  embryos	  (controls	  and	  SPLICMOs-­‐injected)	  confirmed	  
deletion	   of	   exons	   3	   in	   the	   ambra1a	   and	   b	   transcripts.	   The	   arrow-­‐head	   indicates	   the	   residual	   wild-­‐type	  
transcripts	   at	   the	   different	   stages.	   Under	   the	   agarose	   gel,	   sequences	   of	   the	   misspliced	   ambra1a	   and	   b	  
transcripts	  show	  the	  loss	  of	  exon	  3	  (arrow)	  and	  the	  introduction	  of	  a	  premature	  stop	  codon.	  




S-­‐Figure	  3.	  Alkaline	  phosphatase	  staining	  showing	  well-­‐organized	  sub-­‐intestinal	  vessels	  (SIVs)	  in	  WT	  larvae	  at	  3	  
dpf.	   In	  ambra1-­‐MOs-­‐injected	   larvae	  SIVs	  are	   reduced	  or	  absent	  and	  pattern	  of	   intersegmental	   vessels	   in	   the	  
trunk	  and	  tail	  are	  also	  less	  defined.	  Bar=	  200	  μm.	  Sv=sub-­‐intestinal	  vessels.	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201	   36070	   254	   350	   59	   570	   178	   1030	   180	   1820	   65	   1310	   1459	   31260	   87	   4920	   182	   14250	   79	   710	  
Danio	  rerio	  
ambra1a1	  
206	   3010	   233	   2168	   59	   167	   184	   113	   173	   986	   67	   97	   1373	   7293	   87	   4736	   183	   2268	   78	   917	  
Danio	  rerio	  
ambra1a2	  
206	   3010	   233	   2168	   59	   167	   184	   113	   173	   986	   67	   97	   1373	   7293	   87	   4736	   183	   2268	   78	   917	  
Danio	  rerio	  
ambra1a3	  
206	   3010	   233	   2168	   59	   167	   184	   113	   173	   986	   67	   97	   1373	   7293	   87	   4736	   183	   2268	   78	   917	  
Danio	  rerio	  
ambra1a4	  
206	   3010	   233	   2168	   59	   167	   184	   113	   173	   986	   67	   97	   1373	   7293	   87	   4736	   548	  
	   	   	  
Danio	  rerio	  
ambra1b	  









































100	   50360	   113	   9770	   189	   1030	   155	   13520	   137	   9710	   92	   1020	   197	   5720	   878	  
	   	  
Danio	  rerio	  
ambra1a1	  
101	   19177	   111	   20026	   189	   3132	   155	   4999	   140	   3466	   111	   3226	   209	   21056	   132	   3025	   733	  
Danio	  rerio	  
ambra1a2	  
101	   19177	   111	   20026	   189	   3132	   155	   4999	   140	   3466	   111	   3226	   507	  




	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
Danio	  rerio	  
ambra1a4	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
Danio	  rerio	  
ambra1b	  
101	   103	   111	   115	   189	   412	   155	   2050	   140	   4475	   99	   95	   203	   2009	   123	   3125	   1802	  





MO1-­‐ambra1a	   n.	   Dead	  (%)	   n.	  surviving	   Normal	  (%)	   Abnormal	  (%)	  
8.2	  ng/embryo	   161	   12±6	   141	   50±3	   50±3	  
10.3	  ng/embryo	   328	   17±2	   271	   31±9	   69±9	  
15.5	  ng/embryo	   354	   24±12	   269	   30±6	   70±6	  
20.6	  ng/embryo	   350	   25±17	   260	   10±8	   90±8	  
25.8	  ng/embryo	   278	   47±6	   147	   4±8	   96±8	  
MO2-­‐ambra1a	   n.	   Dead	  (%)	   n.	  surviving	   Normal	  (%)	   Abnormal	  (%)	  
8.2	  ng/embryo	   183	   3±1	   176	   96±3	   4±3	  
10.3	  ng/embryo	   152	   3±4	   147	   89±2	   11±2	  
15.5	  ng/embryo	   151	   6±1	   142	   87±2	   13±2	  
18.5	  ng/embryo	   269	   19±7	   218	   64±6	   36±6	  
20.6	  ng/embryo	   173	   22±7	   136	   67±4	   33±4	  
25.8	  ng/embryo	   185	   47±6	   99	   71±5	   29±5	  
MO1-­‐ambra1a-­‐5m	   n.	   Dead	  (%)	   n.	  surviving	   Normal	  (%)	   Abnormal	  (%)	  
8.2	  ng/embryo	   164	   1±2	   162	   99±0	   1±0	  
10.3	  ng/embryo	   304	   14±7	   269	   94±3	   6±3	  
15.5	  ng/embryo	   321	   11±12	   277	   93±5	   7±5	  
20.6	  ng/embryo	   294	   36±5	   182	   92±3	   8±3	  
25.8	  ng/embryo	   245	   30±5	   164	   82±9	   18±9	  
MO1-­‐ambra1b	   n.	   Dead	  (%)	   n.	  surviving	   Normal	  (%)	   Abnormal	  (%)	  
8.2	  ng/embryo	   159	   5±4	   151	   64±4	   36±4	  
10.3	  ng/embryo	   195	   2±2	   189	   61±7	   39±7	  
15.5	  ng/embryo	   298	   4±1	   286	   32±7	   68±7	  
20.6	  ng/embryo	   317	   29±9	   226	   16±8	   84±8	  
25.8	  ng/embryo	   231	   36±16	   150	   14±7	   86±7	  
MO2-­‐ambra1b	   n.	   Dead	  (%)	   n.	  surviving	   Normal	  (%)	   Abnormal	  (%)	  
8.2	  ng/embryo	   163	   7±1	   153	   87±2	   13±2	  
10.3	  ng/embryo	   174	   6±3	   165	   74±7	   26±7	  
15.5	  ng/embryo	   271	   7±1	   253	   45±3	   55±3	  
20.6	  ng/embryo	   161	   13±10	   141	   22±2	   78±2	  
25.8	  ng/embryo	   180	   30±7	   127	   38±3	   62±3	  
MO1-­‐ambra1b-­‐5m	   n.	   Dead	  (%)	   n.	  surviving	   Normal	  (%)	   Abnormal	  (%)	  
8.2	  ng/embryo	   161	   1±1	   160	   98±1	   2±1	  
10.3	  ng/embryo	   218	   3±1	   209	   91±3	   9±3	  
15.5	  ng/embryo	   286	   7±5	   267	   92±3	   8±3	  
20.6	  ng/embryo	   318	   7±2	   295	   83±7	   17±7	  
25.8	  ng/embryo	   287	   13±6	   249	   77±8	   23±8	  
MO1-­‐ambra1a	  +	  MO1-­‐
ambra1b	  
n.	   Dead	  (%)	   n.	  surviving	   Normal	  (%)	   Abnormal	  (%)	  
1/2	  ng/embryo	   276	   55±8	   128	   24±3	   76±3	  
1/4	  ng/embryo	   283	   23±4	   215	   26±4	   74±4	  
Supplementary	  Table	  2.	  Effects	  of	  different	  dosages	  of	  morpholinos	  on	  the	  percentages	  of	  dead	  fish	  and	  of	  
normal	  and	  abnormal	  phenotypes	  calculated	  from	  the	  number	  of	  surviving	  prelarvae	  at	  3	  dpf.	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n.	   Dead	  (%)	   n.	  surviving	   Normal	  (%)	   Abnormal	  (%)	  
MO1-­‐ambra1a	  
+	  20ng	  mRNA	  ambra1a1	  
164	   46±9	   90	   39±7	   61±7	  
MO1-­‐ambra1a	  
+	  15ng	  mRNA	  ambra1a3	  
170	   51±4	   83	   28±5	   72±5	  
MO1-­‐ambra1a	  
+	  20ng	  mRNA	  ambra1a1	  
+	  15ng	  mRNA	  ambra1a3	  
160	   30±3	   112	   73±7	   23±7	  
MO1-­‐ambra1a	  
+	  20ng	  mRNA	  ambra1b	  
240	   58±12	   121	   35±7	   65±7	  
MO1-­‐ambra1b	  
+	  20ng	  mRNA	  ambra1b	  
329	   35±5	   224	   73±9	   27±9	  
MO1-­‐ambra1b	  
+	  20ng	  mRNA	  ambra1a1	  
152	   24±6	   105	   31±6	   69±6	  
MO1-­‐ambra1a	  
+	  MO1-­‐ambra1b	  
+	  20ng	  mRNA	  ambra1a1	  
+	  15ng	  mRNA	  ambra1a3	  
+	  20ng	  mRNA	  ambra1b	  
177	   39±10	   110	   65±10	   35±10	  
Supplementary	  Table	  3.	  Effects	  of	  different	  mRNAs	  coinjected	  with	  MOs	  on	  the	  percentages	  of	  dead	  embryos	  





























Supplementary	  Table	  4.	  List	  of	  Primers	  used	  in	  this	  work.	  The	  recognition	  sequences	  for	  restriction	  enzymes	  are	  
shown	  in	  bold	  italic	  letters.	  
	   	  
Primer	   SEQUENCE	  5’-­‐3’	  
Am1a-­‐F1	   CTGCTGCTCATTGCCACC (18) 
Am1a-­‐F2	   GCAACGCACTCATCCGTC (18) 
Am1a1/2-­‐F3	   GTCGATGTGCATTCTGATGG (20) 
Am1a1-­‐F4	   CGGAGTCTTTAGCTGCAGC (19) 
Am1a-­‐F5	   GAGGAAGAGTGTTTGGAGATG (21) 
Am1a-­‐F6	   ACAGTCTGCCTCCTCTCG (18) 
Am1a-­‐F7	   AGGAGGACTCTCAGCTGG (18) 
Am1a-­‐M-­‐F-­‐ClaI	   CCATCGATGGCTCAGCAACAGTCTTTCGTGATGAAGCTGG (40) 
Am1a-­‐5’-­‐F-­‐XbaI	   GCTCTAGAGCGGTAGCAGCAGAGGTAG (27) 
Am1a-­‐R1	   CTGCTCCTCATGCTGACC (18) 
Am1a-­‐R2	   GTGGCAATGAGCAGCAGC (18) 
Am1a-­‐R3	   ACAAGCTGCTGCAGAACC (18) 
Am1a-­‐R4	   CGCTCTCGACTGGACAGG (18) 
Am1a1-­‐R5-­‐XhoI	   CCGCTCGAGCGGGATAACTACTATCGCTGTTGC (33) 
Am1a-­‐R6	   CGCATCTCCACACTGTCC (18) 
Am1a1/2-­‐R7	   GCTGGTTCTGTGTCTGCG (18) 
Am1a2-­‐R8-­‐XhoI	   CCGCTCGAGCGGCGGATGGACTTCACTCAC (30) 
Am1a3-­‐R9	   CGTCCTACAGTAACTTTGCAC (21) 
Am1a4-­‐R10	   CTCTGGTAGAATCGTTGGC (19) 
Am1a-­‐5’-­‐R-­‐KpnI	   CGGGGTACCCCGGTTCCTCTGTCCCAGC (28) 
Am1b-­‐F1	   GCATACCACGTCAGACTCG (19) 
Am1b-­‐F2	   AGGTGACGGACAGTCAGC (18) 
Am1b-­‐F3	   GAACACACACACCACATCC (19) 
Am1b-­‐F4	   GTAGACTCTCTAGAAGCTCC (20) 
Am1b-­‐F5	   GCGTGCTGCTGAGTTAGTG (19) 
Am1b-­‐M-­‐F-­‐ClaI	   CCATCGATGGGGTGCAGGACTTAACAGCATAAATGGC (37) 
Am1b-­‐F5-­‐XbaI	   GCTCTAGAGCGTGCTGCTGAGTTAGTG (27) 
Am1b-­‐R1	   TCTGCCATACAGGTCGTC (18) 
Am1b-­‐R1-­‐XhoI	   CCGCTCGAGCGGGACTATCTGCCATACAGGTCG (33) 
Am1b-­‐R2	   CTGAGTTCCCTGCAGTCC (18) 
Am1b-­‐R3	   AAGCCATCTCCATACTATCC (20) 
Am1b-­‐R4	   CGATGAGGAGAAGCTGAGC (19) 
Am1b-­‐R5	   CCGCTCGAGCGGTCCAGCACCATGCAGACC (30) 
Am1b-­‐R6	   CCTACCATCACATAGCAGC (19) 
Am1b-­‐5’-­‐R-­‐KpnI	   CGGGGTACCCCGTCTGTTCTGCACAGCCA (29) 
LC3-­‐F	   GAGAAGTTTTTGCCGCCTCT (20) 
LC3-­‐R	   ACCTGTGTCCGAACATCTCC (20) 
BECLIN-­‐F	   GGACCACTTGGAACAACT (18) 
BECLIN-­‐R	   CCGAAGTTCTTCAGTGTCCATC (21) 
ARP-­‐F	   CTGAACATCTCGCCCTTCTC (19) 
ARP-­‐R	   TAGCCGATCTGCAGACACAC (19) 
18S-­‐F	   TCGAATGTCTGCCCTATCAACT (21) 
18S-­‐R	   AGACTTGCCCTCCAATGGATC (20) 
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XM_002667669	   pGEM	   ApaI,	  Sp6	  
z-­‐am1b-­‐3’-­‐UTR	   This	  work	   XR_084457	   pGEM	   SalI,	  T7	  
Supplementary	  Table	  5.	  List	  of	  markers	  used	  in	  the	  whole-­‐mount	  in	  situ	  hybridization	  analyses.	  
Supplementary	  Table	  6.	  Summary	  of	  the	  ratio	  of	  abnormal	  phenotypes	  present	  in	  each	  class.	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No*of*injected*eggs** 354* 320* 269* 317* 288* 271* 283*
Dead*(%)* 24±12* 21±9* 19±7* 29±9* 13±11* 7±1* 23±4*
No*surviving* 269* 250* 218* 226* 253* 253* 215*
Normal*(%)* 30±6* 38±9* 64±6* 16±8* 43±6* 45±3* 26±4*
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Zebrafish	  Ambra1a	  and	  Ambra1b	  are	  involved	  in	  control	  of	  cell	  
proliferation	  
As	  reported	  in	  the	  General	  introduction	  of	  this	  PhD	  thesis,	  inactivation	  of	  Ambra1	  in	  mouse	  
embryos	   determines	   not	   only	   early	   embryonic	   lethality	   and	   severe	   abnormalities	   in	   the	  
neural	   tube	   formation	   but	   also	   uncontrolled	   cell	   proliferation	   [1].	   The	   increase	   of	   cell	  
proliferation	  was	  associated	  to	  the	  onset	  of	  neurulation	  thus	  suggesting	  a	  role	  for	  Ambra1	  in	  
cell	  division,	  in	  particular	  during	  the	  nervous	  system	  development	  [1].	  
Starting	  from	  these	  data,	  we	  decided	  to	  analyze	  if,	  also	  in	  zebrafish,	  the	  two	  Ambra1	  
proteins	  we	   have	   characterized	   are	   involved	   in	   cell	   proliferation	   control	   and	  weather	   this	  
property	  is	  controlled	  by	  cell	  autonomous	  or	  non-­‐cell	  autonomous	  mechanism.	  If	  a	  gene	  acts	  
in	  cell-­‐autonomous	  manner,	  then	  morphant	  cells	  will	  exhibit	  the	  morphant	  phenotype	  when	  
transplanted	   in	   a	   wild-­‐type	   embryo.	   Conversely,	   if	   a	   gene	   acts	   in	   non	   cell-­‐autonomous	  
manner,	   morphant	   cells	   will	   exhibit	   wild-­‐type	   phenotype	   when	   transplanted	   in	   wild-­‐type	  
embryo	  as	  they	  are	  influenced	  by	  surrounding	  environment.	  
The	   results	   of	   the	   experiments	   described	   in	   this	   chapter	   were	   performed	   in	  
collaboration	  with	  the	  group	  of	  Prof.	  Francesco	  Cecconi	   (University	  of	  Rome	   ‘Tor	  Vergata’,	  
IRCCS	   Fondazione	   Santa	   Lucia	   and	   Danish	   Cancer	   Society	   Research	   Center).	   The	   resulting	  
paper,	   submitted	   for	   evaluation,	   shows	   that	   AMBRA1	   is	   implicated	   in	   the	   control	   of	   cell	  
proliferation	  by	  interfering	  with	  the	  C-­‐MYC	  phosphorylation	  pathway.	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A	  great	  number	  of	  evidence	  suggests	  a	  possible	  involvement	  of	  the	  autophagic	  process	  in	  
cell	   cycle	   regulation.	   The	   increase	   of	   proliferation	   in	   the	   neuroepithelium	   of	   the	   Ambra1	  
mutant	  mice	  during	  development	  has	  been	  previously	  described	  in	  the	  general	  introduction	  
[1].	  However,	  Ambra1	  has	  been	  demonstrated	  to	  influence	  cell	  proliferation	  rate	  also	  in	  vitro	  
as	  shown	  by	  downregulation	  and	  overexpression	  experiments	  with	  2F	  cells	  [1].	  	  
As	   dysregulation	  of	   cellular	   proliferation	   is	   present	   also	   in	  other	   adult	  mouse	  model	   of	  
autophagy	   genes	   knockout	   [2],	   the	   involvement	   of	   the	   autophagic	   process	   in	   cell	   cycle	  
regulation	   seems	   to	   be	   a	   more	   general	   feature.	   Actually,	   deletion	   or	   downregulation	   of	  
genes	  such	  as	  Beclin	  1,	  UVRAG,	  Bif-­‐1	  and	  Atg4C	  result	  in	  an	  increase	  of	  tumor	  occurrence	  [3-­‐
6].	  Moreover,	  the	  autophagic	  activity	  has	  shown	  to	  be	  reduced	  in	  tumor	  cells	  [7].	  	  
Autophagy,	  and	  the	  genes	  related	  with	  this	  process,	  can	  protect	  the	  cells	  from	  tumors	  by	  
elimination	   of	   damaged	   mitochondria	   and	   peroxisomes.	   This	   activity	   could	   prevent	   the	  
accumulation	  of	   toxic	  oxygen	   radicals	   that	  may	   cause	  genome	   instability	   and	  mutagenesis	  
[8].	  	  
However,	  it	  is	  important	  to	  underline	  that	  autophagy	  could	  also	  provide	  cancer	  cells	  with	  
a	  survival	  strategy	  under	  unsuitable	  conditions	  [8].	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METHODS	  
Zebrafish	  maintenance	  and	  embryo	  production	  
Zebrafish	   maintenance,	   breeding,	   and	   staging	   were	   performed	   according	   to	   standard	  
procedures	  ([9,	  10].	  
Morpholino	  and	  microinjection	  
Morpholino	  antisense	  oligonucleotides	   (MO)	  were	  obtained	  from	  Gene	  Tools,	  LLC.	  ATG-­‐
morpholinos,	  MO1-­‐ambra1aATG	   (5’-­‐	   CTC	   CAA	   ACA	   CTC	   TTC	   CTC	   ACT	   CCC	   T	   -­‐3’)	   and	  MO1-­‐
ambra1bATG	  (5’-­‐TTT	  TCC	  TCT	  TTA	  GTG	  CTC	  CAC	  GGC	  C-­‐	  3’),	  were	  used	  in	  order	  to	  knockdown	  
both	  the	  maternal	  and	  the	  zygotic	  ambra1a	  and	  ambra1b	  zebrafish	  transcripts	  [11](Benato	  
et	  al.,	  2013).	  As	  control,	  five-­‐nucleotide-­‐mismatched	  MOs,	  MO1-­‐ambra1a5M	  (5’-­‐CTC	  gAA	  AgA	  
CTg	  TTC	  CTg	  AgT	  CCC	  T-­‐3’)	  and	  MO1-­‐ambra1b5M	  (5’-­‐TTa	  TgC	  TgT	  TTA	  GTc	  CTC	  CAC	  cGC	  C-­‐3’)	  
were	   used	   (lowercase	   bold	   letters	   indicate	   the	   mismatch	   changes).	   Morpholinos	   were	  
diluted	  in	  Danieau	  solution	  and	  microinjected	  as	  in	  Nasevicius	  and	  Ekker	  [12].	  	  
Transplantation	  	  
For	   the	   creation	   of	   genetic	   chimeras,	   embryos	  were	   injected,	   at	   one-­‐cell	   stage,	  with	   a	  
mixture	  containing	  200	  pg	  EGFP	  mRNA	  and	  10	  ng	  Biotin-­‐dextran	  Lysine	  Fixable	  (10.000	  Mw,	  
Sigma)	   alone	   (control	   donors),	   or	   in	   combination	   with	   designated	   MOs:	   I)	   10	   ng	   MO1-­‐
ambra1aATG,	  II)	  20	  ng	  MO1-­‐ambra1bATG,	  III)	  2.5	  ng	  MO1-­‐ambra1aATG	  +	  5	  ng	  MO1-­‐ambra1bATG	  
mixture.	   At	   blastula	   stage	   (4	   hpf),	   donor	   and	   wild-­‐type	   host	   embryos	   were	   manually	  
dechorionated	  and	  mounted	  side	  by	  side	  in	  1,2	  %	  agarose	  low	  melting	  chambers	  (Figure	  1.	  
A).	  	  
The	  transplantation	  apparatus	  is	  constituted	  by	  a	  10	  µl	  Hamilton	  syringe	  connected	  to	  a	  
mineral	   oil	   reservoir	   through	   polyethylene	   tubes	   and	   connected	   at	   the	   end	   to	   a	   glass	  
capillary	   needle	   (Figure	   1.	   B).	   The	   use	   of	   mineral	   oil	   provides	   control	   of	   the	   suction	   and	  
pressure	   required	   to	   pick	   up	   and	   expel	   cells	   (ZFIN:	   Zebrafish	   Book:	   Cellular	   Methods,	  
http://zfin.org/zf_info/zfbook/chapt5/5.7.html).	  
Approximately	  30	   cells	   from	  donor	  embryos	  were	   then	   transplanted	   into	  host	  embryos	  
(Figure	  1.	  C).	  At	  90%	  epiboly	  (9	  hpf),	  transplanted	  embryos	  were	  fixed	  in	  paraformaldehyde	  
4%	  in	  phosphate	  buffered	  saline,	  for	  2	  h	  at	  RT	  (Figure	  1.	  D).	  Biotin	  injected	  transplanted	  cells	  






Figure	   1.	   A)	   Petri	   dish	   with	   agarose	   low	   melting,	   holding	   host	   and	   donor	   embryos	   in	   different	   rows.	   B)	  
Transplantation	  needle.	  C)	  Schematic	  representation	  of	  cell	   transplantation	  experiment:	   	  about	  30	  cells	  were	  
transplanted	  from	  donor	  morphants	  to	  the	  host	  embryos.	  D)	  Image	  of	  transplanted	  zebrafish	  embryo	  at	  9	  hpf.	  	  
Population	  of	  transplanted	  cells	  is	  labeled	  in	  purple.	  
Proliferation	  analysis	  
Proliferation	  was	  analyzed	  both	  directly	   in	  morphant	  embryos	  as	  well	   as	   in	   the	  genetic	  
chimeras	   above	   described.	   To	   analyze	   proliferation,	   whole	   mount	   immunohistochemistry	  
was	   performed	   with	   anti-­‐phosphohistone	   H3	   antibody	   (polyclonal	   rabbit	   Millipore)	  
according	  to	  the	  manufacturer	  instructions	  and	  revealed	  with	  NBT/BCIP	  solution	  (Roche)	  or	  
FAST	  BLUE	  (Sigma).	  For	  imaging	  stereomicroscope	  Leica	  DMR	  and	  confocal	  microscope	  Leica	  
SP5	  were	  used.	  
Statistical	  analysis	  
Quantitative	  data	  are	  expressed	  as	  mean	  ±	  SEM.	  Statistical	  significance	  of	  transplantation	  
experiment	   was	   determined	   by	   chi-­‐squared	   test	   using	   the	   Primer	   statistical	   software.	  
Statistical	   significance	   of	   proliferation	   assay	   was	   determined	   by	   Kruskal-­‐Wallis	   one-­‐way	  
analysis	  of	  variance	  (Anova)	  and	  differences	  between	  groups	  were	  assessed	  with	  the	  Mann–
Whitney	   U-­‐test	   using	   the	   statistical	   software	   Statistic	   10.	   p-­‐value	   of	   less	   than	   0.05	   was	  
considered	  statistically	  significant.	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RESULTS	  
Proliferation	  analysis	  
Embryos	   injected	   with	   I)	   MO1-­‐ambra1aATG,	   II)	   MO1-­‐ambra1bATG,	   III)	   MO1-­‐ambra1a	   +	  
MO1-­‐ambra1b	   and	   their	   controls	   (wild-­‐type	   and	   injected	   with	  MO1-­‐ambra1a-­‐5m	   or	   with	  
MO1-­‐ambra1b-­‐5m)	   were	   analysed,	   at	   9	   hpf,	   by	   means	   of	   whole-­‐mount	  
immunohistochemistry	   with	   anti-­‐phosphohistone	   H3.	   The	   number	   of	   phosphohistone	   H3	  
positive	   cells,	   quantified	  within	   an	   equal	   area	   in	   each	  embryo,	   is	   significantly	   higher	   in	   all	  
ATG	  morphant	  embryos	  (MO1-­‐ambra1aATG,	  MO1-­‐ambra1bATG	  and	  coinjection	  of	  both	  MOs)	  
compared	  with	   the	   three	   control	   samples	  with	   the	   exception	   of	   coinjection	   of	   both	  MOs	  
when	  compared	  with	  MO1-­‐ambra1b-­‐5m	  morphant	  control	  embryos.	  In	  particular,	  as	  shown	  
in	  Figure	  2,	  the	  number	  of	  cells	   in	  proliferation	  was	  similar	   in	  all	  the	  three	  control	  samples	  
(WT	  and	  MO1-­‐ambra1a5M	  or	  MO1-­‐ambra1b5M	  morphant	  embryos).	  Moreover,	  proliferation	  
of	   MO1-­‐ambra1b	   embryos	   was	   higher	   than	  MO1-­‐ambra1a	   and	   co-­‐injection	   of	   both	  MOs	  
even	  if	  not	  significantly.	  
Figure	  2.	  Proliferation	  analysis:	  embryos	  were	   injected	  with	  MO1-­‐ambra1aATG	  and	  MO1-­‐ambra1bATG	  (alone	  or	  
together),	   and	   stained,	   by	   immunohistochemistry,	   with	   anti-­‐phosphohistone	   H3	   antibodies	   at	   9	   hpf.	   The	  
number	  of	  pH3	  positive	  cells	  is	  represented	  in	  bar	  graphs	  (mean	  ±	  standard	  error	  of	  the	  mean).	  The	  results	  are	  
the	  average	  of	  three	  independent	  experiments	  with	  at	  least	  7	  embryos	  for	  each	  treatment.	  *	  indicates	  that	  the	  
differences	   in	   the	  number	  of	  cell	   in	  proliferation	  are	  significantly	  different	   (P	  <	  0.05);	  **	   (P	  <	  0.01);	  ***	   (P	  <	  






































To	  determine	  whether	  the	  cellular	  higher	  proliferation	  rate	  observed	  in	  embryos	  injected	  
with	  MO1-­‐ambra1aATG	   and	  MO1-­‐ambra1bATG	   is	   cell-­‐autonomous	   or	   non	   cell-­‐autonomous,	  
we	   transplanted	  a	   small	  population	  of	  MO-­‐microinjected	  cells	   into	  wild	   type	  embryos	  and	  
analyzed	   their	   proliferation	   rate.	   Donor	   embryos	  were	   injected	  with	   a	  mixture	   containing	  
EGFP	  mRNA	  and	  biotin-­‐dextran	   (to	   trace	   the	   cells	   before	  and	  after	   transplantation)	   and	   I)	  
MO1-­‐ambra1aATG,	  II)	  MO1-­‐ambra1bATG,	  III)	  MO1-­‐ambra1aATG	  +	  MO1-­‐ambra1bATG.	  
Cell	   proliferation	   rate	   and	   biotin-­‐dextran	   injected	   transplanted	   cells	  were	   visualized	   by	  
whole	  mount	   immunohistochemistry	   at	   9	   hpf.	   The	   percentage	   of	   proliferating	   cells	   (dark	  
cells)	   that	   co-­‐localized	  with	   transplanted	   cells	   (blue	   cells)	  was	  evaluated	   in	   relation	   to	   the	  
whole	  number	  of	  transplanted	  cells	  (%).	  
Proliferation	   of	   transplanted	   cells	   deriving	   from	   embryos	   injected	   with	  MO1-­‐ambra1a,	  
MO1-­‐ambra1b,	   or	   co-­‐injected	  with	   both	  MOs	  was	   significantly	   higher	  with	   respect	   to	  WT	  
donors.	  Moreover,	  also	  in	  this	  experiment,	  proliferation	  of	  MO1-­‐ambra1b	  transplanted	  cells	  
was	  higher	   then	  MO1-­‐ambra1a	   alone	  or	   after	   coinjection	  with	  MO1-­‐ambra1b,	   even	   if	   not	  
significantly.	  
These	  data	  suggest	  that	  the	  proliferation	  is	  regulated	  by	  a	  cell-­‐autonomous	  mechanism.	  
	  
Figure	  3.	  Transplantation	  and	  proliferation	  analysis:	  a	  small	  population	  of	  MO-­‐treated	  cell	  where	  transplanted	  
into	   wild	   type	   embryos.	   Biotin	   present	   in	   transplanted	   cells	   was	   detected	   by	   using	   an	   avidin-­‐biotinylated	  
complex	   and	   the	   DAB	   substrate	   (dark	   cells).	   Transplanted	   cells	   in	   proliferation	   were	   stained	   with	   anti-­‐
phosphohistone	  H3	  antibodies	  (blue	  cells).	  The	  results	  are	  the	  average	  of	  three	  independent	  experiments	  with	  
at	   least	   7	   embryos	   for	   each	   treatment.	   *	   indicates	   that	   the	   differences	   in	   the	   %	   of	   transplanted	   cells	   in	  
proliferation	  are	  significantly	  different	  (P	  <	  0.05);	  **	  (P	  <	  0.01);	  ***	  (P	  <	  0.001).	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The	   essential	   role	   of	   autophagy	   in	  muscle	   homeostasis	   has	   been	   clearly	   demonstrated	   by	  
phenotype	  analysis	  of	  mice	  with	  muscle-­‐specific	   inactivation	  of	  genes	  encoding	  autophagy-­‐
related	  proteins.	  Ambra1	  is	  a	  key	  component	  of	  the	  Beclin	  1	  complex	  and,	  in	  zebrafish,	  it	  is	  
encoded	   by	   two	   paralogous	   genes,	   both	   required	   for	   normal	   embryogenesis	   and	   larval	  
development.	  In	  this	  study	  we	  focused	  on	  the	  function	  of	  Ambra1,	  a	  positive	  regulator	  of	  the	  
autophagic	   process,	   during	   skeletal	   muscle	   development	   by	   means	   of	   morpholino	   (MO)-­‐
mediated	  knockdown	  and	  compared	  the	  phenotype	  of	  zebrafish	  ambra1-­‐depleted	  embryos	  
with	  that	  of	  Ambra1gt/gt	  mouse	  embryos.	  
Morphological	   analysis	   of	   zebrafish	  morphant	   embryos	   revealed	   that	   silencing	   of	   ambra1	  
impairs	   locomotor	  activity	  and	  muscle	  development,	  as	  well	  as	  myoD1	  expression.	  Skeletal	  
muscles	   in	   ATG-­‐morphant	   embryos	   displayed	   severe	   histopathological	   changes	   and	  
contained	  only	  small	  areas	  of	  organized	  myofibrils	  that	  are	  widely	  dispersed	  throughout	  the	  
cell.	   Double	   knockdown	   of	   ambra1a	   and	   ambra1b	   resulted	   in	   a	   more	   severe	   phenotype	  
whereas	   defects	   were	   much	   less	   evident	   in	   splice-­‐morphants.	   Together,	   these	   results	  
indicate	   that	   ambra1a	   and	   ambra1b	   are	   required	   for	   the	   correct	   development	   and	  
morphogenesis	  of	  skeletal	  muscle.	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INTRODUCTION	  
Autophagy	   is	  an	  evolutionarily	  conserved	  catabolic	  process	   in	  which	  cells,	   through	  the	  
lysosomal	  machinery,	  degrade	  and	   recycle,	   long-­‐lived	  proteins	  and	  dismantle	  organelles	   in	  
order	  to	  maintain	  a	  homeostatic	  intracellular	  environment.	  This	  process	  is	  tightly	  regulated	  
and	   plays	   several	   important	   roles	   in	   normal	   physiology,	   differentiation,	   embryo	  
development,	  and	  cell	  survival	  during	  starvation	  [1].	  Defects	  of	  this	  degradative	  system	  play	  
a	  role	  in	  various	  diseases,	  such	  as	  neurodegenerative	  and	  lysosomal	  storage	  disorders	  and	  in	  
oncogenesis	   and	   cancer	   progression	   [2].	   However,	   little	   is	   known	   about	   autophagy	   in	  
muscular	  pathology.	  	  
In	   skeletal	  muscle,	   the	   role	  of	   autophagy	  was	   initially	  demonstrated	   in	  Atg5	  and	  Atg7	  
muscle-­‐specific	   knockout	   mice	   [3,4].	   In	   both	   models,	   the	   muscle	   showed	   abnormal	  
mitochondria	  and	  disorganized	  sarcomeres,	  confirming	  a	  homeostatic	   role	  of	  autophagy	   in	  
this	   tissue.	   A	   direct	   connection	   between	   autophagy	   deregulation	   and	  muscular	   dystrophy	  
was	  initially	  found	  in	  collagen	  VI	  null	  mice,	  where	  accumulation	  of	  abnormal	  organelles	  and	  
spontaneous	  apoptosis,	  was	  shown	  to	  strictly	  depend	  on	  defective	  autophagy	  regulation	  [5].	  
In	   agreement	   with	   this,	   reactivation	   of	   autophagy	   restored	   myofiber	   survival	   and	  
ameliorated	  the	  dystrophic	  phenotype	  of	  collagen	  VI	  null	  mice.	  More	  recently,	  deregulation	  
of	  the	  autophagic	  process	  was	  also	  demonstrated	  in	  other	  dystrophic	  mouse	  models	  [6-­‐9]	  as	  
well	  as	  in	  the	  Vici	  syndrome,	  a	  human	  genetic	  disease	  caused	  by	  recessive	  mutations	  of	  the	  
EPG5	   gene,	   which	   codes	   for	   a	   key	   autophagy	   regulator	   involved	   in	   the	   formation	   of	  
autolysosomes	  [10].	  
Ambra1,	  originally	  identified	  in	  a	  gene	  trap	  screening	  for	  mutations	  in	  mice,	  is	  a	  positive	  
regulator	  of	  the	  Beclin	  1	  dependent	  programme	  of	  autophagy	  [11].	  Ambra1	  is	  an	  intrinsically	  
disordered	   protein,	   whose	   capability	   of	   binding	   a	   number	   of	   other	   regulatory	   partners	  
involved	  in	  many	  cell	  processes	  highlights	  its	  crucial	  role	  as	  a	  “relay”	  molecule	  for	  autophagy	  
[12].	   In	   mammalian	   cells,	   Ambra1	   is	   normally	   docked	   at	   a	   specific	   cytoskeletal	   site,	  
corresponding	  to	  the	  dynein	  light	  chain,	  where	  it	  is	  unleashed	  upon	  autophagy	  induction	  to	  
translocate	  at	  the	  autophagosome	  origin	  sites	  on	  the	  endoplasmic	  reticulum	  [13].	  Ablation	  
of	   Ambra1,	   as	   demonstrated	   by	   loss-­‐of-­‐function	   in	  mice,	   leads	   to	   embryonic	   lethality	   and	  
causes	  neural	  defects,	  suggesting	  a	  role	  for	  autophagy	  in	  nervous	  system	  development	  [11].	  
Results	   obtained	   with	   the	   zebrafish	   model	   confirmed	   the	   involvement	   of	   this	   protein	   in	  
embryonic	  development	  and	  demonstrated	  that	  the	  duplicated	  fish	  ambra1	  paralogue	  genes	  
are	   required	   for	   normal	   embryogenesis	   and	   larval	   development.	   Indeed,	   MO-­‐induced	  
ablation	   of	   the	   corresponding	   proteins	   was	   found	   to	   be	   associated	   with	   several	  
developmental	  abnormalities	  and	  decreased	  viability	  [14].	  
The	  rapid	  development	  and	  transparency	  of	  zebrafish	  embryos,	  together	  with	  the	  high	  
fecundity	  and	  amenability	  to	  genetic	  manipulation	  of	  this	  vertebrate	  model,	  as	  well	  as	  with	  
the	   feature	   that	   skeletal	   muscles	   represent	   a	   large	   portion	   of	   the	   body	   and	   are	   easily	  
accessible	   for	   analysis,	   have	   made	   this	   organism	   attractive	   for	   investigating	   muscle	  
development	   and	   fiber-­‐type	   specification	   [reviewed	   by	   15]	   as	   well	   as	   myopathies	   and	  




skeletal	   muscle	   development	   by	   means	   of	   knockdown	   of	   ambra1	   paralogue	   genes	   in	  
zebrafish.	  Depletion	  of	  zebrafish	  ambra1	  proteins	  results	  in	  abnormal	  locomotor	  activity	  and	  
a	  severe	  myopathy	  characterized	  by	   irregular	  myofiber	  orientation	  and	  highly	  disorganized	  
sarcomeres,	   suggesting	  a	   role	   for	  ambra1	   in	  muscle	  development.	   In	  agreement	  with	   this,	  
histological	   analysis	   of	   Ambra1	   gene	   trap	  mutant	   (Ambra1gt/gt)	  mouse	   embryos	   showed	   a	  
disorganized	   three-­‐dimensional	   structure	   of	   developing	   muscles	   and	   an	   increased	  
proliferation	  of	  muscle	  cells.	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METHODS	  
Animal	  maintenance	  and	  handling	  
Zebrafish	  were	  raised,	  staged	  and	  maintained	  according	  to	  standard	  protocols	   [17,18].	  
Embryos	  were	  obtained	  by	   natural	   spawning	   and	   cultured	   in	   zebrafish	   fish	  water	   solution	  
(50x:	  25	  g	  Instant	  Ocean,	  39.25	  g	  CaSO4,	  5	  g	  NaHCO3	  for	  1	  l)	  at	  28.5°C	  with	  a	  photoperiod	  of	  
14	   h	   light/10	   h	   dark.	   For	   in	   vivo	   imaging,	   embryos	  were	   anesthetized	  with	   0.04%	   tricaine	  
[18].	  Ambra1gt/+	  mice	   (CD1	   strain)	  breed	   in	  order	   to	  obtain	  Ambra1gt/gt	   embryos	   [11].	  Data	  
were	  obtained	  in	  E13.5	  embryos	  by	  comparing	  Ambra1gt/gt	  and	  wild-­‐type	  animals.	  Mice	  were	  
housed	  in	  individual	  cages	  in	  an	  environmentally	  controlled	  room	  (23	  °C,	  12	  h	  light/12	  h	  dark	  
cycle)	  and	  provided	  food	  and	  water	  ad	  libitum.	  All	  animal	  procedures	  were	  approved	  by	  the	  
Ethics	  Committee	  of	  the	  University	  of	  Padova.	  	  
MO	  microinjection	  
MO	  (Gene	  Tools,	  Philomath,	  OR)	   treatment	  was	  performed	  with	  MOs	  against	   the	  ATG	  
translation	  initiation	  sites	  of	  either	  ambra1a	  or	  ambra1b	  transcripts	  (MO-­‐ambra1a-­‐ATG	  and	  
MO-­‐ambra1b-­‐ATG)	   and	  with	   splice-­‐blocking	  MOs	   designed	   for	   both	   genes	   at	   the	   exon	   3-­‐
intron	  3	   junction	   sequence	   (MO-­‐ambra1a-­‐splice	   and	  MO-­‐ambra1b-­‐splice).	   As	   controls,	  we	  
used	  five-­‐nucleotide-­‐mismatched	  control	  MOs	  (MO-­‐ambra1a-­‐5m	  and	  MO-­‐ambra1b-­‐5m).	  All	  
MOs	  were	  previously	  described	  and	  validated	  [14],	  however	  lower	  MO	  dosages	  were	  used	  in	  
this	   work	   in	   order	   to	   reduce	   embryo	   mortality.	   Specifically,	   for	   each	   MO,	   10.3	   ng	   were	  
injected	   in	   the	   yolk	   of	   1-­‐cell	   stage	   embryos,	   whereas	   the	   dosage	   was	   halved	   in	   the	   co-­‐
injection	   experiments.	   Injections	   were	   performed	   under	   a	   dissecting	   microscope	   using	   a	  
microinjector	   attached	   to	   a	   micromanipulator	   (Leica	   Microsystems,	   Milan,	   Italy).	   MO-­‐
injected	  embryos	  were	  then	  incubated	  in	  1x	  fish	  water	  solution	  at	  28.5	  °C	  up	  to	  the	  desired	  
stages	  of	  development.	  	  
Birefringence	  assay	  	  
Muscle	   birefringence	   was	   analysed	   by	   placing	   anesthetized	   embryos	   on	   a	   glass	  
polarizing	   filter	   and	   covering	   with	   a	   second	   polarizing	   filter	   on	   a	   Leica	   DMR	   microscope	  
(Leica	  Microsystems	   Srl).	   Embryos	   were	   photographed	  with	   a	   Leica	   DC500	   digital	   camera	  
(Leica	  Microsystems	   Srl).	   The	   top	   filter	   was	   twisted	   until	   it	   was	   possible	   to	   see	   the	   light	  
refracting	  through	  the	  striated	  muscle.	  




Whole	  mount	  in	  situ	  hybridization	  (WMISH)	  	  
Zebrafish	   embryos	   were	   fixed	   overnight	   in	   4%	   paraformaldehyde	   (PFA,	   Sigma)	   in	  
phosphate-­‐buffered	   saline	   (PBS)	   at	   the	   required	   stages	   of	   development.	   WMISH	   was	  
performed	  as	  previously	  described	  [19].	  DIG-­‐labeled	  myoD1	  riboprobe	  was	  synthesized	  by	  in	  
vitro	   transcription	   with	   T7	   RNA	   polymerases	   (Roche),	   following	   the	   manufacturer’s	  
instructions	  and	  after	  plasmid	  linearization	  with	  BamHI	  restriction	  enzyme.	  
Imaging	  	  
For	   confocal	  microscopy,	   fixed	   embryos	  were	   embedded	   in	   0.8%	   low-­‐melting	   agarose	  
and	   placed	   on	   a	   depression	   slide,	   and	   a	   Nikon	   C2	   confocal	   system	   was	   used	   to	   record	  
images.	  WMISH-­‐stained	  embryos	  were	  mounted	  in	  87%	  glycerol	  in	  PBT	  (Phosphate-­‐buffered	  
saline	  plus	  0.1%	  Tween20)	  or	  cleared	  and	  mounted	   in	  2:1	  benzyl	  benzoate/benzyl	  alcohol,	  
observed	   under	   a	   Leica	   DMR	   microscope,	   and	   photographed	   with	   a	   Leica	   DC500	   digital	  
camera.	  
Histology	  and	  immunofluorescence	  	  
Zebrafish	   embryos	   were	   fixed	   overnight	   in	   4%	   paraformaldehyde	   in	   PBS	   at	   4	   °C.	   For	  
histology,	  5	  mm	   thin	  paraffin	   sections	  were	   cut	  and	   stained	  with	  haematoxylin	  and	  eosin.	  
Embryos	   were	   fixed	   for	   antibody	   staining	   with	   4%	   PFA	   and	   whole-­‐mount	  
immunohistochemistry	  was	   performed	   according	   to	   Dolez	   et	   al.,	   [20],	   using	   the	   following	  
primary	   antibodies:	   rabbit	   polyclonal	   anti-­‐PH3	   (1:100;	  Millipore,	   USA);	  mouse	  monoclonal	  
anti-­‐Pax7	   (1:20;	   Hybridoma	   Bank,	   USA),	   mouse	   monoclonal	   anti-­‐F59	   (1:100;	   Hybridoma	  
Bank);	   mouse	   monoclonal	   anti-­‐F59	   (1:100,	   Hybridoma	   Bank).	   The	   following	   secondary	  
antibodies	  were	  used:	  Alexa	  Fluor	  488	  goat	  anti-­‐mouse	  IgG1(y1)	  (A-­‐21121,	  Invitrogen);	  Alexa	  
Fluor	  594	  goat	  anti-­‐rabbit	  IgG	  (H+L)	  (A-­‐11012,	  Invitrogen).	  E13.5	  mouse	  embryos	  were	  fixed	  
in	  4%	  paraformaldehyde,	  de-­‐hydrated	  and	  included	  in	  paraffin.	  Haematoxylin-­‐eosin	  staining	  
was	  performed	   following	  standard	  protocols.	   Images	  were	  detected	  using	  a	  Zeiss	  Axioplan	  
microscope	  equipped	  with	  a	  digital	  camera.	  
Transmission	  electron	  microscopy	  	  
Samples	  were	  fixed	  in	  6%	  glutaraldehyde	  in	  0.1	  M	  cacodylate	  buffer	  (pH	  6.9)	  overnight	  
at	  4°C.	  After	  washing	  in	  cacodylate	  buffer,	  the	  specimens	  were	  post-­‐fixed	  in	  1%	  OsO4	  in	  the	  
same	  buffer	  for	  2	  h	  and	  dehydrated	  in	  a	  graded	  ethanol	  series	  followed	  by	  propylene	  oxide.	  
The	  specimens	  were	  embedded	  in	  EPON	  812	  resin.	  Thick	  sections	  (1	  μm)	  were	  cut	  with	  an	  
Ultracut	  S,	  Reichert	  ultramicrotome	  (New	  York,	  USA),	  counterstained	  with	  toluidine	  blue	  and	  
examined	  with	  a	  light	  microscope.	  Thin	  sections	  (100	  nm)	  were	  stained	  with	  uranyl	  acetate	  
and	   lead	   citrate.	   Micrographs	   were	   taken	   with	   a	   FEI	   Tecnai	   G12	   electron	   microscope	  
operating	  at	  100	  kV.	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Microinjection	  of	  the	  hsp	  70l:lamp1-­‐RFP	  plasmid	  into	  fertilized	  eggs	  
A	  total	  of	  25	  ng/μl	  of	  hsp70l:lamp1-­‐RFP	  [21]	  plasmid	  was	  co-­‐injected	  with	  each	  ambra1-­‐
MO	   into	   zebrafish	  embryos	  at	  one-­‐cell	   stage.	  Microinjected	  embryos	  were	   raised	   to	  3	  dpf	  
stage	  and	  heat	  shocked	  by	  replacing	  the	  embryo	  medium	  with	  fish	  water	  preheated	  at	  41	  °C	  
and	   then	   incubated	   in	  an	  air	   incubator	  at	  38	   °C	   for	  30	  min	   to	   induce	  hsp70	  expression.	   In	  
parallel,	  microinjected	  embryos	  were	  incubated	  with	  the	  lysosome	  inhibitor	  bafilomycin	  A1	  
(1	  μM;	  Sigma)	  for	  6	  h	  prior	  to	  the	  heat	  shock.	  Lamp1-­‐RFP	  labeled	  punctae	  were	  analysed	  by	  
confocal	  microscopy.	  





Knockdown	  of	  ambra1a	  and	  ambra1b	  interferes	  with	  embryo	  motility	  and	  muscle	  integrity	  
To	   investigate	   the	   effects	   of	   ambra1a	   and	   ambra1b	   ablation	   during	   muscle	  
development,	  we	  injected	  validated	  antisense	  MOs	  [14]	  into	  the	  yolk	  mass	  of	  1-­‐cell	  embryos	  
to	  suppress	  translation	  of	  both	  maternal	  and	  zygotic	  mRNA	  (ATG	  MOs)	  or	  to	  silence	  zygotic	  
transcription	  of	  the	  two	  genes	  (splice-­‐blocking	  MOs).	  In	  agreement	  with	  previous	  work	  [14],	  
ATG-­‐morphant	  embryos	  displayed	  severe	  abnormalities	  in	  their	  overall	  appearance	  and	  that	  
mainly	  consisted	  in	  body	  growth	  delay,	  curved	  shape,	  hemorrhagic	  pericardial	  cavity,	  as	  well	  
as	   neural	   tube	   defects.	   Almost	   all	   ATG-­‐morphant	   embryos	   had	   to	   be	   manually	  
dechorionated.	  The	  delay	  in	  hatching	  could	  be	  due	  to	  an	  overall	  developmental	  delay	  [14],	  
but	   also	   to	   a	   reduction	  of	   the	  muscle	   activity	   that	   contributes	   to	   the	   exit	   of	   the	   embryos	  
from	  their	  protective	  outer	  chorion.	  Moreover,	  after	  hatching,	  both	  ambra1a	  and	  ambra1b	  
ATG-­‐morphants,	   as	   well	   as	   co-­‐injected	   morphant	   embryos,	   showed	   impaired	   or	   totally	  
absent	  locomotor	  activity	  and	  did	  not	  respond	  to	  touch	  with	  the	  escape	  response	  normally	  
observed	   in	   control	   embryos	   injected	   with	   mismatch	   MOs.	   Less	   severe	   aspects	   of	   the	  
phenotypes	   included	   uncoordinated	   movements	   in	   response	   to	   tactile	   stimuli	   and	   often	  
swim	   in	   a	   circular	   fashion.	   In	   agreement	   with	   the	   impaired	   locomotor	   activity,	   ATG-­‐
morphants	   exhibited	   a	   clear	   reduction	   of	   birefringence	   of	   the	   skeletal	  musculature	  when	  
compared	  with	  control	  embryos,	  which	  is	  indicative	  of	  decreased	  striated	  muscle	  formation	  
or	   loss	   of	   myofiber	   organization.	   Double	   morphants	   zebrafish	   muscle	   showed	   a	   higher	  
reduction	  of	  birefringence	  compared	  with	  single	  morphants.	  Birefringence	  and	  motility	  were	  
almost	  normal	  in	  both	  ambra1a	  and	  ambra1b	  splice-­‐morphants	  (Figure	  1).	  	  
Figure	  1.	  Ambra1	  silencing	  results	  in	  a	  reduced	  birefringence.	  Polarized	  light	  microscopy	  of	  3	  dpf	  live	  embryos	  
shows	   that	   birefringence	  of	   trunk	  muscles	   is	   severely	   reduced	   in	  ambra1	   ATG-­‐morphants	   and	   in	   co-­‐injected	  
morphants.	  The	  birefringence	  is	  weakly	  reduced	  in	  ambra1	  splice-­‐morphants	  whereas	  wild-­‐type	  (WT)	  and	  5m-­‐
control	  embryos	  display	  highly	  birefringent	  skeletal	  muscles.	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ambra1	  downregulation	  interferes	  with	  myoD1	  expression	  during	  myogenesis	  
To	  assess	  the	  requirement	  for	  ambra1a	  and	  ambra1b	  during	  embryonic	  myogenesis,	  we	  
performed	  WMISH	   analysis	  with	   the	   somite-­‐specific	  marker	  myoD1.	   At	   the	   bud	   stage	   (10	  
hpf),	   expression	   of	  myoD1	   in	   the	   adaxial	   cells	   was	   reduced	   in	   ATG-­‐morphants,	   while	   the	  
width	   between	   them	  was	   increased,	   particularly	   at	   the	   posterior	   end	   (Figure	   2).	   This	  was	  
more	   evident	   in	   ambra1a	   ATG-­‐morphants	   and	   in	   co-­‐injected	   morphants.	   Expression	   of	  
myoD1	   appeared	   normal	   in	   splice-­‐morphants	   for	   both	   genes	   as	   well	   as	   in	   5m-­‐control	  
morphants.	  At	  20	  hpf,	  ambra1	  ablation	  resulted	  in	  broad	  shaped	  and	  less	  definite	  somites,	  
suggesting	   impaired	   somite	   organization,	   undulated	   notochord,	   and	   shortened	  
anterior/posterior	   axes.	  All	   defects	  were	  more	  evident	   in	  ambra1a	   ATG-­‐morphants	   and	   in	  
co-­‐injected	   embryos.	   Segmentation	   pattern	   appeared	   normal	   in	   splice-­‐morphants	   and	   in	  
5m-­‐control	  morphants	  (Figure	  2).	  	  
Figure	   2.	   In	   situ	   hybridization	   analysis	   of	  myoD1	   expression	   in	   ambra1	   knockdown	   embryos.	   Expression	   of	  
myoD1,	   analyzed	   in	   embryos	   injected	  with	   the	   indicated	  MOs	   at	   10	   and	  20	  hpf,	   is	   affected	   in	  ambra1	   ATG-­‐
morphants	   and	   in	   co-­‐injected	   morphants.	   No	   differences	   are	   evident	   in	   ambra1	   splice-­‐morphants	   when	  
compared	  to	  wild-­‐type	  (WT)	  and	  5m-­‐control	  embryos.	  Embryos	  are	  shown	  in	  dorsal	  view,	  anterior	  toward	  the	  




ambra1	  deficiency	  generates	  pathological	  changes	  of	  muscle	  morphology	  
To	   fully	   appreciate	   at	   a	   microscopic	   level	   the	   phenotype	   shown	   in	   Figure	   1,	   we	  
performed	   a	   histological	   analysis	   of	   haematoxylin/eosin	   stained	   longitudinal	   sections	   of	  
muscles	  from	  3	  dpf	  embryos.	  This	  showed	  well-­‐organized	  myofibers	  with	  elongated	  nuclei	  in	  
wild-­‐type	  and	  5m-­‐control	  muscles.	   In	  ATG-­‐morphants,	  myosepta	  were	  not	   clearly	   evident,	  
particularly	   in	  ambra1a	  ATG-­‐morphants	  and	  co-­‐injected	  embryos,	  and	  myofibers	  appeared	  
misaligned	   with	  markedly	   disorganized	   shape	   and	   orientation.	  Moreover,	   ATG-­‐morphants	  
displayed	  an	  apparently	   increased	  number	  of	  myonuclei	   (Figure	  3).	  Morphological	  changes	  
were	   much	   less	   evident	   in	   splice-­‐morphants,	   although	   the	   myosepta	   were	   thinner	   with	  
respect	  to	  controls	  and	  myofibers	  appeared	  less	  organized.	  	  
Figure	  3.	  Abnormal	  morphology	  of	  ambra1	  knockdown	  embryos,	  as	  revealed	  by	  haematoxylin/eosin	  staining.	  
Representative	   longitudinal	   sections	   of	   3	   dpf	   control	   and	   ambra1	   morphant	   embryos.	   Images	   show	   that	  
myofibers	  of	  ATG-­‐	  and	  co-­‐injected	  morphant	  muscles	  are	  highly	  disorganized	  and	  present	   irregular	  myosepta	  
boundaries.	  The	  phenotype	  of	  splice-­‐morphants	  is	  much	  less	  severe	  when	  compared	  to	  wild-­‐type	  (WT)	  and	  5m-­‐
control	  embryos.	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The	   irregular	   arrangement	   of	   muscle	   fibers	   was	   confirmed	   by	   toluidine	   blue	   stained	  
semithin	   longitudinal	   sections	   of	   muscle	   fibers	   running	   between	   the	   vertical	   myosepta	  
(Figure.	  4).	  In	  both	  ambra1a	  and	  ambra1b	  ATG-­‐morphants,	  the	  myoseptum	  was	  difficult	  to	  
distinguish	  and	  in	  some	  places	  it	  seemed	  interrupted.	  Multiple	  areas	  devoid	  of	  staining	  were	  
present	  within	  myofibers	  of	  both	  ATG-­‐morphants	  and	  amorphous	  opaque	  material	  replaced	  
lost	   myofibers.	   In	   ambra1a	   ATG-­‐morphants	   and	   in	   co-­‐injected	   morphants	   many	   fibers	  
appeared	   detached.	   Skeletal	   muscles	   of	   splice-­‐morphants	   displayed	   only	   minor	  
modifications.	  Cross	  sections	  of	  the	  trunk	  region	  analysed	  by	  toluidine	  blue	  staining	  showed	  
extensive	   disruption	   of	   muscle	   fiber	   structure	   and	   organization,	   with	   empty	   spaces	   and	  
region	   filled	   with	   amorphous	   opaque	   material.	   Several	   myonuclei	   appeared	   large,	  
abnormally	  rounded,	  and	  centrally	  localized	  (Figure	  4).	  
Figure	   4.	   Abnormal	   morphology	   of	   ambra1	   knockdown	   embryos,	   as	   revealed	   by	   toluidine	   blue	   staining.	  
Representative	   longitudinal	   and	   cross	   sections	   of	   3	   dpf	   control	   and	  ambra1	  morphant	   embryos.	  Muscles	   of	  
ambra1	   ATG-­‐morphants	   show	   a	   severe	   phenotype,	   with	  misaligned	  myofibers	   and	   scattered	   in	   the	   somitic	  
compartment.	   Black	   arrows:	   areas	   devoid	   of	   staining;	   white	   arrows:	   large	   myonuclei	   with	   condensed	  




Immunostaining	  of	  3	  dpf	  embryos	  for	  phospho-­‐histone	  H3,	  a	  mitotic	  marker,	  showed	  a	  
higher	  proliferation	  rate	   in	  ATG-­‐morphant	  embryos,	  while	   the	  number	  of	  phospho-­‐histone	  
H3	  positive	  nuclei	  in	  splice-­‐morphants	  was	  intermediate	  compared	  to	  controls	  (Figure	  5).	  	  
Figure	  5.	  Cell	  proliferation	  in	  muscles	  of	  3	  dpf	  control	  and	  ambra1	  morphant	  embryos.	  	  Mitotic	  cells,	  analyzed	  
by	   immunostaining	   for	   phospho-­‐histone	   H3	   in	   longitudinal	   sections,	   are	   more	   abundant	   in	   ATG-­‐morphant	  
embryos	  with	  respect	  to	  wild-­‐type	  (WT)	  and	  5m-­‐control	  embryos.	  Anterior	  is	  to	  the	  left	  and	  dorsal	  up.	  	  
Immunofluorescence	  at	  2	  dpf	  for	  Pax7,	  a	  key	  regulator	  of	  muscle	  progenitor	  cells	  [22],	  
showed	  that	  both	  ATG-­‐	  and	  splice-­‐morphants	  had	  a	  higher	  incidence	  of	  Pax7-­‐positive	  cells	  in	  
the	   spaces	   between	   myosepta,	   instead	   of	   being	   regularly	   localized	   to	   the	   edges	   of	   the	  
somites	  as	  in	  wild-­‐type	  and	  5m-­‐control	  embryos	  (Figure	  6).	  
Figure	  6.	  Pax7	  expression	  in	  control	  and	  ambra1	  morphant	  embryos.	  Lateral	  views	  of	  2	  dpf	  muscles	  analyzed	  by	  
immunofluorescence	   for	  Pax7.	   In	  wild-­‐type	   (WT)	  and	  5m-­‐control	  embryos	  Pax7-­‐positive	  cells	  are	   localized	  at	  
the	   edge	   of	   somites,	   whereas	   in	   ambra1	   morphants	   many	   Pax7-­‐positive	   cells	   are	   misplaced	   in	   the	   spaces	  
between	  myosepta.	  Anterior	  is	  to	  the	  left	  and	  dorsal	  up.	   	  
Chapter	  III	  
	  
	   89	  
Ablation	  of	  ambra1	  causes	  ultrastructural	  defects	  of	  myofibers	  
To	   better	   understand	   the	   subcellular	   alterations	   responsible	   of	   the	   observed	   fiber	  
disturbances,	   we	   performed	   an	   electron	   microscopy	   analysis	   of	   longitudinal	   and	   cross	  
sections.	   Zebrafish	   embryos	   at	   3	   dpf	   showed	   that	  wild-­‐type	   and	  5m-­‐control	   embryos	   (not	  
shown)	   had	   well-­‐defined	   muscle	   fiber	   structure	   with	   normally	   developed	   sarcoplasmic	  
reticulum	   encircling	   myofibrils	   and	   intermyofibrillar	   mitochondria.	   In	   control	   embryos,	  
sarcomeres	  were	  clearly	  visible	  and	  formed	  regular	  repeating	  units	  with	  alignment	  of	  well-­‐
defined	   Z-­‐lines,	   mitochondria	   were	   aligned	   in	   rows	   and	   had	   tightly	   packed	   cristae,	   and	  
myofibers	  were	  surrounded	  by	  very	  small	  areas	  of	  amorphous	  material	  (Figure	  7,	  panels	  A1-­‐
A4).	  In	  contrast,	  muscle	  fibers	  of	  ATG-­‐morphants	  and	  of	  co-­‐injected	  embryos	  contained	  only	  
small	  areas	  of	  organized	  filaments,	  widely	  dispersed	  throughout	  the	  cells	  and	  surrounded	  by	  
enlarged	   areas	   of	   disorganized	   cytoplasm	   devoid	   of	   normally	   appearing	   organelles.	  
Remnants	  of	  degenerating	  myofibers	  were	  also	  seen	   in	  these	  regions	   (Figure	  7,	  panels	  B1-­‐
B4,	  D1-­‐D4,	  F1-­‐F4).	  Although	  ATG-­‐morphants	  muscle	  fibers	  contained	  sarcomeres,	  they	  were	  
substantially	  reduced	  in	  number,	  torn,	  not	  correctly	  aligned	  and	  dispersed	  within	  amorphous	  
material.	   Areas	  with	  myofibrils	   showing	   orthogonal	   arrangement	   to	   each	   other	  were	   also	  
visible	   (Figure	  7).	   The	  ultrastructural	  muscle	  defects	  were	   less	   severe	   in	   splice-­‐morphants,	  
where	   only	   small	   regions	   devoid	   of	   myofibrils	   were	   present	   together	   with	   a	   milder	  




Figure	   7.	   Ultrastructural	   analysis	   of	   ambra1	   morphants	   reveals	   disorganized	   sarcomeres.	   Representative	  
electron	  micrographs	  of	  cross	  and	  longitudinal	  sections	  of	  3	  dpf	  wild-­‐type	  (WT,	  panels	  A1-­‐A4),	  ambra1a	  ATG-­‐
morphant	   (panels	  B1-­‐B4),	  ambra1a	   splice-­‐morphant	   (panels	  C1-­‐C4),	  ambra1b	  ATG-­‐morphant	   (panels	  D1-­‐D4),	  
ambra1b	  splice-­‐morphant	  (panels	  E1-­‐E4),	  and	  co-­‐injected	  morphant	  (panels	  F1-­‐F4)	  zebrafish	  embryos.	  Columns	  
2	  and	  4	  show	  higher	  magnification	  views	  of	  the	  boxed	  areas	  in	  column	  1	  and	  3,	  respectively.	  Muscles	  of	  WT	  and	  
5m-­‐control	   (not	  shown)	  embryos	  display	  well-­‐organized	  myofibers,	   showing	  densely	  packed	  sarcomeres	  with	  
regular	  organization	  of	  thin	  and	  thick	  myofilaments.	  ambra1-­‐depleted	  muscles	  show	  a	  large	  number	  of	  defects,	  
with	   small	   patches	   of	   disorganized	   myofibers	   and	   mitochondria	   scattered	   throughout	   the	   cytoplasm.	   *,	  
fragments	  of	  torn	  myofibers;	  white	  arrow,	  dilated	  sarcoplasmic	  reticulum	  not	  in	  contact	  with	  myofibers;	  black	  
arrow,	  area	  with	  myofibers	  having	  different	  orientations;	  M,	  mitochondria;	  N,	  nucleus.	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Patterning	   of	   internal	   membranes	   was	   also	   affected	   in	   ATG-­‐morphants	   and	   in	   co-­‐
injected	   embryos,	   as	   the	   sarcoplasmic	   reticulum	   appeared	   dilated	   and	   often	   not	   closely	  
associated	   with	   myofibrils	   (Figure	   8,	   row	   E).	   Ambra1	   morphant	   embryos	   showed	   several	  
ultrastructural	   abnormalities	   of	   T-­‐tubules	   and	   sarcoplasmic	   reticulum,	   ranging	   from	   mild	  
changes	   in	   splice-­‐morphants	   to	   unrecognizable	   triad	   areas	   in	   co-­‐injected	   morphants,	  
whereas	   wild-­‐type	   embryos	   and	   5m-­‐control	   embryos	   displayed	   a	   normal	   pattern	   of	   T-­‐
tubules	  and	  sarcoplasmic	  reticulum	  resulting	  in	  regularly	  spaced	  triads	  (Figure	  8,	  row	  C).	   In	  
ambra1	   morphant	   embryos,	   mitochondria	   were	   scattered	   throughout	   the	   cytoplasm	   and	  
their	   morphology	   was	   also	  markedly	   affected,	   as	   they	   were	   often	   swollen	   and	   devoid	   of	  
cristae	   or,	   when	   present,	   these	   were	   disorganized	   or	   abnormal	   (Figure	   7,	   panel	   B2	   and	  
Figure	  8,	  row	  A).	  Ultrastructural	  analysis	  also	  confirmed	  that	  myonuclei	  were	  often	  larger	  in	  
morphant	  embryos,	  with	  an	  irregular	  shape	  and	  more	  numerous	  when	  compared	  to	  control	  
embryos	   (Figure	   8,	   row	   B).	   	   The	   abnormal	   myofiber	   ultrastructure	   of	   ambra1	   depleted	  
embryos	   was	   particularly	   evident	   in	   cross	   sections,	   where	   myofibers	   of	   control	   embryos	  
showed	  a	   regular	  hexagonal	  arrays	  of	   thick	  and	  thin	   filaments	  while	   in	  ambra1	  morphants	  
the	  hexagonal	  arrays	  were	  irregular,	  with	  areas	  in	  which	  thick	  filaments	  were	  not	  associated	  
with	  thin	  filaments	  (Figure	  8,	  row	  D).	  	  
Taken	  together,	  our	  results	  highlight	  a	  severe	  disorganization	  of	  muscle	  tissue	  and	  cells	  
upon	   ambra1	   disruption.	   Also,	   alteration	   of	   mitochondria	   and	   ER	   structure	   seem	   to	   be	  
causative	  of	  the	  phenotype.	  
Figure	   8.	   Ultrastructural	   analysis	   of	   ambra1	   morphants	   reveals	   disorganized	   subcellular	   structures.	   When	  
compared	   to	   wild-­‐type	   (WT)	   and	   5m-­‐control	   (not	   shown)	   embryos,	   ambra1	   morphant	   embryos	   display	  
abnormal	  features	  of	  mitochondria	  (row	  A),	  nuclei	  (row	  B),	  triads	  (row	  C),	  hexagonal	  arrangement	  of	  thick	  and	  
thin	   filaments	   (row	   D),	   and	   dilations	   of	   the	   endoplasmic	   reticulum	   (row	   E).	  Morphant	   embryos	   display	   the	  
presence	   of	   areas	   with	   reduced	   thin	   filaments	   (black	   circles	   in	   row	   D)	   adjacent	   to	   more	   normal-­‐appearing	  
hexagonal	  structures	  (white	  circles	  in	  row	  D).	  Co-­‐injected	  double	  morphant	  embryos	  show	  exacerbated	  defects	  




Ablation	  of	  ambra1	  affects	  both	  fast	  and	  slow	  muscle	  fibers	  
Next,	   to	   assess	   whether	   knockdown	   of	   ambra1a	   and	   ambra1b	   expression	   results	   in	  
defective	   specification	   and	   patterning	   of	   slow	   and/or	   fast	   muscle	   fibers,	   we	   examined	  
myosin	  thick	  filaments	  in	  ambra1	  knockdown	  embryos	  by	  immunostaining	  with	  the	  F59	  and	  
F310	  antibodies,	  which	  label	  slow	  and	  fast	  myosin	  isoform,	  respectively.	  Slow	  muscle	  fibers	  
were	   still	   present	   after	   ambra1	   knockdown,	   although	  myofiber	   density	   appeared	   lower	   in	  
ambra1a	   ATG-­‐morphants	   and	   in	   co-­‐injected	   embryos	   (Figure	   9).	   However,	   whereas	   in	  
control	  embryos	  the	  thick	  filaments	  were	  nicely	  organized	  and	  the	  myotomal	  segments	  were	  
V-­‐shaped	  and	   regularly	   spaced,	   thick	   filaments	   in	   slow	  muscles	  of	  ATG-­‐morphant	  embryos	  
appeared	   highly	   disorganized,	   with	   wavy	   and	   twisted	   myofibrils.	   Moreover,	   the	  
characteristic	   V-­‐shaped	   appearance	   of	   the	   vertical	   myoseptum	   was	   almost	   completely	  
absent.	   Some	  muscle	   fibers	  were	  missing	  or	  detached	   from	   the	  myosepta	  generating	   cell-­‐
free	   spaces	   in	   ATG-­‐morphants.	   Combined	   injection	   of	   both	   ATG-­‐MOs	   exacerbated	   the	  
phenotype.	   The	   phenotype	   was	   almost	   normal	   in	   ambra1	   splice-­‐morphants,	   where	  
myofibrils	   presented	   only	   a	   slightly	   wavy	   morphology	   (Figure	   9).	   A	   similar	   disruption	   in	  
myofiber	   organization	   was	   also	   evident	   in	   fast	   muscles.	   In	   wild-­‐type	   and	   5m-­‐control	  
embryos,	   the	   fast	   muscle	   fibers	   appeared	   relatively	   uniform	   in	   size	   and	   were	   regularly	  
arranged	   in	   parallel	   rows.	   Conversely,	   in	   ATG-­‐morphants	   fast	   muscle	   fibers	   displayed	  
variable	   shapes	   and	   were	   highly	   disorganized,	   showing	   a	   dystrophic	   appearance	   with	  
detachment	   and	   retraction	   of	   myofibers	   from	   the	   vertical	   myosepta	   forming	   the	   somite	  
boundaries	   and	   with	   irregular	   and	   wavy	   myofiber	   morphology	   (Figure	   9).	   Interestingly,	  
splice-­‐morphants	   displayed	   a	   more	   evident	   phenotype	   in	   fast	   muscle	   fibers	   than	   in	   low	  
muscle	   fibers.	   These	   data	   indicated	   that	   although	   slow	   and	   fast	   muscle	   fibers	   were	   still	  
present	   and	   in	   the	   correct	   positions	   within	   the	   somites,	   myofiber	   organization	   was	  
disrupted.	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Figure	   9.	   Knockdown	   of	   ambra1	   interferes	   with	  myosin	   heavy	   chain	   organization	   in	   slow	   and	   fast	  muscles.	  
Lateral	  views	  of	  3	  dpf	  muscles	  labeled	  with	  the	  F59	  antibody	  (slow	  muscle	  fibers)	  and	  with	  the	  F310	  antibody	  
(fast	  muscle	   fibers),	  showing	  abnormally	  organized	  myofilaments	   in	  ATG-­‐morphant	  embryos	  when	  compared	  
to	  wild-­‐type	   (WT)	  and	  and	  5m-­‐control	  embryos.	   Slow	   fibers	  are	   thinner	   in	  ATG-­‐morphant	  embryos,	  whereas	  
fast	  fibers	  of	  splice-­‐morphant	  embryos	  display	  a	  wavy	  phenotype,	  visibly	  different	  from	  controls.	  The	  asterisks	  
indicate	  broken	  or	  missing	  muscle	  fibers.	  Anterior	  is	  to	  the	  left	  and	  dorsal	  up.	  




Muscle	  fibers	  from	  ambra1	  morphants	  display	  abnormal	  autophagy	  	  
To	   evaluate	   the	   effect	   of	   zebrafish	   ambra1a	   and	   ambra1b	   knockdown	   on	   the	  
autophagic	  process,	  we	  analysed	  autophagy	  in	  muscle	  fibers	  where	  transient	  expression	  of	  
the	   lysosomal	   lamp1-­‐RFP	   reporter	   protein	   was	   obtained	   by	   microinjection	   of	   zebrafish	  
embryos	   with	   hsp70l:lamp1-­‐RFP	   reporter	   construct,	   in	   which	   the	   zebrafish	   lamp1	   gene	   is	  
driven	   by	   the	   hsp70l	   	   promoter	   and	   thus	   induced	   by	   heat-­‐shock	   treatment	   [21].	   Muscle	  
fibers	   were	   analysed	   at	   3	   dpf	   in	   the	   absence	   or	   presence	   of	   the	   lysosomal	   inhibitor	  
bafilomycin	  A1,	   in	  order	  to	  prevent	  the	  fusion	  between	   lysomes	  and	  autophagosomes	  and	  
allow	   accumulation	   of	   lysosomes,	   which	   appear	   as	   punctate	   structures	   at	   the	   confocal	  
microscope	  (Figure	  10).	  This	  analysis	  showed	  that	  several	  lamp1-­‐RFP	  puncta	  were	  present	  in	  
myofibers	   from	   wild-­‐type	   and	   5m-­‐control	   embryos,	   with	   a	   noticeable	   increase	   following	  
bafilomycin	   treatment.	   In	   contrast,	   knockdown	   of	   either	   ambra1a	   or	   ambra1b	   led	   to	   an	  
almost	  complete	  lack	  of	  lamp1-­‐RFP	  puncta	  in	  muscle	  fibers	  and	  to	  a	  very	  low	  increase	  after	  
bafilomycin	  treatment.	  	  
Figure	   10.	   Fluorescence	   detection	   in	   muscle	   fibers	   of	   control	   and	   ambra1	   morphant	   embryos	   following	  
transfection	  with	   a	   lamp1-­‐RFP	   reporter	   construct.	   Fluorescent	   puncta	   are	   detected	   in	  muscle	   fibers	   isolated	  
from	   wild-­‐type	   (WT)	   and	   5m-­‐morphant	   embryos,	   both	   under	   control	   conditions	   and	   following	   bafilomycin	  
treatment,	  whereas	  only	  few	  puncta	  are	  visibile	  in	  ATG-­‐morphant	  embryos	  after	  bafilomycin	  treatment.	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Skeletal	  muscles	  in	  Ambra1gt/gt	  mouse	  embryos	  display	  morphological	  defects	  
To	   further	   get	   insight	   into	   the	   role	   of	   Ambra1	   during	   muscle	   development,	   we	  
investigated	   skeletal	   muscles	   from	   Ambra1gt/gt	   mutant	   mice,	   which	   bear	   a	   gene	   trap	  
insertion	   in	  the	  Ambra1	  gene	  [11].	  We	  first	  analyzed	  muscle	  morphology	  by	  haematoxylin-­‐
eosin	  staining	  in	  E13.5	  mouse	  embryos,	  when	  differentiation	  of	  muscles	  is	  not	  yet	  complete	  
and	  myogenic	  cells	  are	  undergoing	  fusion	  to	  form	  myofibers	  and	  organize	  the	  architecture	  of	  
muscle	  tissue.	   In	  wild-­‐type	  E13.5	  mouse	  embryos,	   the	  structure	  of	   the	  developing	  muscles	  
appeared	   normal.	   Myofibers	   were	   well	   organized	   and	   aligned	   to	   generate	   the	   ordered	  
structure	   of	   the	  muscle,	   with	  many	   nuclei	   already	   localized	   at	   the	   periphery	   (Figure	   11A,	  
upper	  panels).	   In	  Ambra1gt/gt	  E13.5	  mouse	  embryos,	  skeletal	  muscles	  were	  present	  but	  the	  
three-­‐dimensional	  organization	  of	  the	  tissue	  was	  less	  organized	  (Figure	  11A,	   lower	  panels).	  
The	   abnormal	   structure	   of	   developing	   muscles	   in	   Ambra1gt/gt	   embryos	   may	   be	   due	   to	   a	  
failure	   in	   completing	  muscle	   development	   or	   to	   a	   delay	   in	  myofiber	  maturation.	   This	  was	  
also	   supported	   by	   the	   presence	   of	  many	   immature	  myofibers	   displaying	   centrally	   located	  
nuclei	  in	  Ambra1gt/gt	  embryos	  (Figure	  11A,	  lower	  panels).	  These	  features,	  which	  we	  detected	  
in	   all	   muscles	   of	   Ambra1gt/gt	   embryos	   that	   were	   analyzed,	   are	   clearly	   exemplified	   by	   the	  
developing	  tongue.	  In	  wild-­‐type	  E13.5	  embryos,	  the	  tongue	  showed	  a	  well-­‐defined	  array	  of	  
parallel	   myofibers	   distinctly	   organized	   in	   the	   three	   different	   planes	   of	   the	   developing	  
intrinsic	   tongue	   muscles	   (Figure	   11B,	   upper	   panels).	   Conversely,	   in	   Ambra1gt/gt	   E13.5	  
embryos,	   the	   tongue	   displayed	   a	   general	   disorganization	   of	   the	   developing	   muscles	   and	  
myofibers	  were	  less	  defined.	  In	  addition,	  there	  was	  a	  marked	  increase	  of	  cell	  density	  in	  the	  
whole	   muscle	   tissue	   of	   Ambra1gt/gt	   embryos	   (Figure	   11B,	   lower	   panels).	   Similar	  
morphological	  and	  cellular	  alterations	  were	  also	  detected	  in	  the	  developing	  dorsal	  and	  limb	  
muscles	  of	  Ambra1gt/gt	  embryos,	  which	  also	  showed	  a	  noticeable	  increase	  of	  the	  interstitial	  





Figure	  11.	  Morphological	  alteration	  of	  skeletal	  muscles	   in	  Ambragt/gt	  mouse	  embryos.	  Representative	  pictures	  
of	  skeletal	  muscles	  following	  haematoxylin-­‐eosin	  staining	  of	  wild-­‐type	  and	  Ambra1gt/gt	  	  E13.5	  mouse	  embryos.	  
(A)	   Details	   of	   neck	   muscle.	   Wild-­‐type	   embryos	   display	   several	   well-­‐organized	   and	   mature	   myofibers	   (black	  
arrows),	  which	  have	  myonuclei	  already	   localized	  at	   the	  edge	  of	   the	  cell	   (right	  panel).	   In	  Ambra1gt/gt	  embryos,	  
the	  muscle	  is	  much	  more	  immature,	  with	  poorly	  organized	  myofibers	  displaying	  centrally	  located	  nuclei	  (black	  
arrows).	   (B)	   Details	   of	   the	   tongue.	   In	  wild-­‐type	   embryos,	  myofiber	   are	   formed	   and	  well-­‐organized	   (arrows),	  
whereas	  in	  Ambra1gt/gt	  embryos	  there	  is	  a	  general	  disorganization	  of	  muscle	  architecture.	  (C,	  D)	  Representative	  
pictures	   of	   dorsal	   (C)	   and	   limb	   (D)	   muscles	   (black	   arrows).	   In	   Ambra1gt/gt	   embryos,	   besides	   the	   general	  
alteration	  of	  muscle	  organization,	  there	  is	  a	  marked	  thickening	  of	  the	  connective	  tissue	  (black	  asterisks).	  All	  the	  
skeletal	  muscles	  analyzed	  display	  a	  noticeable	  increase	  of	  cell	  density	  in	  Ambra1gt/gt	  embryos.	  Scale	  bar,	  50	  μm.	  
WT,	  wild-­‐type.	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DISCUSSION	  
In	   this	   work,	   we	   used	   a	   targeted	   protein	   depletion	   approach	   to	   investigate	   the	  
involvement	  of	  ambra1	  proteins	  in	  zebrafish	  muscle	  development.	  The	  severe	  phenotype	  of	  
zebrafish	  ambra1a	  and	  ambra1b	  morphant	  embryos	  suggests	  a	  function	  of	  these	  proteins	  in	  
myogenesis.	   Our	   analysis	   on	  muscles	   of	   ambra1a	   and	   ambra1b	   zebrafish	  morphants	   was	  
mainly	  focused	  on	  3	  dpf	  embryos,	  as	  the	  muscle	  structure	  at	  this	  stage	  is	  mature.	  Our	  data	  
show	   a	   severe	   myopathy	   characterized	   by	   a	   marked	   reduction	   of	   myofiber	   density	  
associated	   with	   an	   abnormal	   orientation	   and	   decreased	   alignment	   of	   muscle	   fibers,	   with	  
altered	   myofibrils	   and	   disorganization	   of	   sarcomeres,	   and	   with	   defects	   of	   the	   tubulo-­‐
reticular	   network	   and	   mitochondria	   morphology.	   Although	   a	   role	   for	   Ambra1	   in	   skeletal	  
muscle	  was	  never	   proposed	  before	  now,	   our	   findings	   are	   in	   agreement	  with	  other	   recent	  
studies	   indicating	   that	   autophagy	   plays	   a	   key	   role	   in	   skeletal	   muscles,	   as	   shown	   by	   the	  
myopathic	   phenotype	   of	   Atg5	   and	   Atg7	   muscle-­‐specific	   knockout	   mice	   [3,4]	   and	   by	   the	  
connection	  between	  autophagy	  deregulation	  and	  muscular	  dystrophies	  [5-­‐9].	  	  	  
In	  zebrafish,	  transcripts	  for	  both	  ambra1	  genes	  are	  present	  as	  maternal	  RNAs	  in	  the	  eggs	  
and	   display	   a	   gradual	   decline	   until	   8	   hpf,	   being	   replaced	   by	   zygotic	   mRNAs	   from	   12	   hpf	  
onwards	  [14].	  To	  verify	  a	  possible	  role	  of	  these	  proteins	  in	  the	  early	  stages	  of	  skeletal	  muscle	  
development,	   the	   commitment	   to	   the	  myogenic	   fate	  was	   analysed	  by	  WMISH	   for	  myoD1,	  
whose	   expression	   normally	   begin,	   prior	   to	   somite	   formation,	   in	   the	   adaxial	   cell	   [23,24].	  
These	  cells,	  after	  migrating	   laterally	  through	  the	  somites,	   forms	  the	  slow	  muscle	  cells	  [25],	  
whereas	   those	  remaining	  near	   to	   the	  notochord	   form	  the	  muscle	  pioneer	  cells	   [26].	  Later,	  
myoD1	  expression	  takes	  place	  in	  the	  posterior	  half	  of	  each	  newly	  formed	  somite,	  giving	  raise	  
to	  the	  fast	  muscle	  fibers	  [25].	  Knockdown	  of	  zebrafish	  ambra1	  genes	  led	  to	  marked	  changes	  
of	  myoD1	   expression,	   resulting	   in	   a	   reduced	  myoD1	   signal	   and	   a	   widening	   of	   the	   space	  
between	   the	   bilateral	   adaxial	   cells	   of	   ATG-­‐morphant	   embryos.	   Later,	   somites	   present	   a	  
broad-­‐shaped	   and	   non-­‐homogeneous	  myoD1	   expression.	   Moreover,	   somite	   shape	   is	   not	  
well	   defined.	   Interestingly,	   also	   expression	  of	   shh,	   a	   gene	   coding	   for	   a	   secreted	   signalling	  
protein	  implicated	  in	  the	  commitment	  of	  muscle	  precursors	  [reviewed	  in	  15,26],	  was	  found	  
to	   be	   differently	   shaped	   in	   mouse	   [11],	   as	   well	   as	   in	   zebrafish	   ambra1	   ATG-­‐morphant	  
embryos	  resulting	   in	  notochord	  waving	  [14].	  Depletion	  of	  ambra1	  proteins	   in	  zebrafish	  did	  
not	  prevent	  the	  specification	  and	  differentiation	  of	  slow	  and	  fast	  muscle	  fibers,	  but	  clearly	  
interfered	  with	  myofibrillogenesis	   leading	   to	  an	  anomalous	  pattern	  of	  both	   fiber	   types.	  As	  
different	   levels,	   along	   with	   range	   and	   timing,	   of	   Shh	   signalling	   specify	   different	   muscle	  
subtypes	   [27,28],	   the	   displaced	   expression	   of	   this	   morphogen	   could	   explain	   the	  
disorganization	  of	  the	  ambra1-­‐morphant	  muscle	  fibers.	  
The	   changes	   in	   myoD1	   and	   shh	   expression,	   together	   with	   the	   reduced	   locomotor	  
activity,	  observed	   in	  ambra1	  morphant	  embryos	  occur	  at	  very	  early	  developmental	  stages,	  
when	  embryonic	  cells	  are	  likely	  not	  yet	  competent	  for	  autophagy,	  the	  biological	  process	   in	  
which	  ambra1	  is	  clearly	  involved.	  Actually,	  this	  process	  can	  be	  observed	  in	  zebrafish	  embryos	  
starting	   from	  32	  hpf	   [29],	   and	   thus	   relatively	   late	   compared	  with	   the	  onset	  of	   the	  muscle	  




expression	   program	   responsible	   for	   correct	   muscle	   development,	   as	   suggested	   by	   the	  
displaced	  expression	  of	  shh	  [14]	  and	  of	  myoD1	  and	  it	  is	  still	  unclear	  whether	  this	  regulation	  
is	   related	   to	   ambra1	   pro-­‐autophagic	   roles.	  On	   the	   other	   side,	   ambra1	  morphant	   embryos	  
were	   also	   found	   to	   display	   reduced	   autophagy,	   as	   measured	   by	   immunoblot	   analysis	   for	  
lipidated	  LC3	  at	  2	  dpf	  [14].	  A	  weakening	  of	  the	  autophagic	  process	  was	  also	  suggested	  by	  the	  
lower	   incidence	   of	   puncta	   in	   muscle	   fibers	   isolated	   from	   zebrafish	   embryos	   expressing	   a	  
hsp:lamp1-­‐RFP	  reporter	  plasmid.	  	  
Pax7,	  a	  key	  regulator	  for	  myogenic	  progenitor	  cell	   in	  all	  vertebrates	  [30],	  was	  analysed	  
at	  2	  dpf,	  when	  the	  Pax7-­‐positive	  cells	  are	  generally	  aligned	  along	  the	  vertical	  and	  horizontal	  
myosepta.	   In	   ambra1	   morphants	   embryos,	   the	   regular	   arrangement	   of	   Pax7-­‐positive	   was	  
disturbed	   and	   these	   cells	   also	  occurred	   in	   the	   spaces	  between	  myosepta,	   thus	   confirming	  
the	   disorganization	   of	   somites.	   This	   morphological	   analysis	   did	   not	   reveal	   any	   obvious	  
difference	   in	   the	   number	   of	   Pax7-­‐positive	   cells	   between	   control	   and	   ambra1	   morphant	  
embryos,	  although	  a	  significant	  increase	  of	  these	  cells	  has	  been	  measured	  in	  zebrafish	  with	  
dystrophic	   phenotypes	   [30,31].	   This	   result	   seems	   to	   contrast	   with	   the	   apparently	   higher	  
proliferation	   rate	   seen	   in	  ambra1	  morphants	   both	   by	   haematoxylin/eosin	   staining	   and	   by	  
immunofluorescence	   for	   phosphorylated	   histone	   H3.	   However,	   this	   discrepance	   may	   be	  
explained	  by	  a	  higher	  proliferation	  of	  fibroblasts,	  as	  also	  suggested	  by	  muscles	  of	  Ambra1gt/gt	  
mouse	  embryos	  that	  show	  a	  thickening	  of	  the	  interstitial	  connective	  tissue.	  
Although	   the	   muscle	   pathological	   defects	   of	   ambra1a	   and	   ambra1b	   ATG-­‐morphant	  
embryos	   are	   similar,	   the	   phenotype	   of	   co-­‐injected	   embryos	   deficient	   for	   both	   ambra1	  
paralogue	  genes	  is	  more	  severe.	  This	  suggests	  the	  possibility	  that	  the	  two	  proteins	  not	  only	  
work	   in	   similar	   biological	   process	   but	   also	   play	   roles	   in	   other	   process,	   thus	   justifying	   the	  
retention	  of	  both	  genes	  as	  functional	  in	  the	  zebrafish	  genome	  after	  the	  fish-­‐specific	  whole-­‐
genome	   duplication	   [32].	   This	   was	   also	   indicated	   by	   rescue	   experiments	   in	   our	   previous	  
study,	  which	  showed	  that	  the	  two	  genes	  couldn’t	  fully	  compensate	  each	  other	  deficiencies,	  
at	  least	  morphologically	  [14].	  Moreover,	  knockdown	  of	  only	  zygotic	  ambra1a	  and	  ambra1b	  
transcripts	   by	  means	   of	   splice-­‐MOs	   resulted	   in	   less	   severe	  muscle	   developmental	   defects,	  
indicating	   the	   importance	   of	   maternally	   supplied	   ambra1	   transcripts	   and	   of	   the	  
corresponding	   proteins	   in	   early	   embryonic	   development.	   Interestingly,	   and	   at	   difference	  
from	   other	   parameters,	   splice-­‐morphants	   showed	   a	   remarkably	   stronger	   phenotype	   than	  
ATG-­‐morphants	  with	   regard	   to	   fast	   fiber	  development,	  a	   finding	   that	   is	   in	  agreement	  with	  
the	  different	  timing	  of	  slow	  and	  fast	  fiber	  differentiation	  [33].	  Since	  fast	  fibers	  differentiate	  
after	  slow	  fibers,	  the	  process	  in	  this	  case	  could	  be	  more	  affected	  by	  the	  silencing	  of	  zygotic	  
transcripts	  because,	  at	  that	  stage,	  maternal	  transcript	  would	  be	  no	  longer	  available.	  	  	  
The	   physiological	   and	   pathological	   role	   of	   autophagy	   in	   mature	   skeletal	   muscle,	  
although	  not	  completely	  understood,	  has	  been	  recently	  described	  [reviewed	  in	  34,35].	  Our	  
data	   obtained	   from	   ambra1a	   and	   ambra1b	   zebrafish	   morphant	   embryos	   and	   from	  
Ambra1gt/gt	   mouse	   embryos	   indicate	   that	   this	   autophagy	   related-­‐protein	   plays	   a	   critical	  
function	   during	   skeletal	  muscle	   development.	   In	   both	   animal	  models,	   ablation	   of	   Ambra1	  
leads	   to	   abnormal	   muscle	   morphogenesis.	   Ambra1	   is	   critical	   not	   only	   for	   the	   correct	  
architecture	  and	  maturation	  of	  myofibers,	  but	   it	  seems	  also	   implicated	   in	  cell	  proliferation	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control.	   Our	   data	   suggest	   a	   new	   function	   of	   Ambra1	   in	   muscle	   biogenesis.	   While	   the	  
presence	  of	  abnormal	  organelles	  are	  likely	  be	  associated	  to	  the	  well-­‐known	  role	  of	  Ambra1	  
in	  autophagy	  regulation,	  the	  altered	  morphology	  and	  the	  hypercellularity	  of	  the	  developing	  
skeletal	   muscles	   may	   be	   due	   to	   a	   different	   function	   of	   Ambra1.	   Further	   studies	   will	   be	  
necessary	   to	   fully	  elucidate	   the	   functional	   role	  of	  Ambra1	   in	   the	  developing	  and	  postnatal	  
skeletal	  muscles,	  in	  order	  to	  understand	  the	  role	  of	  this	  protein	  in	  muscle	  homeostasis	  and	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Ambra1	  is	  a	  key	  component	  of	  the	  autophagic	  process	  that	  plays	  several	  important	  roles	  in	  
normal	  physiology,	  differentiation,	  embryo	  development,	  and	  survival	  during	  starvation,	  but	  
is	   also	   implicate	   in	   pathophysiological	   processes.	   The	   ambra1	   gene	   has	   been	   previously	  
characterized	  only	   in	  mammals	  and	  in	  zebrafish.	   In	  this	  study,	  we	  report	  the	  identification,	  
through	  genome	  bioinformatics	  searches	  and	  targeted	  cloning,	  of	  the	  first	  complete	  ambra1	  
transcript	   in	   a	   non-­‐vertebrate	   chordate,	   the	   tunicate	  Botryllus	   schlosseri.	   This	   is	   a	  marine	  
colonial	   species,	   which	   couples	   sexual	   reproduction	   to	   budding	   (blastogenesis).	   Usually,	  
three	   blastogenic	   generations	   are	   present	   in	   the	   colony:	   filtering	   adults,	   their	   buds	   and	  
budlets	   produced	   by	   the	   latter.	   Colony	   life-­‐cycle	   is	   characterized	   by	   a	   cyclical	   change	   of	  
generation	  (take-­‐over),	  in	  which	  adults	  are	  resorbed	  by	  apoptosis,	  buds	  become	  adults	  and	  a	  
new	   generation	   of	   budles	   is	   produced.	   In	   B.	   schlosseri,	   Ambra	   1	   deduced	   amino	   acid	  
sequence	  is	  shorter	  than	  vertebrate	  Ambra1	  proteins	  but	  still	  contains	  the	  WD40	  domain,	  a	  
marker	   of	   this	   protein.	   Moreover,	   not	   all	   conserved	   regions	   are	   present	   in	   the	  
experimentally	  determined	  B.	  schlosseri	  and	  in	  the	  predicted	  C.	  intestinalis	  Ambra1	  proteins:	  
both	  of	  them	  lack	  of	  the	  DLC1-­‐binding	  consensus	  motifs	  (TQT)	  that	  blocks	  the	  protein	  at	  its	  
specific	   cytoskeletal	   site.	   RT-­‐PCR	   analysis	   revealed	   that	   ambra1	   transcripts	   are	   expressed	  
both	   in	   take-­‐over	   and	   in	   blastogenic	   phases	   distant	   to	   takeover	   (mid-­‐cycle).	   Typical	  
autophagosomes,	  bounded	  by	  a	  double	  membrane,	  where	  also	  recognized	  at	   transmission	  
electron	   microscopy	   in	   cells	   of	   colonies	   in	   take-­‐over.	   Our	   data	   allows	   consideration	   on	  
relationships	  between	  autophagy	  and	  apoptosis	  and	  the	  role	  of	   these	  cellular	  processes	   in	  
the	  homeostasis	   of	   the	  organism.	  Moreover,	   they	   open	   to	   evolutionary	   considerations	   on	  
the	  role	  and	  control	  of	  autophagy	  in	  chordates.	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INTRODUCTION	  
Autophagy	   is	   a	   catabolic	   process	   that	   cells	   use	   to	   degrade	   and	   recycle,	   through	   the	  
lysosomal	  machinery,	   long-­‐lived	   proteins	   and	   dismantle	   organelles	   in	   order	   to	  maintain	   a	  
homeostatic	  environment	  within	  the	  cells.	  It	  is	  a	  tightly	  regulated	  process	  that	  plays	  several	  
important	   roles	   in	   normal	   physiology,	   differentiation,	   embryo	   development,	   and	   survival	  
during	  starvation	  [1,	  2].	  Since	  clearance	  of	  unnecessary	  or	  injured	  components	  is	  critical	  for	  
cell	   life,	   dysfunction	   of	   the	   autophagic	   process	   is	   implicated	   in	   several	   pathophysiological	  
processes,	  including	  cancer,	  myopathies	  and	  neurodegenerative	  disorders	  [3].	  	  
Due	  to	  its	  essential	  role	  in	  cell	  survival	  and	  viability,	  the	  autophagic	  process	  is	  conserved	  
throughout	   the	  eukaryotes	   [4].	   In	  particular,	   the	  molecular	  mechanism	  of	   this	  process	  has	  
been	  preserved	  during	  evolution,	  as	  demonstrated	  by	  expression	  in	  different	  organisms	  of	  a	  
basic	   set	   of	   key	   AuTophaGy-­‐related	   genes	   (ATGs).	   These	   genes	  were	   initially	   identified	   in	  
yeast	   [5],	   and	   then	   found	   also	   in	   higher	   eukaryotic	   organisms	   including	   mammal,	   insect,	  
worm	  and	  plant	  [6].	  However,	  some	  differences	  in	  the	  autophagic	  machinery	  exist	  between	  
yeast	  and	  higher	  eukaryotes	  [4,	  6].	  In	  the	  latters,	  the	  Beclin1/Vps34	  complex	  is	  regulated	  by	  
additional	  key	  proteins	  such	  as	  UVRAG,	  Ambra1	  and	  Bif-­‐1	  [7].	  	  
Among	  these	  genes,	  the	  activating	  molecule	  in	  Beclin	  1-­‐regulated	  autophagy	  (Ambra1)	  
was	  identified	  only	  few	  years	  ago	  in	  mice	  [8].	   It	  was	  found	  to	  be	  a	  central	  regulator	  of	  the	  
autophagic	   process	   thanks	   to	   its	   ability	   to	   bind	   Beclin	   1	   upon	   autophagic	   stimuli,	   thus	  
promoting	  the	   interaction	  between	  Beclin	  1	  and	  its	  target	  kinase	  Vps34	  [9].	  Since	   its	   initial	  
characterization,	   Ambra1	   was	   found	   to	   be	   involved	   not	   only	   in	   autophagy,	   a	   catabolic	  
process	  used	  by	   the	   cells	   to	  maintain	  a	  homeostatic	   intracellular	  environment,	  but	  also	   in	  
other	  key	  processes	  such	  as	  apoptosis,	   cell	  proliferation	  and	  nervous	  system	  development	  
[8].	  The	  surprisingly	  varied	  roles	  of	  this	  protein	  likely	  derive	  from	  its	  ability	  to	  bind	  different	  
proteins	   (such	   as	   Beclin1,	   Bcl-­‐2,	   DLC1	   and	   E3-­‐ligase),	   depending	   on	   the	   specific	   process	  
under	   examination	   [10].	   Ambra1	   genes	   have	   been	   cloned	   and	   characterized	   in	   human,	  
mouse	   and	   finally	   in	   zebrafish.	   In	   the	   latter,	   due	   to	   genome	   duplication	   during	   teleost	  
evolution,	   two	   paralogous	   genes	   were	   found,	   both	   required	   for	   a	   correct	   embryonic	  
development	  [11].	  
In	   the	   tunicate,	  Ciona	   intestinalis	  ambra1	   gene	  has	  been	   identified	  by	  genome	  search	  
together	  with	  other	  genes	  involved	  in	  the	  autophagic	  process.	  Moreover,	  presence	  of	  these	  
genes	  has	  been	  compared	  with	  their	  occurrence	  in	  S.	  cerevisiae,	  C.	  elegans,	  D.	  melanogaster	  
and	  H.	  sapiens	  [12].	  This	  analysis	  showed	  that	  all	  the	  non-­‐yeast	  genes	  involved	  in	  autophagy	  
are	  present	  in	  the	  genome	  of	  this	  organism	  that	  has	  an	  autophagic	  machinery	  comparable	  to	  
the	  vertebrate	  one.	  
Tunicates	   are	   marine	   invertebrate	   animals,	   considered	   to	   form	   the	   sister	   group	   of	  
vertebrates.	   Together	  with	   vertebrates	   and	   cephalochordates,	   they	   belong	   to	   the	   phylum	  
Chordata.	  For	  their	  phylogenetic	  position,	  these	  animals	  are	  strategic	  to	  study	  the	  evolution	  
of	  autophagic	  proteins	  in	  chordates.	  Ascidians,	  the	  main	  class	  of	  tunicates,	  are	  characterized	  
by	  a	  bi-­‐phasic	  cycle,	  with	  a	  swimming	  tadpole	  larva	  which	  metamorphoses	  in	  a	  sessile	  zooid.	  




at	   metamorphosis,	   becoming	   sessile	   filter-­‐feeding	   zooids,	   solitary	   or	   colonial.	   The	   last	  
species	   couple	   to	   sexual	   reproduction	   also	   the	   asexual	   one:	   the	   zooid	   derived	   from	   larva	  
metamorphoses	  begins	  a	   lifelong,	  recurring	  asexual	  reproduction	  (called	  also	  blastogenesis	  
or	  budding)	  which	  eventually	  gives	  rise	  to	  genetically	  identical	  individuals,	  the	  blastozooids.	  
Among	  colonial	  ascidians,	  Botryllus	  schlosseri	   is	  considered	  a	  model	  species	  for	  several	  
reasons:	   it	   is	   cosmopolitan,	   easy	   to	   rear	   in	   laboratory,	   its	   genome	   has	   been	   recently	  
sequenced,	  its	  biological	  cycle	  is	  well	  known	  and	  a	  recognized	  staging	  method	  is	  available	  for	  
asexual	  reproduction	  [13,	  14]	  (Figure	  1).	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Figure	  1.	  A-­‐B.	  Colony	  of	  B.	   schlosseri	   in	  mid-­‐cycle	   (stage	  9/8/3)	  and	   in	   take-­‐over	   (stage	  11/8/6).	  Dorsal	  view.	  
Squared	  areas	  are	  enlarged	  in	  insets	  to	  show	  details	  of	  buds	  (b)	  and	  budlets	  (arrowheads).	  a:	  adult;	  bv:	  blood	  
vessels;	   ra:	   regressing	   adults;	   t:	   tunic.	   C.	   Life-­‐cycle	   of	   B.	   schlosseri.	   Oozooid	   and	   blastozooids	   are	   shown	   in	  
ventral	   view	   (modified	   from	   [34]).	   D.	   Colonial	   cycle	   of	   B.	   schlosseri.	   The	   coexisting	   three	   generations	   of	  
blastozooids	   are	   visible.	   The	   change	   of	   generation	   occurs	   at	   take-­‐over	   (stage	   11/8/6),	  when	   adults	   undergo	  














































In	   B.	   schlosseri,	   each	   adult	   blastozooid	   carries	   one	   to	   several	   buds	   that	   bear	   a	  
generation	  of	  young	  budlets.	   In	   laboratory	  condition,	  budding	  follows	  weekly-­‐synchronized	  
waves	   of	   cycles	   accompanied	   by	   regression	   and	   reabsorption	   of	   the	   filtering	   adults	   (a	  
process	  called	  take-­‐over).	  In	  the	  course	  of	  this	  process	  resorbed	  zooids	  are	  replaced	  by	  their	  
buds,	   which	   develop	   into	   mature	   filtering	   zooids.	   After	   several	   blastogenetic	   cycles,	   the	  
colony	  gets	  organized	   in	  a	   star-­‐shaped	   system	  of	  a	  dozen	  of	   clonal	  blastozooids,	   arranged	  
around	  a	  common	  cloacal,	  excurrent	  siphon.	  The	  whole	  colony	   is	  embedded	   in	  a	  common	  
tunic,	  where	  all	  blastozooids	  are	  linked	  by	  a	  complex	  extrazooidic	  vascular	  system.	  	  
During	   the	   regression	   phase	   of	   adults,	   main	   organs	   undergo	   shrinkage	   and	   collapse,	  
circulating	   phagocytes	  massively	   infiltrate	   senescent	   tissues	   and	   rapidly	   ingest	   effete	   cells	  
[15,	  16].	  Within	  24–36	  h,	  cells	  undergo	  apoptosis	  and	  zooids	  are	  completely	  resorbed	  [16-­‐
19].	  Since	  a	  colony	  is	  virtually	  immortal,	  many	  cyclical	  apoptotic	  events	  occur	  during	  its	  life	  
span:	  these	  features	  renders	  B.	  schlosseri	  a	  useful	  and	  uncommon	  model	  to	  study	  on	  large	  
scale	  and	  in	  natural	  conditions	  this	  modality	  of	  programmed	  cell	  death.	  
The	   role	   of	   autophagy	   in	   ascidian	   life	   cycle	   has	   not	   been	   studied	   in	   detail	   yet.	   In	   the	  
solitary	   ascidian	   Ciona	   intestinalis,	   possible	   autophagic	   vacuoles,	   encircled	   by	   a	   single	  
membrane	  and	   containing	  degenerating	  mitochondria	  were	  described	   in	   the	   cytoplasm	  of	  
embryonic	  mesenchymal	  cells	   [20].	   	  Similar	  vacuoles,	  bounded	  by	  a	  single	  membrane,	  and	  
typical	   autophagosomes,	   bounded	   by	   a	   double	   membrane,	   were	   also	   signaled	   in	   B.	  
schlosseri	  in	  different	  ontogenetic	  phases	  [15,	  21,	  22].	  	  
In	  the	  present	  study,	  we	  describe	  the	  molecular	  cloning	  and	  characterization	  of	  ambra1	  
gene	   in	   B.	   schlosseri	   and	   compare	   its	   deduced	   amino	   acid	   sequence	   with	   those	   from	   C.	  
intestinalis	  and	  mammals.	  We	  evidence,	  by	  RT-­‐PCR	  analysis,	  that	  the	  gene	  is	  expressed	  both	  
in	   mid-­‐cycle	   and	   in	   take-­‐over,	   and	   shows	   by	   transmission	   electron	   microscopy	   that	  
autophagy	   and	   apoptosis	   concur	   together	   to	   regulate	   the	   crosstalk	   between	   generations,	  
optimizing	  colony	  survival.	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METHODS	  
Animals	  sampling	  	  
Colonies	  of	  Botryllus	  schlosseri	  (Styelidae,	  Stolidobranchia)	  were	  collected	  in	  the	  Lagoon	  
of	  Venice	  and	  then	  cultured	  in	  laboratory	  according	  to	  Sabbadin’s	  technique	  [23,	  24]	  and	  fed	  
with	  Liquifry	  Marine	  (Liquifry	  Co.,	  Dorking,	  England).	  	  
The	  transparency	  of	  the	  colonies	  allowed	  us	  to	  follow	  the	  daily	  development	   in	  vivo	  of	  
buds	  under	  the	  stereomicroscope,	  thereby	  permitting	  the	  selection	  of	  appropriate	  stages.	  
Three	   colony	   stages	   were	   utilized,	   carefully	   resolved	   in	   vivo	   following	   the	   recently	  
revised	  Sabbadin	  stadiation	  [13,	  19]:	  colony	  stage	  11/8/6,	  that	  identifies	  the	  take-­‐over,	  when	  
adult	   zooids	  are	  absorbed	  and	   replaced	  by	  new	  ones,	   and	   colony	   stages	  9/8/3	  and	  9/8/4,	  
which	  are	  in	  the	  mid-­‐cycle	  phase,	  when	  buds	  and	  zooids	  coexist	  together	  and	  no	  generation	  
change	   occurs.	   Colonies	   at	   the	   appropriate	   developmental	   stages	   were	   immersed	   in	  
RNAlater	  (Qiagen,	  Milan,	  Italy)	  and	  kept	  frozen	  at	  -­‐20°C	  until	  use.	  
RNA	  isolation	  and	  RT-­‐PCR	  
Pools	  of	  colonies,	  not	  genetically	  homogeneous,	  were	  used	  in	  all	  the	  experiments.	  Each	  
set	  of	  colonies,	  averaging	  100	  mg,	  was	  minced	  for	  2	  min	  with	  a	  frosted	  glass	  pestle	  in	  15	  ml	  
tubes	   filled	  with	  2	  ml	  of	   a	  heated	   (65°C)	   extraction	  buffer	   composed	  of	  CTAB	   Lysis	   buffer	  
(Applichem,	  VWR	  International,	  Milan,	  Italy)	  and	  2%	  β-­‐mercaptoethanol.	  Samples	  were	  then	  
maintained	  for	  1,5	  h	  at	  65°C	  in	  a	  waterbath,	  shaking	  strongly	  for	  few	  seconds	  every	  20	  min,	  
and	   cooled	   for	   2	  min	   in	   ice.	   Then,	   3	   volumes	   of	   a	   solution	   of	   chloroform-­‐isoamyl	   Alcohol	  
(24:1)	  was	  added,	  and	  the	  sample	  was	  thoroughly	  mixed	  shaking	  the	  tube	  with	  hands	  to	  get	  
an	  emulsion.	  After	  a	  centrifugation	  step	  at	  1600	  g	  for	  15	  min	  at	  4°C,	  the	  aqueous	  phase	  was	  
collected	   into	  a	  new	  tube.	  An	  equal	  volume	  of	  95%	  ethanol	  was	   then	  added	  and	  the	  total	  
RNA	  was	  purified	  using	   the	  SV	  Total	  RNA	   Isolation	  Kit	   (Promega,	  Milan,	   Italy).	  A	  sample	  of	  
RNA	  extracted	  form	  a	  mixed	  colony	  pool	  was	  enriched	  in	  polyadenylated	  mRNA	  utilizing	  the	  
NucleoTrap	  mRNA	  Kit	  (M-­‐Medical,	  Florence,	  Italy).	  
The	  cDNA	  was	  synthesized	  using	  the	  M-­‐MLV	  Reverse	  Transcriptase	  (Promega)	  according	  
to	   the	  manufacturer’s	   instructions.	   Analysis	   of	  ambra1	   expression	   in	   colonies	   at	   different	  
stages	  was	  performed	  by	  means	  of	  PCR	  analysis	  with	   the	  set	  of	  primers	  Bs-­‐AM-­‐F1	  and	  Bs-­‐
AM-­‐R1	  and	  using	  the	  Biotherm	  Taq	  DNA	  polymerase	  (Società	  Italiana	  Chimici,	  Rome,	  Italy).	  
The	  amplification	  procedure	  consisted	  of	  2	  min	  at	  95°C	  followed	  by	  30,	  35	  and	  40	  PCR	  cycles	  
with	  95°C	  for	  30	  s,	  60°C	  for	  30	  s,	  and	  72°C	  for	  20	  s.	  The	  extension	  phase	  of	  the	  last	  cycle	  was	  
prolonged	  by	  10	  min.	  A	  negative	  control	  was	  prepared	  by	  replacing	  the	  cDNA	  solution	  with	  
sterile	  water.	  The	  amplified	  products	  were	  analyzed	  for	  purity	  and	  size	  by	  electrophoresis	  in	  
2	  %	  agarose	  gel.	  




Cloning	  of	  B.	  schlosseri	  ambra1	  cDNA	  
To	   obtain	   B.	   schlosseri	   ambra1	   cDNA,	   the	   5’-­‐	   and	   3’-­‐RNA	   ligase-­‐mediated	   rapid	  
amplification	   of	   cDNA	   ends	   (5’-­‐	   and	   3’-­‐RLM-­‐RACE)	   was	   performed	   with	   FirstChoice	   RLM-­‐
RACE	   Kit	   (Ambion)	   according	   to	   the	   manufacturer’s	   instruction.	   These	   analyses	   were	  
accomplished	   using	   polyadenylated	   mRNA	   extracted	   from	   a	   mixed	   colony	   pool	   of	   B.	  
schlosseri.	  
Briefly,	   1	   mg	   of	   polyadenylated	   RNA	   was	   treated	   with	   calf	   intestinal	   phosphatase	   to	  
remove	   free	  5’-­‐phosphates	   from	  truncated	  or	  noncapped	  mRNA,	   leaving	  a	  5-­‐OH.	  The	  RNA	  
was	  then	  treated	  with	  tobacco	  acid	  pyrophosphatase	  (TAP)	  to	  remove	  the	  5-­‐cap	  from	  full-­‐
length	  mRNAs.	   This	   treatment	   leaves	   a	   5-­‐phosphate	   required	   for	   ligation.	   A	   5’-­‐RACE	   RNA	  
adapter	   oligonucleotide	   was	   ligated	   to	   the	   5’-­‐end	   of	   the	   mRNA	   using	   T4	   RNA	   ligase.	  
Subsequently,	   first-­‐strand	   cDNA	   synthesis	   was	   made	   by	   reverse-­‐transcribing	   the	   ligated	  
mRNA	  with	  random	  decamers.	  After	  cDNA	  synthesis	  the	  5’-­‐end	  of	  RNA	  was	  obtained	  by	  two	  
rounds	  of	  PCR	  amplifications	  as	  described	  in	  Supplemental	  Figure	  1.	  
To	  obtain	  3’-­‐ends	  of	  B.	  schlosseri	  ambra1,	  2	  mg	  total	  RNA	  was	  reverse-­‐transcribed	  using	  
3’-­‐RACE	   adapter	   primers.	   After	   cDNA	   synthesis,	   the	   3’-­‐end	   of	   RNA	   was	   obtained	   by	   two	  
rounds	  of	  PCR	  amplification	  as	  described	  in	  Supplemental	  Figure	  1.	  	  
The	   amplification	   procedure	   for	   both	   3’-­‐	   and	   5’-­‐RACE	   consisted	   of	   2	   min	   at	   95°C	  
followed	  by	  a	  touch-­‐down	  PCR	  reaction	  with	  annealing	  temperatures	  decreasing	  from	  65°C	  
to	  55°C	  over	  10	  cycles	  and	  the	  final	  30	  cycles	  maintained	  at	  55°C.	  The	  extension	  phase	  of	  the	  
last	  cycle	  was	  prolonged	  by	  10	  min.	  The	  primer	  sequences	  are	  reported	  in	  Table	  1.	  
The	   resultant	   amplicons	  were	   purified	   from	   the	   sliced	   gel	   bands	   and	   the	   gel-­‐purified	  
fragments	  were	   directly	   sequenced	   or	   ligated	   into	   a	   pGEM-­‐T	   vector	   using	   a	   pGEM-­‐T	   Easy	  
vector	   System	   according	   to	   the	   supplier’s	   recommendations	   (Promega).	   Plasmids	   from	  
positive	  colonies	  were	  purified	  and	  the	  clones	  were	  sequenced.	  
	   	  
Chapter	  IV	  
	  
	   113	  
Primer	   Sequence 
Bs-­‐AM-­‐F1	   5’-CCATCCTATGACAATGAGC-3’ 
Bs-­‐AM-­‐R1	   5’-TCCAATGAGACAGTGACG-3’ 
Bs-­‐AM-­‐F2	   5’-GTCACTGTCTCATTGGAG-3’ 
Bs-­‐AM-­‐R2	   5’-GTTGAATCCACGCACACC-3’ 
Bs-­‐AM-­‐F3	   5’-AATCATGGACGCTCGAGC-3’ 
Bs-­‐AM-­‐R3	   5’-GCAATGGCAAGAACGTGC-3’ 
Bs-­‐AM-­‐R4	   5’-GATTTCTGGCAACTGAAGC-3’ 
Bs-­‐AM-­‐F5	   5’-ATCCTAGATGTGAAGCACC-3’ 
Bs-­‐AM-­‐R5	   5’-CAAACGGGACCGAGCAG-3’ 
Bs-­‐AM-­‐F6	   5’-CAGAGATTCCAACTCGG-3’ 
Bs-­‐AM-­‐R6	   5’-CTGGAGGTCTGTCATCGG-3’ 
Bs-­‐AM-­‐F7	   5’-TATGGATAGTCTAGCTGC-3’ 
Bs-­‐AM-­‐R7	   5’-ACACTGTCGATGGTGTCG-3’ 
Table	  1.	  List	  of	  primers	  used	  for	  the	  B.	  schlosseri	  ambra1	  cloning.	  	  
Light	  and	  transmission	  electron	  microscopy	  
Colonies	  were	  fixed	  in	  1.5%	  glutaraldehyde	  buffered	  with	  0.2	  M	  sodium	  cacodylate,	  pH	  
7.4,	  plus	  1.6	  %	  NaCl.	  After	  washing	  in	  buffer	  and	  postfixation	  in	  1%	  OsO4	  in	  0.2	  M	  cacodylate	  
buffer,	  specimens	  were	  dehydrated	  and	  embedded	  in	  Epon	  Araldite.	  Sagittal	  serial	  sections	  
(1	  µm)	  were	  counterstained	  with	  toluidine	  blue;	  thin	  sections	  (90	  nm)	  were	  given	  contrast	  
by	  staining	  with	  uranyl	  acetate	  and	  lead	  citrate.	  Micrographs	  were	  taken	  with	  a	  FEI	  Tecnai	  G2	  
electron	  microscope	   (operating	  at	  100	  kV).	  All	   photos	  were	   collected	  and	   typeset	   in	  Corel	  
Draw	  X3.	  





Isolation	  and	  characterization	  of	  the	  B.	  schlosseri	  ambra1	  gene	  and	  its	  deduced	  protein	  
A	  BLASTN	  search	   for	  B.	  schlosseri	  ambra1	   cDNA	  sequence	  was	   initially	  performed	   in	  a	  
ESTs	   database	   (which	   link	   is	   no	   more	   available)	   using,	   as	   query,	   the	   Ambra1	   amino	   acid	  
sequence	  of	  different	  species:	  C.	  intestinalis	  Ambra1	  (deduced	  from	  the	  KH.L84.31.v1.A.SL1-­‐
1	   transcript	   of	   the	   KH	   assembly	   [25],	   available	   at	   http://ghost.zool.kyoto-­‐u.ac.jp/cgi-­‐
bin/gb2/gbrowse/kh/),	  D.	   rerio	  Ambra1a	   (CCE04070),	  D.	   rerio	  Ambra1b	   (CCA61107)	  and	  H.	  
sapiens	  AMBRA1	  (NP_001254711).	  	  Due	  to	  the	  length	  of	  the	  Ambra1	  proteins,	  no	  full-­‐length	  
clones	  were	  found,	  but	  only	  two	  cDNA	  fragments	  that	  correspond	  respectively	  to	  a	  portion	  
of	  the	  N-­‐terminal	  region	  and	  to	  a	  portion	  of	  the	  C-­‐terminal	  region.	  	  
Based	  on	  these	  partial	   sequences,	  we	  designed	  antisense	  and	  sense	  primers	   to	  obtain	  
the	   5’-­‐	   and	   3’-­‐UTR	   regions	   according	   to	   the	   cloning	   strategy	   described	   in	   Supplemental	  
Figure	   1.	   Moreover,	   the	   central	   coding	   region	   was	   covered	   by	   RT-­‐PCR	   of	   overlapping	  
fragments.	   The	   resulting	   sequence	  has	   been	  deposited	   in	   the	  GenBank	  database	  with	   the	  
accession	  no	  (not	  yet	  assigned).	  
The	  deduced	  amino	  acid	  sequence	  derived	  from	  B.	  schlosseri	  ambra1	  transcript	  is	  based	  
on	   an	   ORF	   (open	   reading	   frame)	   of	   3147	   bp,	   which	   starts	   from	   a	   putative	   initiation	  
methionine	  184-­‐bp	  downstream	  from	  the	  5’-­‐end	  and	  continues	  to	  a	  stop	  codon	  TGA	  (Figure	  
2).	   The	   first	   24	   nucleotides	   of	   the	   5’-­‐UTR	   correspond	   to	   a	   characteristic	   5’-­‐spliced	   leader	  
sequence	   [26].	   The	   ORF	   encodes	   a	   1048	   amino	   acids	   long	   protein.	   The	   3’-­‐untranslated	  
terminal	  region	  (3’-­‐UTR)	  contains	  83	  bases.	  The	  3’-­‐UTR	  does	  not	  contains	  a	  canonical	  poly-­‐A	  
signal,	  AATAAA,	  characteristic	  of	  the	  eukaryotic	  mRNA.	  However,	  two	  putative	  poly-­‐A	  signals	  
were	   identified,	   AAGAAA	   and	   AATATA,	   that	   correspond	   to	   natural	   variants	   of	   this	   region	  
[27].	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                            M  R  N  S  N  C  H  L  V  P  G  Q  P  L  S  L  L  L 
AGCAGTGACAACACTTTGCTCGGTACGTGGAAATGTAGGCTCTGTTACAGGAAATGCGAGTCTTATTTTTGTTGCAGCTA 
  A  V  T  T  L  C  S  V  R  G  N  V  G  S  V  T  G  N  A  S  L  I  F  V  A  A  
GCTGTCACGGAGACCACAACACACACATCCTAGATGTGAGCACCAAGGAGGTTGTTCGGACTTTGTCAGGCCACGAGAGA 
S  C  H  G  D  H  N  T  H  I  L  D  V  S  T  K  E  V  V  R  T  L  S  G  H  E  R  
TCTCCCTGGTGCGTGACTTTTCATCCAAAGTCGAACGAAATCATTGCAACGGGATCCCTCAATGGGGAGgtaacagactt 





 V  R  V  W  D  L  R  G  A  G  S  E  S  W  T  L  E  H  P  D  E  E  Q  I  A  I  A  
CTCGCTTTCATTTCATCCGTACGAGCACGTTCTTGCCATTGCTGGCGGCAATGAAATTTACTTCTGGGACTGGAGCCTTC 
  A  S  L  S  F  H  P  Y  E  H  V  L  A  I  A  G  G  N  E  I  Y  F  W  D  W  S  
CGCAGCCTTTTGCTTCTGTCAGAACCAACACCAAAGAAGAAAAGgtaggagagccattatgactatgttatttcacatat 
L  P  Q  P  F  A  S  V  K  T  N  T  K  E  E  
gaataatatcttgatattgagatacacagattatgtttatctcaatatgaatatatgattcaaaacccaacttccgtacc
tccaagagtctttgcgaatacttgacatccataaattgcagGTACGACTGGTTCGTTTTGATCCATGGGGTTCTTCCATC 
                                          K  V  R  L  V  R  F  D  P  W  G  S  S 
ATAACTGGAGTTGGAAGTGTTGATGACGATGAATTTATGGgttggtttggttgtcttgtagttccgtttcttgcaaacca 
 I  I  T  G  V  G  S  V  D  D  D  E  F 
atcgagttgattccagATTCAAGCAGTAGCTCTTTGCCTCAAAGAACACTAGATGCCAGTCTGATAAGGTCTCCGAGATT 
                 M  D  S  S  S  S  S  L  P  Q  R  T  L  D  A  S  L  I  R  S  P   
TCAAGACAGgtgggcgttttcttttatgatcggccgccgattcacatgtattagaagtagggctgacaaatcgagtgtct 









  R  S  R  S  I  L  S  H  G  S 
aatacgtccaaatgacaaatctgttgttttcaaattcatgctcatctctgatctataatgatgaatgaagtaaattgttc
actcagACGTGAAATATCCGAGACTCATCAAAGAATACTTCACGCTCGAGTCAGCGTAAATGAAGAGATCCGGCAACAGT 
M  R  R  E  I  S  E  T  H  Q  R  I  L  H  A  R  V  S  V  N  E  E  I  R  Q  Q  Y  
ACACACGATTGGAAAGATTGCGGCAGgtgggaaggaataaaaatctctgtatactattgaatgattatattttatatgga 





  R  H  R  L  E  M   R  L  R  E  L  Q  N  S  A  N  E  V  R  N  S  T  P  G  G  R 
TTCTCGCCCTTCCATGTCTCGTGTCGCCGTAGGGCAAGATTCAATAAATTTGAGCCATCCAACCAATTTGAGCGATGCGC 
 S  R  P  S  M  S  R  V  A  V  G  Q  D  S  I  N  L  S  H  P  T  N  L  S  D  V  H 
ACCAACACAGTCATGCACCACTACCCGTGTTACCATCGGAATCTGCCGCATTTACGCCATATATGGATAGTCTAGCTGCT 
  Q  H  S  H  A  P  L  P  V  L  P  S  E  S  A  A  F  A  P  Y  M  D  S  L  A  A 
AGCGCGCGTCGCAGCATCGCCGGACTCGGGCCGACAGCCCGGGACACAGAAATACCTGCTTTTGACAATTTGAGAAATGT 
S  A  R  R  S  I  A  G  L  G  P  T  A  R  D  T  E  I  S  A  F  D  N  L  R  N  V 
TGATCATACTTTGGTCGGGGCGTACAGGCGGTGGCGTCGTGATTCGCAGGATCATGTCACCCAATCGGACCCCTTGACAT 
  R  N  V  D  H  T  F  V  G  A  Y  R  R  W  R  R  D  S  Q  D  H  V  T  Q  S  D 
CGAGTACCTTGGCTTCGAGACATTCTATTTTTTCAGACGTTCAGAACCGCAGTTTGCACACCGGCCGGAACACGAGCCCG 
P  L  T  S  S  T  L  A  S  R  H  S  I  F  S  D  V  Q  N  R  S  L  H  T  G  R  N  
CGCCTTATCCATGAACGAATGCGGACATTACTGCGCCAACGCAGAGATTCCAACTCGGAATCGCGCCATCTATTAGAAAG
T  S  P  R  L  I  H  E  R  M  R  T  L  L  R  Q  R  R  D  S  N  S  E  S  R  H  L  
TCCACATCAATCATTAACTGCTCGGTCCCGTTTGGATTCATCAGTATATTCCGAACCGCGCATTGCGCCTTACGTGTATT 













	   	  
  V  Y  F  P  D  L  L  P  R  G  D  S  T  D  D  R  P  P  A  R  S  V  Y  G  A  F  
CCCGCGATCACTGACATGGGGATGCGGAACGAGACTTTATCTAACGACGCAGGCAGTCGACGTGACCAATACGCTGATTT
D  E  R  P  A  I  T  D  M  G  M  R  N  E  T  L  S  N  D  A  G  S  R  R  D  Q  Y 
TTTTGGTGCGTTGGTGACGCGACCGGCCGGTCTTGACTCGTTTCAGGAGATTCCAGTGCCCGGCGTTCAGATGTCTGGAA 
 A  D  F  F  G  A  L  V  T  R  P  A  S  L  D  S  F  Q  E  I  P  V  P  D  V  Q  M 
TTGAACTCGGGGTGGTTTCGGATCAGAGTGAACCCGCAAACGCAGATGAGCTAGGGTCAGGCGTTGTCGATGACCAGTCT  
  S  G  I  E  L  G  V  V  S  D  Q  S  E  P  A  N  A  D  E  L  G  S  G  V  V  D 
TCTTTTCCAGCTCTGTTCTCTCCGGTTGACGAAGTGATATCCGGTTCTATACTGCTTGAACAGTCTAATACGGGAAACAC 
D  Q  S  S  F  P  A  L  F  S  P  V  D  E  V  I  S  G  S  I  L  L  E  Q  S  N  T  
TCGAAACGACACCATCGACAGTGTTCTGCAGGGTCACGGTCATGAAAATATCACACAAAATGACTCGATGAATACTAGTC 
 G  N  T  R  N  D  T  I  D  S  V  L  Q  G  H  G  H  E  N  I  T  Q  N  D  S  M  N 
TTGCCACGAGCCAACCCAGCAGTTCGAACGCGGTAGATTCATCGCCAGCACACAGCAGAAGCTCGTCTTCGTTAGAGGCT  
T  S  L  A  T  S  Q  P  S  S  S  N  A  A  D  S  S  P  A  H  S  R  S  S  S  S  L  
GCACAAAATCTGTCGGCGGCCGTTAACTCGTTAGTGGAGGCCACGGATACGTTGAACGAAGCCGCTGATAATCTACTGCG 
 E  A  A  Q  N  L  S  A  A  V  N  S  L  V  E  A  T  D  T  L  N  E  A  A  D  N  L  
TGACGCGGCTTCCTCTGCGTCGCAATTGATGGACGACTCTGACAGTTCGTCAGGTGATGGTGATCCGTGGACTGCAAACG 
  L  R  D  A  A  S  S  A  S  Q  L  M  D  D  S  D  S  S  S  G  D  G  D  P  W  T 
ATACGCCTCTACCCAGgtatgtctttctgattcctgtttgatcgtggcatgttagcagggctcgtaatatgatcagtact 






  P  S  F  V  E  S  G  A  D  G  R  V  R  P  I  N  A  W  R  S  R  S  G  R  H  D  
TATTCCGgtaagcgagacgattttggttagtgcggcacagatagccaatgcagatattgatcggagacttggacaactag






  F  R  R  A  R  S  I  W  R  M  P  R  E  V  N  H  F  Q  S  E  R  E  R  R  N  R 
ATTCAGgtagaaactcaaatacggagaaaacggaatcggatccagaaaaagttactttttgagacttgcaaggggcactg 




N  S  G  P  T  H  S  R  R  R  V  W  E  D  V  R  H  S  N  P  F  G  S  N  R  Q  R  
CTCAGAATTCGTCCTGCACAgtaatccaccatcgattttctctcaagatccgtcctctcatttcctgtgttgacagGCGG 
 R  L  R  I  R  Q  R                                                          P 
CTGGCAAGCCTGAGACGCAACAGACGAAACAACATCAACAGGATCATATCGGACGTGTATGCAGAAAATCACGGCCTTCG 
A  L  A  S  L  R  R  N  R  R  N  N  I  N  R  I  I  S  D  V  Y  A  E  N  H  G  L  
GTCGGTGCTGCTTAGCATTGATCACATGATGTACAGACTTCAATATTGGGACTTCAGTAAGCTTCAGTTGCCAGAAATCA  
 R  S  V  L  L  S  I  D  H  M  M  Y  R  L  Q  Y  W  D  F  S  K  L  Q  L  P  E  I 
GCAGgtatgttcgtcacaggtagacttggcaattataaaattttcagctttccagattagaattagaatgatagctacag 





 S  H  M  K  N  V  V  V  D  A  C  K  I  Y  N  D  S  S  I  D  I  S  R  D  G  R  V  
TTGCTGCATTTGTTCCATCCTATGACAATGAGCCGCCCGGGAGTGATTCAATGGAAGTTGCCATTTTCTCGTTGGAACGC 
  L  A  A  F  V  P  S  Y  D  N  E  P  P  G  S  D  S  M  E  V  A  I  F  S  L  E 
AAAACTTTCGGCCAAGTTCTATTCAAgtattgcatatgctaaaacaacttcctgagaacttggttagatattgttgtcct 
R  K  T  F  G  Q  V  L  F   
atgcttcagGAAAGAATACGAACACACCGTGGTATGTCTCAGTATATCGCCGCTGTGTAATCATATCTGCGTTGGATTCA 
          K  K  E  Y  E  H  T  V  V  C  L  S  I  S  P  L  C  N  H  I  C  V  G  F  
AGTACCGTCACTGTCTCATTGGAGATCCACACATGAACAAgtatagttcacgtttttttaccctgtgaaagactggtctg 
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Figure	  2.	  Nucleotide	  sequence	  of	  B.	  schlosseri	  ambra1	  gene	  and	  its	  deduced	  amino	  acid	  sequence.	  The	  capital	  
letters	  correspond	  to	  the	  exon	  sequence.	  The	  5’-­‐spliced	   leader	  sequence	  at	  the	  beginning	  of	  the	  transcript	   is	  
marked	  in	  bold	  and	  underlined.	  The	  intron	  sequence	  is	  in	  lower-­‐case	  letters.	  The	  intron	  dinucleotide	  acceptor	  
and	  donor	  sites	  for	  RNA	  splicing	  are	  indicated	  by	  lower	  case,	  bold	  letters.	  One-­‐letter	  symbols	  of	  encoded	  amino	  
acids	  are	  shown	  below	  the	  DNA	  sequence.	  The	  start	  codon	  as	  well	  as	  the	  stop	  codon	  are	  boxed	  and	  given	  in	  
bold	  type.	  The	  positions	  of	  putative	  poly	  (A)+	  signals	  are	  underlined.	  The	  cDNA	  sequence	  has	  been	  submitted	  
to	  the	  GeneBank	  under	  the	  accession	  number	  (not	  yet	  assigned).	  










                                                                  D  R  N  T  R  
GTCGTCAGCATCAACACTGTGACGTGGTCACCGGAACCTGGTGGTGGGCTCGTTTATGGCACCAACAGTGGAGAGGTACG 
 V  V  S  I  N  T  V  T  W  S  P  E  P  G  G  G  L  V  Y  G  T  N  S  G  E  V  R 
GATGGTATCCGTGATGCCAAAACCCCCTGAAGCTGTCGGTTTATCGAATGACTTACTGACCCACGCCGACAGTTGAATCC 








The	  alignment	  of	  B.	  schlosseri	  Ambra1	  amino	  acid	  sequence	  with	  those	  of	  sea	  squirt	  (C.	  
intestinalis),	  human	  and	  mouse	  showed	  only	  a	  partial	  conservation	  of	  the	  primary	  structure	  
of	   Ambra1	   proteins	   between	   tunicates	   and	   vertebrates.	   As	   shown	   in	   Figure	   3,	   the	  WD40	  
repeat	   region,	   that	   is	   a	   marker	   of	   this	   protein	   in	   vertebrates,	   is	   also	   present	   and	   well	  
conserved	   in	   B.	   schlosseri	   and	   C.	   intestinalis.	  However,	   other	   conserved	   regions,	   such	   as	  
Beclin	   1	   binding	   region,	   which	   is	   highly	   conserved	   between	  mouse,	   human	   and	   zebrafish	  
Ambra1	   proteins	   [11],	   present	   a	   low	   level	   of	   amino	   acid	   identity.	   Nevertheless,	   in	  
vertebrates,	   the	   Beclin	   1	   binding	   region	   also	   contains	   a	   serine-­‐rich	   region.	   Although	   not	  
conserved	  in	  their	  position	  with	  respect	  to	  mammal	  proteins,	  a	  high	  number	  of	  these	  amino	  
acids	  are	  also	  present	  in	  this	  region	  in	  tunicates	  (residues	  marked	  in	  bold	  in	  Figure	  3).	  
Moreover,	  due	  to	  a	  reduced	  length,	  tunicate	  Ambra1	  proteins	  lack	  the	  two	  DLC-­‐binding	  
consensus	  motifs	  (TQT)	  that	  are	  usually	  present	  at	  the	  C-­‐terminal	  region	  of	  this	  protein	  and	  
that	  mediate	  the	  interaction	  with	  dynein	  light	  chains	  (DLCs)	  [28].	  
Some	   of	   the	   human	  Ambra1	   phosphorylation	   sites	   reported	   by	   Fimia	   and	   co-­‐workers	  
[10]	   in	   the	   human	   protein	   are	   also	   conserved	   in	  B.	   schlosseri	   and	  C.	   intestinalis	  proteins.	  
Moreover,	   the	   lysine	  ubiquitination	  site,	   located	  at	   the	  end	  of	   the	  WD40	  domain,	  and	   the	  
aspartic	   acid	   residue	   that	   mediates	   the	   Ambra1	   caspase	   cleavage	   during	   the	   apoptotic	  
process	  [10]	  are	  present	  and	  maintain	  the	  same	  localization	  both	  in	  tunicate	  and	  vertebrate	  
Ambra1	  proteins.	  
Finally,	  another	  well-­‐conserved	  fragment	  between	  tunicate	  and	  vertebrate	  sequences	  is	  
present	  in	  the	  C-­‐terminal	  region	  of	  tunicate	  protein	  but	  no	  specific	  functions	  of	  this	  area	  are	  
up	  to	  now	  known.	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Bo_am1 --------------MRN-----SNCHLVPGQPLSLLLAVTTLCSVRGNVGSVTGNASLIFVAAS---------CHGDHNTHILDVSTKEVVRTLSGHERS 72 
Ci_am1 MSSKQSRKPNIVVALRNRSSGCTQRKFTQGPLKAFAEKCAATLSSKNRKVELPARTRTTFMTAFSPDNRLIASCHGDHNIYISNISTGKVENSLVGHSRS 100 
Mm_am1 --MKVVPEKNAVRILWGRERG-TRAMGAQRLLQELVEDKTRWMKWEGKRVELPDSPRSTFLLAFSPDRTLLASTHVNHNIYITEVKTGKCVHSLIGHRRT 97 
Hs_am1 --MKVVPEKNAVRILWGRERG-ARAMGAQRLLQELVEDKTRWMKWEGKRVELPDSPRSTFLLAFSPDRTLLASTHVNHNIYITEVKTGKCVHSLIGHRRT 97 




Bo_am1 PWCVTFHPKSNEIIATGSLNGEVRVWDLRGAGSESWTLEHPDEEQIAIASLSFHPYEHVLAIAGGNEIYFWDWSLPQPFASVKTNTKEEKVRLVRFDPWG 172 
Ci_am1 PWCLSFHPSSNDIIATGCLNGEVRVWDLRGGGSESWMVSE-NEAMVTIASLSFHPTDHVLLIAAGNEIHFWDWSLPQPFASVKTGSAAERVRLVRFDMWG 199 
Mm_am1 PWCVTFHPTISGLIASGCLDGEVRIWDLHG-GSESWFTDS----NNAIASLAFHPTAQLLLIATANEIHFWDWSRREPFAVVKTASEMERVRLVRFDPLG 192 
Hs_am1 PWCVTFHPTISGLIASGCLDGEVRIWDLHG-GSESWFTDS----NNAIASLAFHPTAQLLLIATANEIHFWDWSRREPFAVVKTASEMERVRLVRFDPLG 192 




Bo_am1 SSIITGVGSVDDDEFMDSSSSSLPQRTLDASLIRSPRFQDRDSGRNARSRSILSHGSMRREISETHQRILHARVSVNEEIRQQYTRLERLRQERHRLEMR 272 
Ci_am1 TNILTGVVNFEEE----QNSGTDEEENESVENPVSSWNQPSSIGDSLTRRRQLLRSWMR------GRPRTPVSVENDETVEPREIPLPSNPVRRAPIPLY 289 
Mm_am1 HYLLTAIVNPSNQ-----QGDDEPEIPIDGTELSHYRQRALLQSQPVRRTPLLHNFLHMLSSRSSGIQVGEQSTVQDSATPSPPPPPPQPSTERPRTSAY 287 
Hs_am1 HYLLTAIVNPSNQ-----QGDDEPEIPIDGTELSHYRQRALLQSQPVRRTPLLHNFLHMLSSRSSGIQVGEQSTVQDSATPSPPPPPPQPSTERPRTSAY 287 




Bo_am1 LRELQNSANE-VRNSTPGGRSRPSMSRVAVGQDSINLSHPTNLSDVHQHSHAPLPVLPSESAAFAPYMDSLAASARRSIAGLGPTARDTEISAFDNLRNV 371 
Ci_am1 IRRRQAGGRS-NSPSVYNLRSRD------------RRSVATDFPDTEQLETSRPETNTSEETEPQERFLSLRLHSLNRLFELR-----QRMSDLSNSRAV 371 
Mm_am1 IRLRQRVSYPTTVECCQHPGILCLCSRCAGTRVPSLLPHQDSVPPASARATTPSFSFVQTEPFHPPEQASSTQQDQGLLNRPSAFSTVQSSTAGNTLRNL 387 
Hs_am1 IRLRQRVSYP-TAECCQHLGILCLCSRCSGTRVPSLLPHQDSVPPASARATTPSFSFVQTEPFHPPEQASSTQQDQGLLNRPSAFSTVQSSTAGNTLRNL 386 




Bo_am1 DHTFVGAYRRWRRDSQDHVTQSDPLTSSTLASRHSIFSDVQNRSLHTGRNTSPRLIHERMRTLLRQRRDSNSESRHLLESPHQSLTARSRLDSSVYSEPR 471 
Ci_am1 DH------------------------QRILHARVSVNAEIQH------QYNRLRLLRQERRRLELRLQQLQGRSSQSNSSPVQPTVVPS--EAPLLNNPA 439 
Mm_am1 SLG-----------------PTRRSLGGPLSSHPSRYHRELAPGLTGSEWTRTVLTLNSRSEVESMPPPRTSASSVSLLSVLRQQEGGS--QASVYTSAT 468 
Hs_am1 SLG-----------------PTRRSLGGPLSSHPSRYHREIAPGLTGSEWTRTVLSLNSRSEAESMPPPRTSASSVSLLSVLRQQEGGS--QASVYTSAT 467 







Bo_am1 IAPYVYFPDLLPRGDSTDDRPPARSVYGAFDERPAITDMGMRNETLSNDAGSRRDQYADFFGALVTRPASLDSFQEIPVPDVQMSGIELGVVSDQSEPAN 571 
Ci_am1 ADIVPIFSELHPHTDPEHNDLSTESVT----------------ENISTEFNSHS------------RPRNLLTPSRTNVAEESIP--------------- 496 
Mm_am1 EGRGFPSSGLATESDGGNGSSQNNSGSIRHELQCDLRRFFLEYDRLQELDQSLSG-----------ETPQTQQAQEMLNNNIESERPGPSHLPTPHSSEN 557 
Hs_am1 EGRGFPASGLATESDGGNGSSQNNSGSIRHELQCDLRRFFLEYDRLQELDQSLSG-----------EAPQTQQAQEMLNNNIESERPGPSHQPTPHSSEN 556 




Bo_am1 ADELGSGVVDDQSSFPALFSPVDEVISGSILLEQSNTGNTRNDTIDSVLQGHGHENITQNDSMNTSLATSQPSSSNAADSSPAHSRSSSSLEAAQNLSAA 671 
Ci_am1 ----GNLVVPINPEIPVYLSPMEETP---------------------------ATNPSPSPSRNRTIPSYFPTLSNSTSSTYRSSGSSR----------- 554 
Mm_am1 NSNLSRGHLNRCRACHNLLTFNNDTLR----WERTTPNYSSG---EASSSWHVSTTFEGMPPSGNQLPPLERTEGQMPSSSRLELSSSASSQEERTVGVA 650 
Hs_am1 NSNLSRGHLNRCRACHNLLTFNNDTLR----WERTTPNYSSG---EASSSWQVPSSFESVPSSGSQLPPLERTEGQTPSSSRLELSSSASPQEERTVGVA 649 




Bo_am1 VNSLVEATDTLNEAADNLLRDAASSASQLMDDSDSSSGDGDPWTANDTPLPSFVESGADGRVRPINAWRSRSGRHDSALFRRARSIWR--------MPRE 763 
Ci_am1 ---------------------------------------------RTTQPPFYFVPGTQG---------------------------------------- 15 
Mm_am1 FNQETGHWERIYTQSSRSGTVSQEALHQDMPEESSEEDSLRRRLLESSLISLSRYDGAGSREHPIYPDPARLSPAAYYAQRMIQYLSRRDSIRQRSMRYQ 750 
Hs_am1 FNQETGHWERIYTQSSRSGTVSQEALHQDMPEESSEEDSLRRRLLESSLISLSRYDGAGSREHPIYPDPARLSPAAYYAQRMIQYLSRRDSIRQRSMRYQ 749 




Bo_am1 VNHFQSERERRNRSGNSGPTHSRRRVWEDVRHSNPFGSNRQRRLRIRPAQRLASLRRNRRNN-------------------INRIISDVYAENHGLR--- 841 
Ci_am1 ---------------------------PDLELSQDFTFSRTPNQRLRLRQSRAIWRRHRRRF-------------------HASNINQILSLHPQG---- 569 
Mm_am1 QNRLRSSTSSSSSDNQGPSVEGTDLEFEDFEDNGDRSRHRAPRNARMSAPSLGRFVPRRFLLPEYLPYAGIFHERGQPGLATHSSVNRVLAGAVIGDGQS 850 
Hs_am1 QNRLRSSTSSSSSDNQGPSVEGTDLEFEDFEDNGDRSRHRAPRNARMSAPSLGRFVPRRFLLPEYLPYAGIFHERGQPGLATHSSVNRVLAGAVIGDGQS 849 




Bo_am1 SVLLSIDHMMYRLQYWDFSKLQLPEISSHMKNVVVDACKIYNDSSIDISRDGRVLAAFVPSYDNEPPGSDSMEVAIFSLERKTFGQVLFKKEYEHTVVCL 941 
Ci_am1 ----HVDRFSYRLQWWDFSKLALPEIGRSDTNVIVPHCKIYNDSSVDISKDGTKLATFIPTEVGFP---ESMQVAVYSLLPDTLGEVLFRKPFGPHAVCL 662 
Mm_am1 AVASNIANTTYRLQWWDFTKFDLPEISNASVNVLVQNCKIYNDASCDISADGQLLAAFIPSSQRGFP--DEGILAVYSLAPHNLGEMLYTKRFGPNAISV 948 
Hs_am1 AVASNIANTTYRLQWWDFTKFDLPEISNASVNVLVQNCKIYNDASCDISADGQLLAAFIPSSQRGFP--DEGILAVYSLAPHNLGEMLYTKRFGPNAISV 947 








Figure	   3.	   Multiple	   sequence	   alignment	   of	   human	   (Hs,	   Homo	   sapiens,	   NP_001254711),	   mouse	   (Mm,	   Mus	  
musculus,	  NP_766257),	  sea	  squirt	  (Ci,	  C.	  intestinalis	  KH.L84.31.v1.A.SL1-­‐1)	  and	  B.	  schlosseri	  (Bs,	  number	  not	  yet	  
assigned)	  Ambra	  1	  proteins	  was	  originated	  with	  the	  program	  ClustalW.	  	  In	  the	  alignment,	  identical	  residues	  in	  
all	  sequences	  are	  indicated	  by	  ‘*’.	  Conservative	  and	  semi-­‐conservative	  substitutions	  are	  indicated	  by	  ‘:’	  and	  ‘.’,	  
respectively.	  Structural	  domains,	  as	  reported	  for	  human	  Ambra1	  by	  Fimia	  and	  co-­‐workers	  10],	  are	  highlighted	  
by	  a	  horizontal	  line	  just	  over	  the	  alignment.	  Post-­‐translational	  phosphorylation	  in	  human	  and	  mouse	  aminoacid	  
residues	  are	  shadowed	  in	  red,	  the	  ubiquitination	  lysine	  residue	  is	  shadowed	  in	  green	  and	  the	  caspase-­‐cleavage	  
aspartic	  acid	  residue	  in	  yellow.	  







Bo_am1 SISPLCNHICVGFKYRHCLIGDPHMNKFLMGHVLAMTDEEE---MPIAQQIHH---PDRNTRVVSINTVTWSPEPGGGLVYGTNSGEVRMVSVMPKPPEA 1035 
Ci_am1 SLSPLGDYLAVGVKNRPYLPEALSTSRSPMAQILKLNKNGENNYSPVVNQIMHPINPDTPHRFVSINTVAWLPNIGDGLLYGTNNGELRICQPAS----- 757 
Mm_am1 SLSPMGRYVMVGLASRRILLHPSTEHMVAQVFRLQQAHGGETSMRRVFNVLYP--MPADQRRHVSINSARWLPEPGLGLAYGTNKGDLVICRPEALNSGI 1046 
Hs_am1 SLSPMGRYVMVGLASRRILLHPSTEHMVAQVFRLQQAHGGETSMRRVFNVLYP--MPADQRRHVSINSARWLPEPGLGLAYGTNKGDLVICRPEALNSGV 1045 




Bo_am1 VGLSNDLLTHADS--------------------------------------------------------------------------------------- 1048 
Ci_am1 ----------------------------------------------------------------------------------------------------  
Mm_am1 EYYWDQLSETVFTVHSSSRSSERPGTSRATWRTDRDMGLMNAIGLQPRNPTTSVTSQGTQTLALQLQNAETQTEREEEEPGAASSGPGEGEGSEYGGSGE 1146 
Hs_am1 EYYWDQLNETVFTVHSNSRSSERPGTSRATWRTDRDMGLMNAIGLQPRNPATSVTSQGTQTLALQLQNAETQTEREVPEPGTAASGPGEGEGSEYGASGE 1145 






Mm_am1 DALSRIQRLMAEGGMTAVVQREQSTTMASMGGFGNNIIVSHRIHRSSQTGTESGAARTSSPQPSTSRGLPSEPGQLAERALSPRTASWDQPSTSGRELPQ 1246 
Hs_am1 DALSRIQRLMAEGGMTAVVQREQSTTMASMGGFGNNIIVSHRIHRSSQTGTEPGAAHTSSPQPSTSRGLLPEAGQLAERGLSPRTASWDQPGTPGREPTQ 1245 






Mm_am1 PALSSSSPVPIPVPLASNEGPTMHCNVTNNSHLPEGDGSNRGEAAGPSGEPQNR 1300 
Hs_am1 PTLPSSSPVPIPVSLPSAEGPTLHCELTNNNHLLDG-GSSRGDAAGPRGEPRNR 1299 
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Genomic	  organization	  of	  B.	  schlosseri	  ambra1	  gene	  	  
The	   genomic	   organization	   of	   ambra1	   gene	   was	   obtained	   by	   BLAST	   analysis	   of	   the	   B.	  
schlosseri	   genome	   (http://genepyramid.stanford.edu/botryllusgenome/)	   with	   the	   cDNA	  
sequence	  just	  obtained.	  This	  analysis	  found	  three	  contig	  fragments	  covering	  completely	  the	  
new	   cDNA	   sequence	   (botctg036000,	   botctg051220	   and	   botctg014012).	   In	   Figure	   4	   the	   B.	  
schlosseri	  ambra1	  genomic	  organization	  is	  compared	  with	  those	  of	  the	  corresponding	  genes	  
in	   H.	   sapiens	   and	   C.	   intestinalis	   obtained	   by	   analysis	   of	   their	   nucleotide	   or	   amino	   acid	  
sequences	   with	   the	   BLAT	   program	   (http://genome.ucsc.edu/cgi-­‐
bin/hgBlat?command=start).	  Moreover,	  in	  Table	  2,	  we	  report	  the	  sizes	  of	  each	  of	  the	  exons	  
and	  introns	  of	  the	  B.	  schlosseri	  ambra1	  gene	  as	  well	  as	  data	  from	  vertebrates	  and	  Ciona.	  As	  
for	  the	  other	  species	  reported	  in	  Table	  2,	  the	  canonical	  splice	  consensus	  sites	  “GT”	  and	  “AG”	  
are	  present	  in	  all	  B.	  schlosseri	  ambra1	  introns,	  as	  shown	  in	  Figure	  2.	  
B.	   schlosseri	   ambra1	   gene	   contains	   16	   exons	   and	   15	   introns.	   Differently	   from	  
vertebrates,	  in	  this	  species,	  ambra1	  gene	  lacks	  a	  non-­‐coding	  first	  exon	  and	  the	  first	  exon	  is	  
then	  partially	  coding.	  Data	  on	  genomic	  organization	  of	  C.	  intestinalis	  ambra1	  were	  obtained	  
by	   the	   Ghost	   Database	   (http://ghost.zool.kyoto-­‐u.ac.jp/)	   that	   integrates	   expression	   and	  
genomic	  information	  (Figure	  4).	  Based	  on	  this	  analysis,	  C.	  intestinalis	  ambra1	  gene	  contains	  
11	   exons	   and	   10	   introns	   and	   thus	   presents	   a	   reduced	   number	   of	   exon	  with	   respect	   to	  B.	  
schlosseri	  and	  mammals.	  
Although	   the	   number	   of	   exons	   is	   not	   conserved	   between	   vertebrates	   and	   tunicates,	  
some	  features	  of	  the	  genomic	  organization	  are	  preserved:	  position	  of	  the	  WD40	  domain	  and	  
the	  ubiquitination	  lysine	  residue	  that	  are	  localized	  in	  the	  first	  exons	  or	  the	  caspase-­‐cleavage	  
aspartic	  acid	  residue	  that	  is	  positioned	  in	  the	  longest	  exon	  in	  all	  the	  genes	  analysed	  (yellow	  
line	  in	  Figure	  4).	  




Figure	  4.	  Genomic	   structure	   and	  organization	  of	  B.	   schlosseri,	  H.	   sapiens,	  D.	   rerio	  and	   C.	   intestinalis	  ambra1	  
genes.	   Plain	   boxes	   indicate	   exons	   and	   are	   numbered	   with	   Roman	   numerals.	   The	   coding	   region	   is	   in	   black	  
whereas	  the	  untranslated	  terminal	  regions	  are	  in	  grey.	  The	  SL	  (splice	  leader)	  sequence	  is	  shown	  as	  a	  red	  linein	  
the	  first	  exons.	  Caspase-­‐cleavage	  aspartic	  acid	  residue	  is	  shown	  as	  a	  yellow	  line	  in	  the	  longest	  exon.	  This	  amino	  
acid	  residue	  is	  not	  present	  in	  the	  D.	  rerio	  ambra1a1	  gene.	  The	  positions	  of	  the	  WD40	  domain,	  Beclin1	  and	  DLC1	  
binding	   regions	   are	   indicated.	   Introns,	   represented	   as	   lines,	   are	   not	   drawn	   to	   scale,	   but	   the	   corresponding	  
lengths	  can	  be	  found	  in	  Table	  1	  together	  with	  the	  exon	  sizes.	  




I% II% III% IV% V% VI% VII% VIII% IX% X% XI% XII% XIII% XIV% XV% XVI% XVII% XVIII%
ambra1&&
Botryllus&schlosseri& I% II% III% IV% V% VI% VII% VII% IX% X% XI% XII% XIII% XIV% XV% XVI%
WD40% Beclin%1%binding%





Danio&rerio& I% II% III% IV% V% VI% VII% VIII% IX% X% XI% XII% XIII% XIV% XV% XVI% XVII% XVIII% XIX%
WD40% Beclin%1%binding% DLC1%binding%
ambra1b&&
















































240	   42624	   135	   370	   57	   520	   186	   1336	   174	   1562	   63	   576	   1455	   29131	   87	   4356	   183	   13986	  
Danio	  rerio	  
ambra1a1	  
206	   3010	   233	   2168	   59	   167	   184	   113	   173	   986	   67	   97	   1373	   7293	   87	   4736	   183	   2268	  
Danio	  rerio	  
ambra1b	  








489*	   387	   201	   299	   118	   275	   47	   258	   964	   154	   94	   243	   138	   2046	   177	   319	   111	   172	  












































78	   415	   102	   50009	   111	   8450	   189	   1220	   156	   15421	   141	   7544	   93	   1569	   192	   10569	   484	   	  	   	  	  
Danio	  rerio	  
ambra1a1	  
78	   917	   101	   19177	   111	   20026	   189	   3132	   155	   4999	   140	   3466	   111	   3226	   209	   21056	   132	   3025	   733	  
Danio	  rerio	  
ambra1b	  








83	   307	   456	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
	  
Table	  1.	  Exons	  and	  introns	  size	  of	  Homo	  sapiens,	  Danio	  rerio	  ambra1a,	  Botryllus	  schlosseri	  and	  Ciona	  intestinalis	  
genes.	  *	  The	  first	  exon	  contains	  SL	  (splice	  leader)	  sequence.	  




Expression	  analysis	  of	  ambra1	  mRNA	  in	  different	  B.	  schlosseri	  stages	  	  
A	   preliminary	   study	   of	   the	   expression	   pattern	   of	   B.	   schlosseri	   ambra1	   gene	   was	  
performed	  by	  RT-­‐PCR	  analysis	  on	   cDNA	  obtained	   from	  different	   stages	   (Figure	  5).	  A	  gene-­‐
specific	   primer	   set	  was	   designed	   to	   span	   an	   intron,	   in	   order	   to	   reveal	   any	   contaminating	  
genomic	  DNA	  as	  a	  larger-­‐sized	  PCR	  fragment.	  A	  different	  number	  of	  amplification	  cycles	  (30,	  
35,	  40)	  was	  used	  in	  order	  to	  reveal	  difference	  in	  the	  transcripts	  contents	  between	  different	  
life	  stages	  of	  the	  B.	  schlosseri.	  
The	  analysis	  revealed	  that	  ambra1	  transcripts	  are	  expressed	  both	  in	  mid-­‐cycle	  (samples	  
1-­‐3)	   and	   in	   the	   take-­‐over	   phases	   (sample	   4).	   Expression	   is	   variable	   inside	   samples	   of	   the	  
same	  stage	  and	  between	  different	  stages.	  However,	  this	  was	  a	  qualitative	  analysis	  and	  thus,	  
before	  to	  make	  quantitative	  consideration,	  we	  need	  to	  set	  up	  a	  real	  time	  PCR	  protocol.	  	  
	  
Figure	   5.	   Expression	   of	   B.	   schlosseri	   ambra1	   transcripts	   as	   shown	   by	   RT-­‐PCR	   performed	   on	   RNA	   extracted	  
during	  different	  phases	  of	  the	  life	  cycle	  and	  different	  number	  of	  PCR	  cycles.	  C-­‐	  =	  negative	  control;	  1,	  2	  =	  stage	  
9/8/3;	  3	  =	  stage	  9/8/4;	  4	  =	  stage	  11/8/6.	  	  
	   	  
Chapter	  IV	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Light	  and	  transmission	  electron	  microscopy	  analysis	  of	  autophagy	  in	  B.	  schlosseri	  
Taking	  into	  account	  that	  in	  B.	  schlosseri	  autophagic	  vacuoles	  were	  detected	  during	  the	  
regression	  phase	  [15,	  21]	  and	  a	  complex	  crosstalk	  exists	  between	  autophagy	  and	  apoptosis	  
[10],	   we	   concentrated	   our	   morphological	   analyses	   in	   colonies	   in	   takeover.	   Regressing	  
blastozooid	   were	   characterized	   by	   contraction	   of	   zooids	   and	   their	   internal	   organs,	  
particularly	   evident	   in	   the	   branchial	   sac,	   and	   pyknotic	   nuclei	   in	   tissues,	   suggesting	   the	  
occurrence	   of	   cell	   death	   (Figure	   6	   A,	   B).	   Moreover,	   abundant,	   large	   macrophages	   were	  
circulating	  in	  blood	  lacunae.	  The	  Figure	  6	  C	  shows	  a	  giant	  phagocyte	  in	  blood	  lacuna,	  with	  a	  
phagosome	   containing	   an	   ingested	   cell	   (Figure	   6	   C).	   The	   cytoplasm	   of	   the	   ingested	   cell	  
exhibits	   clear	   sign	   of	   degeneration,	   evidenced	   by	   the	   great	   number	   of	   vesicles	   filling	   the	  
cytoplasm,	   the	   condensed	   chromatin	   at	   the	   nucleus	   periphery,	   and	   mitochondria	   with	  
swollen	  cristae.	  Cytoplasmic	  vesicles	  are	  heterogeneous	  in	  content.	  Some	  of	  them	  are	  typical	  
autophagic	   vacuoles.	   Figure	   6	   E	   shows	   an	   autophagosome	   bordered	   by	   a	   double	   layer	   of	  
membranes,	  containing	  a	  mitochondrion.	   In	  some	  cases,	  cisterns	  of	  endoplasmic	  reticulum	  
are	  also	  recognizable	  close	  to	  degenerating	  organelles	  (Figure	  6	  F).	  





Figure	  6.	  Morphological	  evidence	  of	  autophagy	   in	  B.	  schlosseri.	  A-­‐B.	  Histological	  sections	  of	   regressing	  adults	  
belonging	   to	  colonies	   in	  early	   take-­‐over.	  A.	  Transverse	   section	  at	  branchial	   chamber	   (bc)	   level.	   Squared	  area	  
enlarged	  in	  B.	  B.	  Detail	  of	  A,	  to	  show	  the	  dorsal	  blood	  lacuna	  (bl)	  containing	  numerous	  circulating	  phagocytes	  
(arrowheads).	   Note	   the	   degenerating	   epithelium	   (arrows).	   e:	   endostyle;	   ep:	   epidermis;	   i:	   intestine;	  
peribranchial	  chamber;	  st:	  stomach;	  t:	  tunic;	  te:	  testis.	  Toluidine	  blue.	  C-­‐F.	  Transmission	  electron	  microscopy	  of	  
a	   regressing	   blastozooid	   in	   early	   take-­‐over.	   C.	   A	   circulating	   phagocyte	   (p)	   with	   a	   giant	   phagosome	   (ps)	  
containing	   a	   degenerating	   cell	   (arrowheads).	   The	   cytoplasm	   of	   the	   degenerating	   cell	   is	   rich	   in	   autophagic	  
vacuoles.	   Squared	   area	   is	   enlarged	   in	   D.	   D.	   Autophagosomes	   (arrows),	   characterized	   by	   the	   typical	   double	  
membrane.	   C.	   Autophagosome	   containing	   a	   mitochondrion	   (m).	   Note	   the	   double	   membrane	   (arrowheads)	  
encircling	   the	   autophagosome.	   D.	   Endoplasmic	   reticulum	   cistern	   (arrowheads)	   partially	   enveloping	   a	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DISCUSSION	  
Ambra1	  gene	  identification	  and	  characterization	  in	  Botryllus	  schlosseri	  
In	  this	  study,	  we	  report	  the	  identification,	  through	  genome	  bioinformatic	  searches	  and	  
targeted	   cloning,	   of	   the	   first	   complete	  ambra1	   transcript	   in	   a	   non-­‐vertebrate	   species,	   the	  
tunicate	  B.	  schlosseri.	  Before	  this	  study,	  expression	  of	  ambra1,	  together	  with	  expression	  of	  
other	  genes	  important	  in	  the	  mammalian	  autophagic	  process	  but	  not	  present	  in	  yeast,	  was	  
demonstrated	  only	  in	  the	  tunicate,	  C.	  intestinalis	  [12].	  The	  authors	  also	  showed	  that	  ambra1	  
expression,	   as	   analysed	   by	  means	   of	   RT-­‐PCR,	   is	   developmentally	   regulated.	   However,	   the	  
experimental	   determination	  of	   the	   complete	   sequence	   allowed	  us,	   not	   only	   to	   analyse	   its	  
expression,	   but	   also	   to	   compare	   the	   B.	   schlosseri	   ambra1	   sequence	   with	   those	   from	  
vertebrate	  species.	  	  
The	  deduced	  amino	  acid	  sequence	  of	  B.	  schlosseri	  is	  shorter	  than	  vertebrate	  sequences	  
till	  now	  characterized	  and	  lacks	  completely	  of	  the	  DLC1-­‐binding	  consensus	  motifs	  (TQT)	  that,	  
in	  absence	  of	  autophagy	   induction,	  docked	  the	  protein	  at	   its	  specific	  cytoskeletal	  site	   [28].	  
However,	  splicing	  variants,	  represented	  by	  truncated	  isoforms	  missing	  the	  carboxyl-­‐terminal	  
region	  and	  thus	  the	  crucial	  binding	  site	  to	  DLC1,	  have	  been	  identified	  on	  zebrafish	  [11]	  and	  
are	   likely	   present	   also	   in	   human	   and	  mouse,	   as	   suggested	   by	   the	   occurrence	   of	   different	  
Ambra1	   protein	   isoforms	   in	   the	   UniProt	   website	   (http://www.uniprot.org/uniprot/).	  
However,	  looking	  for	  alternative	  splicing	  in	  this	  region,	  we	  repeat	  the	  3’-­‐RACE	  analysis	  three	  
times	  and	  also	  analysed	  B.	  schlosseri	  and	  C.	   intestinalis	  EST	   libraries	  without	  finding	   longer	  
transcripts.	   Therefore,	   we	   assume	   that	   in	   tunicates	   ambra1	   genes	  may	   encode	   a	   shorter	  
isoform	  of	  the	  vertebrate	  Ambra1	  proteins.	  	  
Differently	  form	  the	  high	  amino	  acid	  identity	  between	  vertebrate	  Ambra1	  proteins	  [11],	  
not	  all	  conserved	  regions	  are	  present	  in	  the	  experimentally	  determined	  B.	  schlosseri	  and	  in	  
the	  predicted	  C.	  intestinalis	  Ambra1	  proteins.	  	  
Among	   the	   conserved	   features,	   it	   is	  possible	   to	   find	   the	   caspase	   cleavage	   site,	   always	  
located	   inside	  the	   longest	  exon,	   the	  N-­‐terminal	  WD40	  domain,	  which	   is	  a	  signature	  of	   this	  
protein	  and	  the	  ubiquitination	  site	  at	  its	  end.	  The	  WD40	  domain	  is	  present	  in	  a	  large	  family	  
of	   eukaryotic	  proteins	   that	  normally	   acts	   as	   scaffold	  by	   interaction	  with	  different	  proteins	  
[29].	  This	  allows	  proteins	  bearing	  this	  domain	  to	  play	  specific	  roles	  in	  different	  processes,	  as	  
was	  also	  proposed	  for	  Ambra1	  [10].	  	  	  
A	   low	  degree	  of	   identity	  was	   instead	   found	   in	   the	   fragment	  corresponding	   to	  Beclin	  1	  
binding	   region.	   However,	   based	   on	   results	   obtained	   with	   Disorder	   Predictor	   Programs	  
(http://www.disprot.org/predictors.php,	  data	  not	  shown)	  and	  as	  also	  proposed	  by	  Nazio	  and	  
co-­‐workers	   [30],	   in	   vertebrates	   Ambra1	   was	   found	   to	   belong	   to	   the	   class	   of	   Intrinsically	  
Disordered	   Proteins	   (IDPs).	   The	   same	   result	   was	   also	   obtained	   with	   tunicates	   Ambra1	  
proteins.	  	  IDPs	  are	  able	  to	  adapt	  their	  tridimensional	  structure	  to	  their	  binding	  partners,	  and	  
thus	  can	  carry	  out	  important	  biological	  functions	  in	  different	  cells	  and	  in	  several	  subcellular	  
organelles.	   The	   finding	   that	   Ambra1	   belongs	   to	   this	   class	   of	   proteins,	   together	   with	   the	  




proteins	   and	   to	   act	   in	  many	   cell	   processes.	   It	   is	   possible	   that	   tunicates	   Ambra1	   proteins,	  
despite	   their	   low	   sequence	   identity	   with	   vertebrates	   Ambra1,	   retain	   similar	  multi-­‐protein	  
complex	   assembly	   functions	   thank	   to	   the	   presence	   of	   intrinsically	   disordered	   segments	   in	  
which	  functionality	  could	  be	  more	  related	  to	  amino	  acid	  composition	  than	  to	  conservation	  of	  
primary	  sequence	  [31].	  
Autophagy	  in	  the	  blastogenic	  cycle	  of	  B.	  schlosseri	  
Our	   results	   confirm	   that	   autophagy	   is	   a	   strategy	   adopted	   by	   B.	   schlosseri	   during	   its	  
blastogenic	   cycle.	   Autophagy	   in	   this	   species	   was	   previously	   shown	   in	   different	   cells	   and	  
developmental	   phases.	   In	   zymogenic	   cells	   of	   the	   stomach,	   autophagic	   vacuoles	   were	  
proposed	  to	  be	  related	  to	  the	  control	  of	  the	  cycle	  of	  zymogen	  production,	  or	  to	  the	  initiation	  
of	  the	  general	  process	  of	  involution	  of	  these	  cells	  when	  take-­‐over	  approaches	  [21].	  Similarly,	  
autophagic	   vacuoles	   were	   found	   in	   gut	   cells	   and	   in	   endostyle	   cells	   of	   adult	   blasotzooids	  
during	  the	  regression	  phase	  [15].	  At	  larval	  metamorphosis,	  a	  limited	  number	  of	  autophagic	  
vacuoles	  bounded	  by	  single	  or	  a	  double	  limiting	  membrane	  were	  also	  found	  in	  caudal	  muscle	  
involuting	  cells	  [22].	  A	  number	  of	  these	  vacuoles	  displayed	  also	  a	  positive	  reaction	  for	  acid	  
phosphatase,	   the	  reaction	  product	  being	  often	  confined	  to	  the	  space	  between	  the	   limiting	  
membranes.	   Both	   the	   take-­‐over	   and	   the	   metamorphosis	   are	   dominated	   by	   apoptosis	   in	  
remodelling	  tissues	  and	  organs	  [16-­‐18,32,33].	  	  
In	  this	  study,	  we	  demonstrate	  that	  ambra1	  transcripts	  are	  expressed	  both	  in	  mid-­‐cycle	  
and	  in	  takeover	  of	  B.	  schlosseri.	  Moreover,	  we	  show	  unequivocal	  autophagosomes,	  bounded	  
by	  a	  double	  membrane,	  in	  cells	  during	  take-­‐over.	  This	  reinforces	  the	  idea	  that	  autophagy	  is	  a	  
crucial	   mechanism	   operating	   in	   the	   life-­‐cycle.	   It	   is	   to	   note	   that	   we	   recognized	  
autophagosomes	   in	   a	  degenerating	   cell	   phagocyted	  by	  a	   circulating	  macrophage.	   This	   fact	  
highlights	   the	   interesting	   link	   between	   autophagy	   and	   apoptosis,	   and	   allows	   us	   to	  
hypothesize	  that	  autophagy	  play	  a	  role	  in	  the	  crosstalk	  between	  bud	  and	  parent,	  optimizing	  
the	  colony	  survival.	  A	  quantitative	  real	  time	  PCR	  protocol	  will	  be	  necessary	  to	  understand	  if	  
expression	  of	  ambra1	  transcript	  is	  tightly	  regulated	  during	  the	  life	  cycle	  of	  this	  species.	  
In	   conclusion	   in	   this	   study,	  we	  evidence	   that	   the	  autophagic	  process	  has	  a	   role	   in	   the	  
blastogenic	  cycle	  of	  B.	  schlosseri,	  showing	  that	  the	  ambra1	  gene,	  coding	  for	  a	  key	  autophagic	  
factor,	  is	  expressed	  in	  different	  phases	  of	  the	  cycle,	  and	  that	  typical	  autophagosomes	  can	  be	  
recognized.	  	  
In	   recent	   years,	   B.	   schlosseri	   has	   become	   an	   emergent	   model	   to	   study	   dynamics	   of	  
development	  and	  homeostasis	  [13,	  34,	  35].	  The	  specificity	  of	  its	  asexual	  reproduction,	  based	  
on	   cyclical	   changes	   of	   generation,	   rendered	   this	   animal	   particularly	   suitable	   to	   study	  
apoptosis	  and	   its	   regulation	  [18,	  36].	   It	  has	  been	  shown	  that	   the	  survival	  of	  animal	   tissues	  
and	  organs	  is	  controlled	  through	  both	  activation	  and	  suppression	  of	  programmed	  cell	  death	  
at	   takeover:	   apoptosis	   is	   crucial	   to	   ensure	   macromolecular	   recycling	   and	   engineer	   the	  
reconstitution	   of	   a	   functional	   asexual	   generation	   every	   week	   [37,	   36].	   In	   the	   light	   of	   the	  
complex	   relationships	   between	   autophagy	   and	   apoptosis	   [10,	   38],	   our	   data	   allow	  
considerations	  on	   the	   role	  of	   these	  cellular	  processes	   in	   the	  homeostasis	  of	   the	  organism.	  
Moreover,	   taking	   into	   account	   that	   tunicates	   are	   believed	   the	   sister	   group	   of	   vertebrates	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[39],	  our	  data	  open	  to	  new	  evolutionary	  considerations	  on	  the	  role	  and	  the	  control	  of	   the	  
autophagic	  mechanism	  in	  chordates.	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Supplemental	   Figure	   1.	   Schematic	   representation	   of	   the	   cloning	   strategy	   for	   the	   sequencing	   of	  B.	   schlosseri	  
ambra1	  cDNAs.	  The	  thick	  black	  horizontal	  line	  represents	  the	  cDNA	  coding	  sequence	  for	  ambra1	  whereas	  the	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This	   study	  describes	   the	   identification	  and	  characterization	  of	   two	  paralogous	  ambra1	  
genes	   in	   the	   zebrafish,	   their	   roles	   during	   early	   embryogenesis	   and	   muscle	   development.	  
Ambra1a	   and	   ambra1b	   arose	   as	   part	   of	   the	   fish-­‐specific	   whole-­‐genome	   duplication	   that	  
occurred	   after	   the	  divergence	  of	   the	   fish	   and	   tetrapod	   lineages.	   These	   two	   genes	   share	   a	  
similar	  genomic	  organization	  with	  mammalian	  ambra1.	  Expression	  analysis	   shows	   that	   the	  
paralogous	   gene	   ambra1a	   is	   spliced	   in	   four	   alternative	   transcripts,	   whereas	   only	   one	  
ambra1b	   transcript	   has	   been	   identified.	   The	   finding	   of	   alternatively	   spliced	   transcript	  
variants	   in	  zebrafish	  suggests	  that	  some	  specific	  Ambra1	  functions	  may	  depend	  on	  distinct	  
protein	   isoforms	  able	   to	   interact	  with	  other	  proteins	   in	  different	  ways	  with	   respect	   to	   the	  
complete	   isoform.	   This	   assumption	   found	   support	   in	   a	   recently	   published	   paper	   that	  
describes	   the	   occurrence	   of	   Atg16L1	   splice	   variants	   playing	   different	   functions	   in	   the	  
autophagic	  process	  [1].	  	  
Interestingly,	   alternatively	   spliced	   transcripts	   for	  Ambra1	   seem	   to	   be	   common	   also	   in	  
mammals,	  as	  revealed	  by	  bioinformatics	  analysis	  of	  databases	  containing	  human	  and	  murine	  
cDNA	  sequences.	  One	  remarkable	  and	  very	  peculiar	  splicing	  variant,	   identified	  on	  zebrafish	  
but	   likely	  present	  also	   in	  human	  and	  mouse,	   is	  represented	  by	  a	  truncated	   isoform	  lacking	  
the	   carboxyl-­‐terminal	   region	   and	   thus	   the	   crucial	   binding	   site	   to	   DLC1.	   Physiological	  
significance	   of	   these	   different	   alternative	   forms	   is,	   for	   the	   moment,	   unknown.	   	   A	   new	  
potential	   goal	   in	   the	   Ambra1	   research	   field	   could	   be	   the	   detailed	   characterization	   of	   the	  
tissue-­‐specific	   expression	   of	   the	   different	   protein	   isoforms	   and	   their	   specific	   binding	  
capabilities,	   to	  get	  knowledge	  on	  their	   functions	   in	  different	  physiological	  and	  pathological	  
processes.	   In	   order	   to	   do	   this,	   zebrafish	   represents	   a	   good	  model	   organism,	   also	   for	   the	  
presence	  of	   two	  paralogous	   genes	   in	  which	   the	  multiple	   roles	   of	   the	  mammalian	  Ambra1	  
orthologous	  seem	  to	  have	  been	  partitioned.	  	  
At	   the	   molecular	   level,	   also	   in	   zebrafish,	   the	   down-­‐regulation	   of	   Ambra1	   expression	  
leads	   to	   impairment	   of	   the	   autophagy	   process	   associated	   with	   hyperproliferation	   and	  
increased	   cell	   death,	   confirming	   the	   crucial	   role	   of	   Ambra1,	   previously	   demonstrated	   in	  
mouse,	   in	   the	   crosstalk	   among	   these	   processes	   during	   embryogenesis.	   The	   functional	   link	  
between	   proliferation,	   apoptosis	   and	   autophagy	   suggests	   that	   these	   processes	   are	  
coordinately	   regulated	   in	   early	   development	   in	   order	   to	   limit	   uncontrolled	   cell	   demise	  
and/or	   cell	   growth	   during	   the	   profound	   remodelling	   occurring	   in	   the	   course	   of	  
organogenesis.	  	  
	  
Only	   few	   aspects	   of	   the	   involvement	   of	   these	   proteins	   in	   zebrafish	   development	   has	  
been,	   up	   to	   now,	   analysed	   more	   deeply,	   starting	   with	   their	   functions	   during	   muscle	  
development.	  Data	  obtained	  from	  ambra1a	  and	  ambra1b	  zebrafish	  morphant	  embryos	  and	  
from	  Ambra1gt/gt	  mouse	  embryos	  indicate	  that	  this	  autophagy	  related-­‐protein	  plays	  a	  critical	  
function	   during	   skeletal	   muscle	   development	   in	   agreement	   with	   other	   recent	   studies	  
indicating	   that	   autophagy	   plays	   a	   key	   role	   in	   skeletal	   muscles.	   While	   the	   presence	   of	  
abnormal	  organelles	  is	  likely	  associated	  to	  the	  well-­‐known	  role	  of	  Ambra1	  in	  the	  first	  steps	  
of	   the	   autophagic	   process,	   the	   altered	   morphology	   and	   the	   hyper-­‐cellularity	   of	   the	  




will	   be	   necessary	   to	   fully	   elucidate	   the	   functional	   role	   of	   Ambra1	   in	   the	   developing	   and	  
postnatal	   skeletal	   muscles,	   in	   order	   to	   understand	   the	   role	   of	   this	   protein	   in	   muscle	  
homeostasis	  and	   identify	  possible	  human	  muscle	  pathologies	   linked	   to	  Ambra1	  mutations.	  
Moreover,	  Ambra1	  morphants	  defects	  are	  not	  limited	  to	  the	  skeletal	  muscle	  but	  involve	  also	  
the	   cardiac	   muscle	   as	   morphants	   embryos	   exhibit	   a	   small	   string	   like	   heart	   with	   severe	  
pericardial	  edema,	  likely	  due	  to	  developmental	  heart	  malformation	  (work	  in	  process).	  
Another	   aspect	   that	   requires	   further	   analyses	   is	   the	   involvement	   of	   Ambra1	   in	   head	  
cartilages	   formation	   as	   these	   structures	   resulted	   strongly	   altered	   after	   morpholinos	  
knockdown	  of	  ambra1a	  and	  ambra1b	  expression	  (data	  not	  shown).	  According	  to	  they	  origin	  
from	   neural	   crest	   cells,	   in	   situ	   hybridization	   analyses	   with	   markers	   specific	   show	  
modifications	  in	  their	  migration	  and	  expression	  pattern	  (work	  in	  process).	  	  	  
Collectively,	  our	  findings	  confirm	  an	  important	  developmental	  role	  for	  Ambra1	  in	  early	  
vertebrate	  embryogenesis.	  	  
In	  this	  study,	  we	  also	  report	  the	  identification,	  through	  genome	  bioinformatic	  searches	  
and	   targeted	   cloning,	  of	   the	   first	   complete	  ambra1	   transcript	   in	   a	  non-­‐vertebrate	   species,	  
the	  tunicate	  B.	  schlosseri.	  ambra1	  expression	  was	  demonstrated	  by	  RT-­‐PCR	  analysis	  whereas	  
autophagosomes	  were	  visualised	  by	  electron	  microscopy	  in	  a	  degenerating	  cell	  phagocyted	  
by	  a	  circulating	  macrophage.	  This	  fact	  highlights	  the	  interesting	  link	  between	  autophagy	  and	  
apoptosis,	   and	  allows	  us	   to	  hypothesize	   that	   autophagy,	   in	   this	   species,	   play	   a	   role	   in	   the	  
crosstalk	   between	   bud	   and	   parent,	   optimizing	   the	   colony	   survival.	   Moreover,	   taking	   into	  
account	   that	   tunicates	  are	  believed	   the	  sister	  group	  of	  vertebrates,	  our	  data	  open	   to	  new	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   leads	   to	   defects	   in	   skeletal	   muscle	   development	   and	  
organization”.	  8th	  European	  Zebrafish	  Meeting;	  9-­‐	  13	  July	  2013,	  Barcelona,	  Spain.	  
	  
• F.	   Benato,	   T.	   Skobo,	   E.	   Colleti,	   E.	  Moro,	   F.	   Argenton,	   L.	   Dalla	   Valle.	   “Generation	   of	   a	  
transegenic	  zebrafish	  line	  for	  studying	  the	  GRE	  mediated	  glucocorticoid	  activity	  in	  vivo”.	  
8th	  European	  Zebrafish	  Meeting;	  9-­‐	  13	  July	  2013,	  Barcelona,	  Spain	  
	  
• Miccoli,	  G.	  Gioacchini,	   F.	  Maradonna,	  F.	  Benato,	  T.	   Skobo,	   L.	  Dalla	  Valle,	  O.	  Carnevali.	  
“Parental	  microbial	   changes	  affect	  eggs	  quality	  by	   the	  modulation	  of	  maternal	   factors	  
involved	   in	   autophagic	   and	   apoptotic	   process	   during	   Danio	   rerio	   development”.	   17th	  
International	   Congress	   of	   Comparative	   Endocrinology,	   ICCE	   2013;	   15-­‐	   19	   July	   2013,	  
Barcelona,	  Spain.	  
	  
• Miccoli,	  G.	  Gioacchini,	   F.	  Maradonna,	  F.	  Benato,	  T.	   Skobo,	   L.	  Dalla	  Valle,	  O.	  Carnevali.	  
“Parental	  microbial	   changes	  affect	  eggs	  quality	  by	   the	  modulation	  of	  maternal	   factors	  
involved	   in	   autophagic	   and	   apoptotic	   process	   during	   Danio	   rerio	   development”.	   4th	  
International	  Workshop	  on	  Biology	  of	  Fish	  Gametes;	  17-­‐	  20	  September	  2013,	  Albufeira 
–Faro,	  Portugal.	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• FEBS	  Advanced	  Lecture	  Course;	  Spetses	  Summer	  School,	  Nuclear	  Receptor	  Signalling	  in	  
Physiology	  and	  Disease;	  August	  28-­‐	  September	  2,	  2011,	  Island	  of	  Spetses,	  Greece.	  
	  
• Programma	  Summer	  School;	  Scuole	  di	  Dottorato	  di	  Ricerca	  dell’Area	  Medica-­‐	  ciclo	  26,	  
26-­‐30	  September	  2011,	  Padova,	  Italy.	  
	  
• Advanced	  Lecture	  Course;	  l	  Logics	  in	  developmental	  biology;	  March	  2012,	  Padova,	  Italy.	  
	  
• The	   NUS/TLL/NIBB	   workshop	   “Genetics,	   genomics	   and	   imaging	   in	   zebrafish	   and	  
medaka”	  22-­‐31	  July	  2012,	  Singapore,	  Singapore.	  
	  
• Advanced	  Lecture	  Course;	  Paradigm	  of	  Cell	  Fate	  Specification;	  November	  2013,	  Padova,	  
Italy.	  	  
